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Abstract 
 
The role of skeletal muscle PLIN proteins at rest  
and following lipolytic stimulation 
 
Rebecca EK MacPherson       Advisor: 
Brock University, 2013          Dr. S.J. Peters 
 
 
 This thesis investigated the subcellular location of skeletal muscle PLIN 
proteins (PLIN2, PLIN3, and PLIN5) as well as protein interactions with ATGL 
and HSL at rest and following lipolytic stimulation. In addition, the serine 
phosphorylation state of PLIN2, PLIN3, and PLIN5 was determined at rest and 
following lipolytic stimulation. 
 An isolated whole muscle technique was used to study the effects of 
contraction and epinephrine-induced lipolysis.   This method allowed for the 
examination of the effects of contraction and epinephrine alone and in 
combination.  Further, the soleus was chosen for investigating the role of PLIN 
proteins in skeletal muscle lipolysis due to its suitability for isolated incubation, 
and the fact that it is primarily oxidative in nature (~80% type I fibres).  It has 
also been previously shown to have the greatest reliance on lipid metabolism 
and for this reason is ideal for investigating the role of PLIN proteins in lipolysis. 
 Immunofluorescence microscopy revealed that skeletal muscle lipid 
droplets are partially co-localized to both PLIN2 and PLIN5 and that contraction 
does not affect the amount of colocalization, indicating that PLIN5 is not 
recruited to lipid droplets with contraction (PLIN2 ~65%; PLIN5 ~56%).  
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Results from the immunoprecipitation studies revealed that with lipolysis in 
skeletal muscle the interaction between ATGL and CGI-58 is increased (study 2: 
128% with contraction, p<0.05; study 3: 50% with contraction, 25% 
epinephrine, 80% contraction + epinephrine, p>0.05).  Further PLIN2, PLIN3, 
and PLIN5 all interact with ATGL and HSL, while only PLIN3 and PLIN5 interact 
with CGI-58.  Among these interactions, the association between PLIN2 and 
ATGL decreases with lipolytic stimulation (study 2: 21% with contraction, 
p<0.05).  Finally our results demonstrate that PLIN3 and PLIN5 are serine 
phosphorylated at rest and that the level of phosphorylation remains unchanged 
in the face of either contractile or adrenergic stimulation. 
 In summary, the regulation of skeletal muscle lipolysis is a complex 
process involving multiple proteins and enzymes. The skeletal muscle PLIN 
proteins likely play a role in skeletal muscle lipid droplet dynamics, and the data 
from this thesis indicate that these proteins may work together in regulating 
lipolysis by interaction with both ATGL and HSL.   
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Chapter 1 
 
 
Introduction 
 2 
 
The discovery of a family of lipid droplet proteins known as the perilipin 
(PLIN) family has lead to a resurgence in research in the area of lipid metabolism. 
Due to the structural location of PLIN proteins on lipid droplets, they have gained 
increasing attention in the past decade with regard to potential roles in lipogenesis 
and lipolysis.  The PLIN family of proteins consists of five members, all of which 
have a unique tissue distribution and likely a unique function in lipid droplet 
dynamics.  Specifically in adipose tissue, PLIN1 plays a key role in regulating basal 
and stimulated lipolysis by directly controlling the activity and access of lipases at 
the lipid droplet surface.  However, PLIN1 is not expressed in skeletal muscle and 
the roles of the PLIN proteins that are expressed in this tissue (PLIN2, PLIN3, and 
PLIN5) remain unknown.  
In skeletal muscle triglycerides are stored inside dynamic organelles known 
as lipid droplets.  It is on the surface of these lipid droplets that the PLIN proteins 
are thought to play a role in regulating both storage and use of intramuscular 
triglycerides (IMTG).  In times of increased energy demand, such as exercise, fatty 
acids released from triglycerides stored in lipid droplets can provide a significant 
amount of energy.  
Our understanding of the regulation of triglyceride lipolysis in skeletal 
muscle is continuously growing, and the exact mechanisms that regulate skeletal 
muscle lipolysis remain largely unknown.   While research investigating the 
regulation of hormone sensitive lipase (HSL) in skeletal muscle is abundant, there 
are few papers investigating the regulation of the recently discovered rate limiting 
lipase, ATGL.  Further, given the large role that PLIN1 plays in regulating adipose 
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tissue lipolysis by interacting with the lipases, it seems likely that the skeletal 
muscle PLIN proteins play a similar role in exercise induced lipolysis. 
 This thesis examines the effects that skeletal muscle lipolysis has on PLIN2, 
PLIN3, and PLIN5.  Specifically, this thesis examines subcellular location, protein 
interactions with lipases, as well as serine phosphorylation status at rest and 
following lipolysis. 
 4 
Chapter 2  
 
 
Literature Review 
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Overview of Skeletal Muscle Lipolysis  
 
Intramuscular triglycerides (IMTGs) represent an important energy source 
that can be mobilized during exercise. While research investigating the use of IMTGs 
during exercise began in 1958 (30, 39, 47, 52) a complete understanding of the 
mechanisms regulating this process remain largely unknown. It is now known that 
IMTGs are stored in metabolically active organelles, known as lipid droplets. These 
lipid droplets are encased by a phospholipid monolayer coated with a number of 
different proteins.  Growing evidence indicates that skeletal muscle lipolysis is 
regulated at the surface of these triglyceride storing lipid droplets by protein-
protein interactions (16, 99, 116, 122). However, the exact mechanisms regulating 
the protein interactions are relatively unknown in skeletal muscle. 
Recently, a family of lipid droplet associated proteins, known as the PLIN 
family of proteins, have gained increasingly more attention with regards to a role in 
lipid droplet dynamics and metabolism, specifically to a role in regulating lipolysis. 
Our understanding of PLIN proteins in skeletal muscle is limited, however studies in 
other tissues and in cell culture indicate that PLIN proteins are key regulators of 
lipid metabolism as they appear to be directly involved with how cells and tissues 
store, mobilize, and utilize fatty acids (22, 27, 43, 97, 100, 146). PLIN1 is the only 
member of this family for which a specific role in regulating lipolysis through 
interactions with the lipases has been identified, however this member is only 
expressed in adipose tissue and a similar role for the skeletal muscle PLINs has not 
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been determined.  In general, mobilization of fatty acids from triglycerides stored in 
lipid droplets is mediated by three lipases: 1) adipose triglyceride lipase (ATGL); 2) 
hormone sensitive lipase (HSL); and 3) monoglyceride lipase (MGL). These lipases 
work in a sequential fashion, where ATGL releases the first fatty acid from the 
triglyceride (TG) leaving a diglyceride (DG) (180, 187). HSL acts predominantly on 
diglycerides but can also hydrolyze triglycerides, monoglycerides (MG), and 
cholesterol esters. Finally, MGL completes the hydrolysis by releasing the last fatty 
acid and a glycerol backbone (Figure 1). In adipose tissue, PLIN1 directly controls 
the activity of the rate limiting lipase, ATGL, as well as the access of HSL to the lipid 
droplet at rest and with adrenergic stimulation.  
To date a similar role for the remaining PLIN proteins expressed in skeletal 
muscle has not been identified, therefore the focus of this thesis is the skeletal 
muscle PLIN proteins and their potential role in skeletal muscle lipolysis.  
 
 7 
TG 
DG 
MG 
FA 
FA 
FA 
Glycerol 
 
Figure 1. 
Sequential hydrolysis of TG by ATGL, HSL, and MGL, resulting in the release of three 
fatty acids and a glycerol backbone (TG=triglyceride; DG=diglyceride, 
MG=monoglyceride; ATGL= adipose triglyceride lipase; HSL= hormone sensitive 
lipase; MGL monoglyceride lipase). 
  
Lipid droplets  
 
Structure and function 
 
Although adipose tissue is the predominant site for triglyceride storage, 
nearly all cell types possess the capacity to store fatty acids as triglycerides in 
intracellular lipid droplets. Lipid droplets were initially considered inert storage 
depots for intracellular fats, and consequently little was known about the exact 
regulation of lipid droplet formation, growth, or degradation. Today, lipid droplets 
are recognized as highly dynamic organelles that play critical roles in lipid 
 8 
metabolism, cell signaling, vesicle trafficking, and energy homeostasis (13). Due to 
these dynamic roles, lipid droplets are continuously being synthesized and 
degraded as they traffic within the cell to interact with other organelles such as the 
endoplasmic reticulum (site of triglyceride synthesis) and the mitochondria (site of 
fatty acid oxidation) (127) [reviewed in (13, 155, 162)] (Figure 2a).   
Lipid droplets have a unique structure, as they are the only cellular organelle 
to be surrounded by a single phospholipid monolayer and not a bilayer. This 
monolayer encases a hydrophobic core consisting of neutral lipids (triglycerides, 
diglycerides, monoglycerides, cholesterol esters, and free cholesterol) (11, 114, 116, 
149) (Figure 2b).  Lipid droplets are formed as small (0.2 μm diameter) spherical 
structures (103), and can vary in size (1-200 μm) as well as in function depending 
on the tissue and the cellular condition (116).  For example, in adipocytes one large 
lipid droplet can occupy up to 90% of the total cell volume (54), whereas skeletal 
muscle contains several small lipid droplets located in close proximity to 
mitochondria and sarcoplasmic reticulum (33, 127, 148). In skeletal muscle, 
transmission electron microscopy (TEM) images show that lipid droplets occupy the 
gaps between adjacent mitochondria in the A band region on both sides of the 
sarcomere (Figure 2c). It has been hypothesized that the close proximity of lipid 
droplets to mitochondria has a functional role that allows for the fatty acids released 
from the droplet to be oxidized efficiently during exercise (148). 
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Figure 2 
A: Electron micrograph showing a lipid droplet in a cultured hepatoma cell.  The 
phospholipid monolayer surrounding the lipid droplet is visible, as are close 
associations with mitochondria and ER membranes (Adapted from Walter and RV 
Farese 2009). B: Structural features of a lipid droplet.  Showing lipid droplet 
phospholipid monolayer surrounding neutral lipid core containing triglycerides and 
cholesterol esters.  The surface of the lipid droplet is coated with a variety of 
proteins (ATGL: adipose triglyceride lipase; DGAT: diglyceride acyltransferase, Rab:, 
PLINs: perilipins, etc). C: Transmission electron micrograph (TEM) of human 
skeletal muscle. Image from a type IIX or IIA fiber (note the thin Z-line), with light 
arrow, indicating an intramyocellular lipid droplet and dark arrows, indicating 
mitochondrial fragments in cross section, notice close proximity of each organelle 
(Adapted from Tarnopolsky et al. 2007). 
 
 
In times of excess fatty acid delivery to the tissue, lipid droplets will increase 
in volume and number in order to store the energy for a later time or to be used as 
precursors for membrane or hormone synthesis (95, 183).  This protects cells from 
lipotoxicity and is essential for survival in cases where food is not always in 
abundance.  Conversely, at times of increased energy needs (such as during 
exercise), the cell can mobilize the stored lipids to produce energy (21, 43, 182).  
What is currently known about the processes of lipid droplet synthesis and growth 
as well as degradation will be covered in the following sections. 
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Lipid Droplet Proteome 
 
Studies of the lipid droplet proteome have found more than 300 different 
proteins on the surface of the droplet (168, 184), yet little is known about the 
function of any of these proteins.  A few of these proteins are known to be involved 
in triglyceride synthesis (diacylglycerol acyl transferase; DGAT2) and breakdown 
(ATGL), vesicle trafficking (Rab proteins), intracellular signaling, and lipid droplet 
fusion and fission events (SNAREs) (16, 99, 65, 117). But the majority of the protein 
functions remain to be determined.  The lipid droplet protein coat is highly 
heterogeneous depending on the subcellular location and the tissue that it is found 
in, therefore it has been hypothesized that lipid droplet function is mediated by the 
proteins coating the phospholipid monolayer. Among the many proteins found on 
lipid droplets the perilipin or PLIN family of proteins (formerly known as PAT 
proteins) have emerged as essential in regulating lipid droplet hydrolysis (14), 
however information on the role of PLIN proteins in skeletal muscle is still limited.  
 
Lipid droplet synthesis 
 
The exact mechanism of lipid droplet formation is not fully understood, 
particularly for skeletal muscle; consequently information must be extrapolated 
from in vitro cell studies or other tissues. The current model of lipid droplet 
formation suggests that lipid droplets originate from the endoplasmic reticulum 
(16). It is hypothesized that once synthesized, neutral lipids accumulated between 
the lipid bilayer of the endoplasmic reticulum.  In support of this theory, the 
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endoplasmic reticulum contains many of the enzymes that are involved in the 
synthesis of triglycerides (DGAT) and cholesterol esters (acyl coenzyme 
A:cholesterol acyltransferase, ACAT) (28, 49). Eventually a lipid lens is formed in the 
lipid bilayer of the endoplasmic reticulum which then buds completely off of the 
endoplasmic reticulum forming a lipid droplet (reviewed by (13, 26, 43, 155)) 
(Figure 3).  
These newly formed small lipid droplets can continue to grow either by local 
synthesis of neutral lipids or by fusing with other droplets.  The protein catalyzing 
the final step in triglyceride synthesis (DGAT2) is found on lipid droplets, suggesting 
that triglycerides can also be made on the droplet surface (86, 138).  However, once 
it is formed, it is not clear how the newly synthesized neutral lipids are delivered to 
the core of a growing lipid droplet. Lipid droplets can also increase in size by fusing 
with other lipid droplets. Again the mechanisms remain largely unknown however it 
is known that the proteins that mediate vesicle fusion (SNAREs) are found on the 
lipid droplet surface (20).  
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Figure 3 
Model of lipid droplet formation and expansion. For formation, the lipid droplet 
buds and detaches from the endoplasmic reticulum. The neutral lipid synthesis 
enzymes, ACAT or DGAT, catalyze the formation of lipids that fill the core. For lipid 
droplet expansion, the models of local synthesis of triacylglycerol at the lipid droplet 
and of lipid droplet fusion are shown. (DAG=diacylglycerol; FA-CoA=fatty acyl-
coenzyme A; SE=sterol ester; PC=phosphatidylcholine; DGAT=diacylglycerol acyl 
transferase; ACAT=acyl coenzyme A:cholesterol acyltransferase) (Adapted from 
Walther et al 2012). 
 
The PLIN family of proteins  
 
The PLIN family includes PLIN1 (perilipin), PLIN2 (adipocyte differentiation-
related protein, ADRP), PLIN3 (tail interacting protein 47, TIP47), PLIN4 (S3-12), 
and PLIN5 (lipid storage droplet protein 5, LSDP5, also known as myocardial lipid 
droplet protein, MLDP, or OXPAT) (21, 82).  In general the members of the PLIN 
family are characterized as being localized to lipid droplets, and having a similarity 
to either PLIN1 or PLIN2 at either the amino- or the carboxy-terminal of the protein 
(21).  With the exception of PLIN4, the PLIN proteins share a 100 amino acid 
sequence at the amino-terminal known as the PAT1 domain, and have weaker 
 13 
homology in the central region (21, 101, 111). The function of this well conserved 
PAT domain has not yet been identified. The middle portion of PLIN1 contains three 
sequences of hydrophobic amino acids that are required to direct and anchor the 
protein into the lipid droplet (59, 140).  Of the five proteins PLIN1 is, thus far, the 
only one for which six protein kinase A (PKA) phosphorylation sites have been 
identified (21, 101).  PLIN2 and PLIN4 are expressed in the majority of cells and 
share a high identity (43%) between amino acid sequences (21). PLIN5 is similar to 
PLIN2 and PLIN3 (55% and 51% homology over the entire protein), with highest 
homology at the PAT1 domain (36, 125).  PLIN2, 3, 4, and 5 all share a hydrophobic 
cleft at the carboxy-terminal that is thought to position these proteins at the surface 
of lipid droplets to optimally serve their function (21) (Figure 4).  
 
 
Figure 4 
Schematic diagram of the structural features of PLIN family proteins (mouse 
sequences are depicted); greater intensity of color represents higher similarity of 
the sequences between family members. (Adapted from Brasaemle et al. 2007).  
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Transcriptionally, four of the five PLIN proteins are regulated by members of 
the peroxisomal proliferator-activated receptors (PPARs). The PPAR family consists 
of three isoforms: PPARα, PPAR ß/δ, and PPARγ, each having a different tissue 
distribution. PPARγ is highly expressed in white adipose tissue and macrophages, 
PPARα is expressed in the liver, muscle, and kidney, and PPAR ß/δ is more 
ubiquitously expressed (reviewed in (3)). PPARγ regulates PLIN1 (8), PLIN4(36), 
and PLIN5 (171) and PPARα regulates PLIN2 (37, 45, 147) and PLIN5 (176), 
whereas PLIN3 expression does not appear to be regulated by PPARs. Interestingly, 
it has recently been shown that PLIN3 mRNA is upregulated by high glucose and 
insulin concentrations (48). 
Each PLIN family member has a unique tissue distribution and therefore 
likely a unique role and function in regulating lipid droplet dynamics (171) (Figure 
5). Further, within tissues, lipid droplets have a heterogeneous coat of PLIN proteins 
indicating specific roles for these proteins depending on the size or location of the 
droplet. In fact, in cultured adipocytes (170) and hepatocytes (12), PLIN3 and PLIN4 
are generally associated with smaller nascent lipid droplets, whereas increased 
association of PLIN1 and PLIN2 is observed as the droplets mature, suggesting that 
there are differential roles for these proteins during the different stages of a lipid 
droplet development. The following sections will discuss the role of PLIN1 in 
regulating basal and stimulated lipolysis in adipocytes as well as speculate on the 
potential roles of the remaining PLIN proteins in regulating skeletal muscle lipolysis. 
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Figure 5 
PLIN family protein expression in 3T3-L1 adipocytes and mouse tissues.  PLIN5 is 
expressed in tissues with high oxidative capacity. PLIN1 is only expressed in adipose 
tissue (adapted from Wolins et al. 2006). 
 
 
PLIN1 
 
PLIN1 or perilipin was the first of the PLIN family to be identified, and the 
only member for which a specific role in regulating lipolysis has been determined. 
PLIN1 is located on lipid droplets, and is only expressed in adipocytes and 
steroidogenic cells (98). There are three PLIN1 splice variants: 1A, 1B and 1C; 
however PLIN1A is the most abundant and by far the most studied of the three (99, 
101). The past two decades of research has determined a specific role for PLIN1A in 
the turnover of adipocyte triglycerides and will be the focus of the following section. 
PLIN1 was initially identified as a protein phosphorylated by PKA in 
lipolytically stimulated adipocytes (65).  It wasn’t until a decade later that the role of 
PLIN1 in regulating adipocyte lipolysis came into light.  Overexpression of PLIN1 in 
3T3-L1 pre-adipocytes resulted in a dramatic reduction in lipolytic activity and a 
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significant increase in stored triglycerides, suggesting that PLIN1 limited the access 
of lipases to lipid droplets thus protecting the triglyceride core (25).  This role for 
PLIN1 was further confirmed in PLIN1 knockout mice that demonstrated a 
substantial increase in basal lipolysis, a 75% reduction in adipose tissue mass, and a 
resistance to diet-induced obesity. Further, these mice did not respond to beta-
adrenergic stimulation of lipolysis, and cells derived from these mice failed to show 
translocation of HSL to the lipid droplet (105, 145).  It was later determined that 
PLIN1 restrains basal lipolysis and facilitates hormone-stimulated lipolysis (25, 57, 
62, 65, 113).  This facilitation of lipolysis by PLIN1 under stimulated conditions is 
controlled by the phosphorylation of its six PKA sites in response to PKA activation 
(25, 57, 62, 65, 113).   
The currently understood role of PLIN1 in regulating adipose tissue lipolysis 
will be discussed in terms of a basal state and a stimulated state (Figure 6).  The 
basal state in adipocytes and adipose tissue refers to a resting state where 
circulating catecholamines (epinephrine and norepinephrine) are low. Under basal 
conditions, PLIN1 is found on the lipid droplet surface preventing the full activation 
of ATGL and the access of HSL to the lipid core (21, 145). HSL is in the cytosol and 
cannot access the PLIN1-coated lipid droplets and therefore its substrates stored in 
the core (21, 24, 143).  ATGL is found both in the cytosol and on the surface of lipid 
droplets. The ATGL that is associated with lipid droplets during the basal state is 
thought to be responsible for a low level of triglyceride hydrolysis (102, 180). 
Comparative gene identification-58 (CGI-58), a potent co-activator of ATGL (92), is 
bound to the carboxyl-terminus of PLIN1, thus limiting the availability of CGI-58 to 
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interact with ATGL (62, 141, 178).  As a result of these conditions there is low 
lipolytic activity; triglycerides are hydrolyzed to diglycerides and most of the 
released fatty acids are re-esterified (for review (88)).  Due to this continuous 
recycling, triglyceride levels remain relatively constant. 
The stimulated state refers to times of energy demand such as exercise and 
fasting where stored fats are mobilized and used to produce energy in peripheral 
tissues. Lipolysis in adipose tissue is initiated by catecholamines (epinephrine and 
norepinephrine) binding to β-adrenergic receptors on the plasma membranes (31, 
150). This stimulates a Gs-protein-mediated signaling cascade activating adenylate 
cyclase, which converts ATP to cyclic AMP (cAMP), increasing intracellular cAMP 
levels (136, 150). The increased cAMP levels then activate PKA, which can then 
phosphorylate both PLIN1 (65, 185) and HSL (7, 143, 146, 157) 
Phosphorylation of PLIN1 leads to the activation of ATGL as well as allows 
access of both ATGL and HSL to the lipid droplet. Therefore PLIN1 phosphorylation 
is essential in assembling the required machinery on lipid droplets in a 
phosphorylation dependent manner (21, 145). PLIN1 contains six PKA 
phosphorylation sites (Ser81, Ser222, Ser276, Ser433, Ser492, and Ser517 in the 
murine sequence) (65, 185) (Figure 4). In order for HSL to interact with PLIN1, both 
proteins must be phosphorylated by PKA (139, 143, 157).  Mutagenesis studies of 
the six PKA sites of PLIN1 have found that the three N-terminal PKA sites (serine 81, 
222, 276) are critical for HSL catalyzed lipolysis (134, 144, 185). All three of these 
sites must be phosphorylated for HSL to bind to PLIN1 (157).  Once phosphorylated, 
PLIN1 changes its conformation from basal conditions, providing a docking site for 
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phosphorylated HSL on lipid droplets (21) (139).   Once HSL is phosphorylated, it 
translocates to the lipid droplet surface where it binds to phosphorylated PLIN1, 
gaining access to substrate lipids within the droplet (21, 24, 143, 157).   
PLIN1 contains three additional C-terminal PKA sites (Ser433, Ser492, and 
Ser517) (66). A definitive function for each of these sites has yet to be determined, 
but serine 517 is known of as the “master regulator” of PKA stimulated lipolysis 
(112). Overexpression of PLIN1 with an alanine substitution of serine 517 
eliminated 95% of PKA-stimulated release of fatty acids and glycerol relative to 
control cells. When ATGL was present, phosphorylation of the serine 517 site 
contributed to the control of lipolysis catalyzed by ATGL with CGI-58. These findings 
suggest that phosphorylation of serine 517 is somehow required in ATGL-mediated 
lipolysis (66, 112, 185). It is now known that with phosphorylation, PLIN1 releases 
CGI-58 allowing it to interact with ATGL (62, 141, 178).  This interaction leads to a 
fully activated ATGL (62, 92, 141, 178, 186).  With stimulation, ATGL moves from 
the cytosol to the lipid droplet through a PLIN1-independent mechanism that is yet 
to be determined (180). It is unclear if ATGL binds to lipid droplets through 
interactions with CGI-58 or if it binds directly to the lipid droplet surface. One 
possibility is that a direct physical interaction between ATGL and CGI-58 is not 
actually necessary to increase the lipolytic activity of ATGL (102).  Gruber et al. (68) 
demonstrated that CGI-58 is able to bind directly to the phospholipid monolayer of 
lipid droplets and that without this there is a complete loss of the ability of CGI-58 to 
activate ATGL, regardless of their interaction.  In addition, a single mutation of the 
PKA site at serine 492 of PLIN1 caused ~30% inhibition of PKA-stimulated lipolysis, 
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indicating that the phosphorylation of serine 492 plays a role in the PKA-stimulated 
lipolysis, together with serine 517. The accessory role of serine 492 of PLIN1 in 
PKA-stimulated lipolysis may be due to its contribution to lipid droplet 
fragmentation and dispersion (104). Fragmentation of larger lipid droplets into 
smaller ones during lipolysis would be advantageous as it provides a larger surface 
area for lipases to work.  
With ATGL and HSL now on the surfaces of the lipid droplets, triglycerides 
(TG) are hydrolyzed to diglycerides via ATGL working in partnership with CGI-58. 
Diglycerides (DG) are hydrolyzed by HSL to monoglycerides (MG). The remaining 
MG is cleaved by monoglyceride lipase (MGL) to release the final fatty acid. In total, 
one molecule of TG is hydrolyzed to three molecules of fatty acid and one molecule 
of glycerol. Fatty acids and glycerol are exported from adipocytes for use by other 
tissues. Overall, PLIN1 is considered a scaffolding protein on the surface of lipid 
droplets that interacts with both HSL and the ATGL co-activator CGI-58, thus 
providing an essential role in regulating lipolysis in adipocytes under both basal and 
stimulated conditions. 
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Figure 6 
A. Basal lipolysis: PLIN1 on the lipid droplet is bound to CGI-58. ATGL is found both 
in the cytosol and on the lipid droplet and HSL is found in the cytosol. There is a low 
rate of lipolysis occurring in this situation. B. Stimulated lipolysis: Adrenergic 
stimulation by epinephrine and norepinephrine increases intracellular cAMP levels 
and activates PKA. PKA activation phosphorylates HSL and PLIN1 at six serine 
residues (denoted by P). Phosphorylation of PLIN1 releases CGI-58, which binds 
ATGL to initiate lipolysis. HSL translocates to the lipid droplet and binds to 
phosphorylated PLIN1. HSL then degrades DG. MG lipase cleaves the final FA to 
produce glycerol. (ATGL=adipose triglyceride lipase; HSL=hormone sensitive lipase; 
B=beta-adrenergic receptor; G= stimulatory G protein; AC=adenylate cyclase; 
TG=triglyceride; DG=diglyceride; MG=monoglyceride; FA=fatty acid; cAMP=cyclic 
AMP; PKA=protein kinase A). 
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PLIN2 
 
The second PLIN protein to be discovered was PLIN2 (adipophilin or ADRP). 
It was identified as a fatty acid binding protein implicated in adipocyte 
differentiation, and was found to have a striking homology with PLIN1 at the amino-
terminal end (78). PLIN2 coats the lipid droplet membrane and is stable in the 
presence of neutral lipids but is otherwise believed to be targeted for degradation 
by proteasomes (174, 175).  It is for this reason that PLIN2 has been considered a 
marker of lipid droplets.  PLIN2 is ubiquitously expressed (14, 23, 71, 78) and is one 
of the most predominant PLIN proteins in skeletal muscle (23, 71, 110, 120, 122, 
129-131). To date, PLIN2 has mainly been studied in fibroblasts, macrophages and 
the liver, with only a few studies in skeletal muscle (17, 38, 120, 129-131). 
Therefore it has been difficult to determine a role for PLIN2 in skeletal muscle.  
PLIN2 is thought of as a marker of lipid droplets, although in skeletal muscle 
information regarding PLIN2 distribution and its association with lipid droplets is 
limited and contradictory.   One study determined that PLIN2 is highly co-localized 
(80%) to the lipid droplet surface in isolated rat soleus fibres, making it an ideal 
marker of lipid droplets (122), while another study has found that this is not the 
case with only 64% of PLIN2 associated with lipid droplets in human vastus lateralis 
(129). A specific function for PLIN2 has yet to be identified, however it is considered 
to be involved in both lipid droplet biogenesis as well as regulation of lipolysis (32, 
76, 96, 123).   
The role of PLIN2 in neutral lipid storage has been established in a range of 
in vivo and in vitro studies  (6, 32, 55, 76). Originally, PLIN2 was identified as a 
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protein likely to be involved in lipid droplet synthesis because PLIN2 is expressed 
early during adipocyte differentiation and localizes to lipid droplet surfaces (23).  
Wolins et al. later observed that the addition of fatty acids to cultures of fully 
differentiated adipocytes drives PLIN2 onto the surfaces of both small and large 
lipid droplets (170). In most cell types and animal models, PLIN2 protein expression 
is increased with treatments that induce lipid droplet formation (6, 107, 175). These 
studies provide evidence for a role of PLIN2 in lipid droplet growth. Further, PLIN2 
overexpression was shown to be associated with increased fatty acid uptake (58). In 
studies where the expression of PLIN2 is increased there is also an increased 
triglyceride content.  This effect was seen in fibroblasts (76), HEK 293 cells (94), 
hepatic stellate cells (55), and COS-7 cells (58). Together, these studies suggest that 
PLIN2 has a role in both the development and growth of lipid droplets.  
Interestingly, PLIN2 interacts with DGAT2 (138), providing more evidence for a role 
in lipid droplet synthesis and growth.  
However, PLIN2 knockout mice indicate a role for PLIN2 in regulating lipid 
droplet stability and lipolysis.  Interestingly, knocking out PLIN2 does not result in 
any dramatic changes in phenotype or effects on adipocyte differentiation or 
lipolysis (32), however there is a major effect in the liver where there is a 
significantly reduced triglyceride content and lipid droplet number (12, 32). 
Furthermore, PLIN2 knockout mice were found to be resistant to diet-induced 
hepatosteatosis. In skeletal muscle knockdown of PLIN2 prevented oleate-induced 
IMTG accumulation and lipid droplet storage. In the absence of PLIN2, lipid droplet 
accumulation was restricted to a few lipid droplets per myotube (17). These 
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knockout mice provide evidence in support of PLIN2 somehow preventing high 
rates of lipolysis and also for a role of PLIN2 in lipid droplet synthesis.  In further 
studies using cells from PLIN2 knockout mice, PLIN3 was directed to the droplets 
replacing PLIN2 (142), and perhaps compensating for the loss. When PLIN3 function 
was also ablated, the ability to store neutral lipids as lipid droplets was deminished, 
and exogenously added fatty acids were directed to phospholipid biosynthesis 
(142). Together, these data indicate that the role of PLIN2 may be tissue specific and 
that PLIN2 is not only involved in lipid droplet synthesis but also in lipid droplet 
stability or basal lipolysis.  
In general, there is a high correlation between PLIN2 protein content and the 
amount of neutral lipid within a cell indicating that the relative expression of PLIN2 
may determine the capacity for intracellular triglyceride storage.  This is especially 
true in skeletal muscle.  For example, PLIN2 content is greater in type I fibres 
compared to type II fibres (129), it is higher in endurance trained athletes in 
comparison to sedentary controls (5, 110, 120, 128, 131), is higher in women 
compared to men (120), and is closely associated with triglyceride levels in skeletal 
muscle of Zucker diabetic fatty rats (110).  These are all cases in which IMTG 
content is higher suggesting that PLIN2 may either promote triglyceride synthesis 
or reduce lipolysis. With interventions that increase IMTG content, such as fatty acid 
loading of myotubes in culture or fasting and high fat diets in vivo, PLIN2 protein 
content increases (17). In human skeletal muscle, higher PLIN2 content has been 
found in muscle from insulin-resistant subjects that have undergone therapeutic 
weight loss or metformin treatment to increase muscle insulin sensitivity, 
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suggesting that it might play a role in decreasing intramuscular lipid toxicity by 
promoting either lipid synthesis or oxidation (121). At this point it is unclear 
whether PLIN2 increases the amount of lipid or whether lipid droplet formation 
stabilizes PLIN2 and increases protein expression. However, overexpression of 
PLIN2 in vitro and in vivo resulted in elevated neutral IMCL levels as well as 
increased expression profiles of genes involved in lipid synthesis (17), indicating 
that PLIN2 helps increase lipid storage.  
 Recent work in human skeletal muscle found that PLIN2-associated lipid 
droplets are preferentially depleted over those lipid droplets not associated with 
PLIN2, strongly supporting a role for PLIN2 in exercise induced lipolysis (130).  
It has been suggested that PLIN2 acts in a similar fashion to PLIN1 as a scaffold 
protein regulating stimulated lipolysis through interactions with lipolytic enzymes 
(12, 94, 96, 122, 129, 153). In agreement with this, CGI-58 has been identified as an 
interaction partner for PLIN2 (179).  Further, overexpression of PLIN2 in human 
embryonic kidney cells leads to a reduced association of ATGL at the lipid droplet 
and reduced lipolysis (96, 156). Examination of interactions between PLIN2, CGI-58, 
and ATGL has yet to be investigated in skeletal muscle. Thus far, it has been shown 
that in isolated soleus muscle, HSL translocates to PLIN2-coated lipid droplets with 
either β-adrenergic stimulation or electrically stimulated contraction (122), 
however a direct physical interaction between the two proteins was not 
determined.  Research into the role of PLIN2 in skeletal muscle lipolysis should 
focus on interactions with the lipases.  
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PLIN3 
 
PLIN3 (TIP47) was the third PLIN protein to be identified and is one of the 
least studied of this family of proteins. PLIN3 was initially described as a 
ubiquitously expressed cytosolic and endosomal 47-kDa protein involved in the 
intracellular transport of mannose-6-phosphate receptors between the trans-Golgi 
apparatus and endosomes (40, 85). However, in 2001, PLIN3 was reported to be 
present on lipid droplets in HeLa cells and has an amino acid sequence 43% similar 
to PLIN1 and PLIN2 (172). A functional role in skeletal muscle has not been 
confirmed, but studies in other cell types indicate that PLIN3 is involved in lipid 
synthesis (29).  
In response to lipid loading in both HeLa cells (human cell line derived from 
cervical cancer cells) and adipocytes, PLIN3 appeared to move from the cytosol and 
onto lipid droplets (170, 172). Thus, PLIN3 was the first PLIN family protein 
discovered that had the ability to translocate between the cytosol and the lipid 
droplet surface (170, 172). Upon lipid loading of cultured differentiated 3T3-L1 
adipocytes, PLIN3 localized to smaller nascent lipid droplets, providing evidence 
that PLIN3 might support the rapid formation of new lipid droplets (170).  Further, 
the homology of PLIN3 is similar to that of PLIN2 (117), and, as described earlier, 
PLIN3 compensates for the loss of PLIN2 in PLIN2 knockout mice (142). When 
PLIN3 function was also ablated in these cells, the ability to store neutral lipids as 
lipid droplets was diminished, and exogenously added fatty acids were directed to 
phospholipid biosynthesis (142). These findings define PLIN3 as playing an 
important role in the formation of new lipid droplets. 
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PLIN3 is expressed in skeletal muscle (120, 171), however few studies have 
investigated a role for PLIN3 in this tissue. In human skeletal muscle PLIN3 
expression is higher in women but does not increase with training (120). 
Interestingly, in a human study in which no differences were found regarding the 
protein expression of enzymes/proteins involved in triglyceride synthesis or 
lipolysis, the protein abundance of PLIN3 was lower in muscle of obese versus lean 
controls when expressed relative to IMTG content (93). The cellular localization of 
PLIN3 is not altered with contraction or epinephrine administration in isolated rat 
soleus fibres (122). PLIN3 was also shown to associate with mitochondria in 
NIH3T3 cells (fibroblasts) under conditions that induce oxidative stress and it is 
speculated that PLIN3 prevents cell death by maintaining mitochondrial membrane 
potential, although the mechanisms are not fully understood (73). It is possible that 
through interactions with skeletal muscle lipases, PLIN3 regulates the delivery of 
fatty acids to the mitochondria, thus preventing a lipid overload.   However, it is not 
presently known whether CGI-58 or ATGL bind to PLIN3 in skeletal muscle.  
 
PLIN4 
 
PLIN4 (S3-12) was identified in a screen for adipocyte-specific secretory or 
plasma membrane proteins (125). To date, only a small number of reports have 
investigated PLIN4 as a lipid droplet protein.  PLIN4 is ubiquitously expressed (14), 
however PLIN4 expression is low in heart and skeletal muscle, and is higher in 
white adipose tissue (125, 173). Little is known about PLIN4 function, but it does 
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appear to function in a manner similar to PLIN3, translocating to newly formed lipid 
droplets in response to fatty acid stimulation (173).  In 2003, Wolins et al. used 
immunofluorescence microscopy to show that PLIN4 localized to tiny lipid droplets 
in cultured 3T3-L1 adipocytes (142). When adipocytes were incubated with oleate 
over a time-course of four hours, PLIN4 localized to the smallest, newly formed lipid 
droplets (170). PLIN4 has not been defined as having a role in coordinating lipase 
interaction with lipid droplets. Due to the low expression of PLIN4 in skeletal 
muscle it will not be discussed in detail in this thesis.  
 
PLIN5 
 
In 2006, PLIN5 was identified and described by three independent groups 
within a year, and therefore received three different names: lipid droplet storage 
protein 5 (LSDP5), OXPAT, and myocardial lipid droplet protein (MLDP) (34, 171, 
176). This PLIN protein is mainly expressed in tissues with high rates of lipolysis 
and beta-oxidation such as muscle, heart, liver, and brown adipose tissue (8, 44, 47, 
110, 120, 129-131, 171). PLIN5 shares high homology with the other PLIN proteins 
(especially PLIN2), and is transcriptionally regulated by PPARα in muscle and liver, 
and by PPARγ in white adipose tissue (although expression is generally low in this 
tissue) (34, 171, 176). Like PLIN3, PLIN5 is found at the lipid droplet surface as well 
as in the cytosol (34, 35, 171, 177). Due to its unique tissue distribution, it has been 
hypothesized that PLIN5 is a key regulator of lipolysis in skeletal muscle.  PLIN5 
might translocate to the lipid droplet surface in circumstances that promote 
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lipolysis, such as muscle contraction.  If this is true, PLIN5 may function by directly 
regulating lipase action at the lipid droplet surface.  
Similar to PLIN2, PLIN5 protein expression correlates well with the neutral 
lipid content of the cell. In skeletal muscle PLIN5 content is higher in obesity or 
animal models of type 2 diabetes (110), in women compared to men (120), and it 
increases with training (120, 131), while high fat feeding increases PLIN5 
expression only modestly in skeletal muscle (171). Cardiac PLIN5 expression is also 
induced in situations that would increase fat oxidation (e.g., fasting (34)).  It appears 
from cell culture studies that PLIN5 may be important for the accumulation of 
triglycerides, since expression of PLIN5 in Chinese hamster ovary cells (34) or COS-
7 cells (171) increases triglyceride concentration.  In skeletal muscle, PLIN5 
overexpression resulted in increased lipid droplet size and elevated neutral lipid 
content mainly consisting of triglycerides (19), it was hypothesized from these 
results that PLIN5 overexpression may serve as an indication for inhibition of 
lipolysis (19). These observations suggest that PLIN5 may either promote 
triglyceride synthesis or act as a scaffold protein regulating the rate of lipolysis and 
delivery of fatty acids to the mitochondria for oxidation.  
Recently, Kuramoto et al. described the phenotype of PLIN5 knockout mice.  
These mice lacked detectable lipid droplets in the heart and lipid droplets in skeletal 
muscle were smaller and less abundant. This provides evidence in support of a role 
for PLIN5 in inhibiting lipolysis and stabilizing lipid droplets.   Further work using 
cultured cardiomyocytes from these PLIN5 knockout mice showed a higher rate of 
fatty acid oxidation, potentially reflecting a compensation for a lack of lipid droplet 
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stability and storage capacity as a result of increased lipase activity.  They next 
perfused the PLIN5 knockout hearts with an acute inhibitor of ATGL and found that 
the lipid droplet content was recovered, suggesting an interaction between PLIN5 
and ATGL in this tissue (87). Therefore in tissues that lack PLIN1, PLIN5 is thought 
to be an important scaffold protein regulating triglyceride storage and mobilization 
by controlling the availability lipases on the lipid droplet surface. 
Studies in 3T3-L1, Chinese hamster ovary (CHO), COS-7, H4IIe, and human 
embryonic kidney-293T cells show that PLIN5 binds both CGI-58 and ATGL (but not 
both at the same time) to negatively regulate basal and PKA-activated lipolysis (63, 
64, 156). PLIN1, 2, 3, and 5 contain a conserved amino terminal sequence allowing 
them to bind to HSL (7) and the carboxyl terminal region of PLIN5 is able to bind 
either ATGL or CGI-58 (63, 64, 156). In CHO cells when PLIN5 is bound to CGI-58 or 
ATGL there is a reduction in triglyceride hydrolysis in the absence of PKA 
stimulation (156). However, activation of PKA in cells with ectopic expression of 
PLIN5 and ATGL resulted in increased lipolysis (156).  Further, with PKA 
stimulation there is a 2-fold increase in [32P]-orthophosphate incorporation into 
PLIN5 (156). It is possible that phosphorylation of PLIN5 releases CGI-58 and/or 
ATGL, allowing the two proteins to interact at the surfaces of lipid droplets, thus 
increasing hydrolysis of triglycerides (156).  It is not known if PLIN5 interacts with 
either of these proteins in skeletal muscle and future studies will be required to 
unravel the molecular mechanisms regulating the interaction between ATGL, CGI-
58, and PLIN5 in the control of lipolysis in skeletal muscle.  Subsequent studies 
identifying the phosphorylation site(s) of PLIN5 as well as any relevant kinase 
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would also help to identify the mechanism by which phosphorylation of PLIN5 
affects lipolysis. 
Given that PLIN5 is expressed in highly oxidative tissues, PLIN5 has been 
hypothesized to play a role in channeling fatty acids towards mitochondria for β-
oxidation (18, 19, 158, 171). In support of this hypothesis, PLIN5 expression is 
induced by physiological, pharmacological, and genetic perturbations that increase 
utilization of fatty acids for oxidative phosphorylation (35, 171, 177). For example, 
PLIN5 mRNA and protein content is increased in both the liver and the heart in 
response to fasting (35, 171, 177).  In skeletal muscle, PLIN5 protein expression is 
increased under conditions that increase fatty acid oxidation, such as fasting and 
insulin deficiency (34, 171).  Further, PLIN5 expression is markedly higher in 
endurance-trained athletes in comparison to sedentary BMI-matched controls (5, 
84), and increases in response to both endurance and interval training (120, 131).  
Further, lipid droplets containing PLIN5 are preferentially broken down during an 
acute bout of exercise, compared to those lipid droplets not containing PLIN5 (131).  
These findings provide evidence for a role of PLIN5 in regulating stimulated 
lipolysis in skeletal muscle.   
Due to the tissue expression of PLIN5, it has also been associated with 
regulating fatty acid oxidation.  Recently, PLIN5 has been shown to localize to 
mitochondria in smooth and skeletal muscle cells (18) as well as link lipid droplets 
to mitochondria (158).  Overexpression of PLIN5 results in a more intimate 
interaction between the lipid droplets and mitochondria, where almost all lipid 
droplets in PLIN5 overexpressing muscle were in contact with mitochondria (18). 
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Peters et al. showed that increased PLIN5 is associated with improved oxidative 
capacity (120) and PLIN5 correlates with markers for oxidative capacity (18). 
Further, PLIN5 overexpression in vitro (171) and in tibialis anterior was associated 
with increased fatty acid oxidation (13) and increased expression of genes under 
control of PGC1α suggesting improved oxidative capacity (19).  
Collectively, these studies suggest an important role for PLIN5 in lipid 
droplet stability by directly interacting with both HSL and ATGL as well as ATGLs 
co-activator, CGI-58.  Further, PLIN5 appears to play an important role in fatty acid 
oxidation and perhaps delivery of fatty acids to the mitochondria.  PLIN5 may be a 
key player in regulating cellular metabolism upon energy demand by regulating 
lipolysis and interactions between lipid droplets and mitochondria. 
 
Lipolysis in Skeletal Muscle  
 
The use of IMTGS as an important substrate contribution to fat oxidation 
during exercise has been demonstrated by the use of several different techniques 
(biochemical extraction (137, 160), tracer methodology (152), 
immunohistochemistry (153) and magnetic resonance spectroscopy (126)).  It is 
now known that during exercise IMTGs are mobilized through a combination of 
external hormonal (increased epinephrine) and internal metabolic signals 
(intracellular Ca2+, and metabolite concentrations). However, the exact mechanisms 
regulating IMTG hydrolysis at the lipid droplet during exercise are poorly 
understood. Previous studies in skeletal muscle have focused on the role of HSL in 
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regulating lipolysis and there are only a handful of studies investigating ATGL 
regulation or the role of skeletal muscle PLIN proteins.  
As outlined above, most research in the field of lipid droplet coat proteins has 
focused on adipose tissue and PLIN1. While PLIN1 is not expressed in skeletal 
muscle, evidence suggests that skeletal muscle lipolysis is regulated by PLIN protein 
interactions occurring on the lipid droplet surface in a manner similar to that 
observed in adipose tissue (15, 22, 43, 120, 122). Skeletal muscle is very distinct 
from adipose tissue given its higher metabolic rate, which is accelerated during 
exercise. Adipose tissue lipolysis aims to export and deliver fatty acids to other 
tissues for use, but the goal of skeletal muscle lipolysis is to provide fatty acids 
directly to the mitochondria for oxidation and energy production. Exercise leads to 
the activation of several skeletal muscle kinases, each of which may play into 
regulating the rate of lipolysis.  Hormonal regulation of skeletal muscle lipolysis is 
similar to adipose tissue lipolysis, but the full activation of ATGL and HSL in skeletal 
muscle is likely more complex involving contraction-mediated routes (108). 
Increased circulating epinephrine concentrations during dynamic exercise will lead 
to the activation of PKA, but at the same time contraction increases intramuscular 
calcium levels witch stimulate calcium calmodulin kinase (CaMK) and extracellular 
signal regulated kinase (ERK) activation. Further, the mismatch between ATP 
utilization and production during contraction also leads to increased levels of AMP, 
which activates AMP-activated kinase (AMPK). The following sections will focus on 
what is currently known about the regulation of lipolysis in skeletal muscle, with a 
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focus on how the above-mentioned kinases are currently known to regulate HSL and 
ATGL. 
 
Skeletal Muscle Hormone Sensitive Lipase Regulation 
 
Until 2005 HSL was considered to be the only triglyceride lipase and 
therefore the function of HSL has been extensively studied and reviewed (163, 164, 
181). In skeletal muscle, HSL protein content is highly correlated with IMTG 
concentration and oxidative capacity and therefore has a higher expression in type I 
fibres compared to type II fibres (91, 119).  HSL has a high substrate specificity for 
diglycerides (50, 51) but is also active against a variety of lipid substrates, including 
triglycerides, monoglycerides, and cholesteryl esters (181). Ablation of the HSL gene 
in mice results in a significant accumulation of diglycerides, this finding highlights 
the importance of HSL in complete trigyceride hydrolysis (70). In skeletal muscle, 
HSL activity increases in response to exercise at varying intensities but is not 
proportional to exercise intensity (159, 160).  During exercise skeletal muscle HSL 
can be activated by both catecholamines (91, 167) and muscle contraction (44, 74, 
90, 135), and these effects on HSL activity have been shown to be partially additive 
(89). Together this indicates that epinephrine and contraction activate HSL through 
different signaling mechanisms.  HSL contains three domains: a catalytic domain, a 
regulatory domain containing several phosphorylation sites, and an NH2 -terminal 
domain involved in protein-protein and protein-lipid interactions (163). Studies 
using isolated HSL protein have demonstrated that HSL is phosphorylated on five 
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serine residues (563, 565, 600, 659, 660; rat sequence) in vitro (7).  It is now known 
that HSL phosphorylation and activity during exercise is regulated by multiple 
kinases; PKA, ERK, CaMK, and AMPK (124, 161).  The regulation of skeletal muscle 
HSL phosphorylation and activity through adrenergic and contractile stimulation 
will be discussed further in the following sections.  
 
Epinephrine 
 
During exercise circulating epinephrine concentrations are increased leading 
to increased HSL activity in skeletal muscle in both isolated muscle and in vivo (53, 
91).  Similar to adipose tissue, in skeletal muscle epinephrine binds beta-adrenergic 
receptors on the cell membrane leading to subsequent PKA and HSL activation (91, 
160, 161) (Figure 7). Mutagenesis experiments demonstrate that Ser563, Ser659 , 
and Ser660  are the major PKA phosphorylation sites responsible for stimulating 
HSL (7, 42), although Ser563  may not affect catalytic activity directly (7). In skeletal 
muscle, PKA activation leads to HSL phosphorylation at serine 563 and 660 (161). 
Overall, PKA phosphorylation of HSL results in modest activation of the 
enzyme (2-to 3-fold) and promotes the translocation of HSL to the lipid droplet (46).  
The recruitment of HSL to the lipid droplet appears to be crucial for complete 
hydrolase activity of HSL (122, 157), and has been shown to occur in isolated rat 
soleus muscle following epinephrine incubation or electrically-stimulated muscle 
contraction (122).  This indicates that PKA phosphorylation is not the only effect 
that can cause HSL translocation to the lipid droplet.  In isolated soleus muscle 
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incubated with epinephrine, HSL colocalization with PLIN2 and lipid droplets 
increased significantly indicating that there may be an essential role for he 
association of HSL with PLIN2 in lipolytic control (122).  However direct protein-
protein interactions between PLIN2 and HSL have yet to be investigated in skeletal 
muscle. Thus, phosphorylation of HSL by PKA stimulates lipolysis by increasing 
lipase activity and moving HSL to its substrates, however this may not be essential 
for HSL translocation as HSL also moves to the lipid droplet with contraction (122). 
In human experiments, skeletal muscle samples obtained before, 15 and 90 
min during a 120 min steady state exercise showed that HSL activity was increased 
by ~80% at 15 min compared with rest and returned to resting rates at the 
cessation of and 120 min after exercise. Consistent with changes in plasma 
epinephrine, skeletal muscle HSL Ser563 and Ser660 phosphorylation were 
increased by 27% at 15 min, remained elevated at 90 min, and returned to resting 
values post-exercise. Skeletal muscle phosphorylation of the inhibitory site of HSL 
(Ser565) as well as AMPK signaling were increased at 90 min during, and after, 
exercise (161). These findings show that increased HSL activity in skeletal muscle 
occurs at the onset of exercise due to phosphorylation of the PKA sites (Ser563 , 
Ser659 , and Ser660 ), but HSL activity is reduced later on in prolonged exercise and 
recovery likely due to phosphorylation of HSL Ser565 by AMPK (124, 161).  
Therefore, epinephrine and PKA play a large role in activating HSL during exercise 
but other contractile mechanisms (e.g. AMPK) also appear to regulate the rate of 
lipolysis through HSL activity. 
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Figure 7 
Skeletal muscle adrenergic stimulation by epinephrine increases intracellular cAMP 
levels and activates PKA. PKA activation phosphorylates HSL at Ser563 and Ser660 
(denoted by P). Phosphorylation of HSL causes translocation to the lipid droplet 
where HSL can hydrolyze diglycerides. (EPI=epinephrine; B=beta-adrenergic 
receptor; G= stimulatory G protein; AC= adenylate kinase; cAMP= cyclic AMP; PKA= 
protein kinase A; ATGL= adipose triglyceride lipase; HSL= hormone sensitive lipase; 
TG=triglyceride). 
 
Contraction 
 
 In the absence of adrenergic stimulation, contraction alone has been shown to 
increase skeletal muscle triglyceride utilization, suggesting that kinases other than 
PKA are important for stimulating IMTG hydrolysis and fatty acid oxidation (44). 
Contraction leads to increased intracellular calcium and AMP concentrations, both 
of which are important signals activating different kinases (CaMK, protein kinase C: 
PKC, and AMPK) (161). The roles of these kinases on HSL activity will be discussed 
in the following sections. 
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Calcium ion and HSL activity 
 
During muscle contraction, calcium ions are released from the sarcoplasmic 
reticulum and acts as a critical second messenger involved in changing metabolism 
(166, 109).  Increased skeletal muscle calcium concentrations lead to the activation 
of both PKC and CaMK. This is interesting, as these kinases have been shown to have 
opposing effects on HSL activity (60, 67). For example, isolated skeletal muscle 
incubated with caffeine in a concentration known to increase intracellular calcium 
without causing contraction has resulted in both an increase (41) and a decrease 
(159) in neutral lipase activity.  
The effect of PKC on stimulated HSL activity seems to be mediated via 
extracellular signal-regulated kinase (ERK) (41, 67).  Contraction increases ERK 
activity in skeletal muscle, while epinephrine does not influence this activity (118, 
169).  In adipose tissue, ERK phosphorylates HSL at Ser660 and increases activity 
(67).  It seems as though ERK plays a similar role in regulating skeletal muscle HSL 
activity. Using PKC inhibitors, Donsmark et al. were able to abolish the contraction-
mediated HSL activation in muscle without effecting epinephrine-stimulated HSL 
activation (41).  Also complete blockade of ERK activation in contracting muscle 
reduces the increase in HSL activity by 50% (41). Further, direct pharmacological 
activation of PKC in resting muscle is accompanied by ERK phosphorylation and 
increased HSL activity (41). Therefore, it has been determined that ERK increases 
HSL activity in isolated rodent skeletal muscle (41), likely by phosphorylation at 
Ser660.  
From studies in adipose tissue it is known that CaMK phosphorylates the 
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“inactivating” Ser565 site on HSL preventing further phosphorylation and activation 
(60).  The role of CaMK in skeletal muscle seems to be similar. To investigate if this 
occurs in skeletal muscle, Watt et al. incubated isolated soleus muscles with 
cyclopiazonic acid, a sarcoplasmic reticulum calcium-ATPase inhibitor, or caffeine, 
both of which increase intracellular calcium. Both experimental conditions lead to a 
significant decrease in HSL activity. They then used an inhibitor of CaMK (KN-93) in 
these incubations and saw that HSL activity was returned back to base values, thus 
indicating that CaMK is also an inhibitor of HSL in skeletal muscle (166). 
It seems perplexing that in skeletal muscle calcium ion leads to the activation 
of two kinases that have opposing effects on HSL activity, but perhaps as the calcium 
concentration changes with exercise duration or intensity one kinase could overrule 
the other.  Because both kinases are activated by calcium, it has been difficult to 
determine the overall effect of calcium in regulating HSL activity (Figure 8).  
 
AMP and HSL activity 
  
Due to the high ATP turnover rate during exercise, there is an increase in 
AMP levels, which leads to the activation of AMPK.  In adipocytes, AMPK 
phosphorylates HSL at Ser565, preventing HSL activation by PKA (61).  Similarly, in 
both resting (115) and contracting (133) skeletal muscle, triglyceride hydrolysis is 
suppressed in response to AMPK activation by the adenosine analogue AICAR (5-
amino-4-imidazolecarboxamide-1-β-D-ribofuranoside).  These studies have found 
that AMPK attenuates HSL activity during exercise (159, 160, 165).  AMPK 
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phosphorylation of HSL also prevents activation by PKA, as demonstrated in L6 
myotubes treated with AICAR which result in reduced PKA stimulated HSL activity 
(165). It has been suggested that increased activation of AMPK is capable of 
overriding elevations in adrenaline and PKA stimulation of HSL, this is consistent 
with a reduction in fatty acid oxidation during intense exercise. 
In support of this a study involving 90min of steady state cycling found that 
HSL Ser565, which is proposed to prevent the increase in HSL activity (61), was 
phosphorylated at 90 min of exercise as well as in recovery (161).  This finding was 
consistent with the significant activation of AMPK signaling at these times points.  
The increased AMPK phosphorylation and HSL Ser565 phosphorylation at 90 min 
corresponded to decreased HSL activity, consistent with previous results suggesting 
that phosphorylation of HSL by AMPK prevents activation of this enzyme (61, 165).  
HSL activity declined to resting rates late in prolonged exercise (90 min) despite 
high circulating epinephrine concentrations and further increases in the 
phosphorylation on the PKA site Ser563 (161), which would be expected to increase 
HSL activity (83, 91, 167). In addition to increased AMPK activity during exercise, 
the observation that fatty acyl-CoA accumulation occurs at high exercise intensities 
may also allosterically inhibit HSL activity (81). Consistent with the in vivo findings, 
results from in vitro studies found that AMPK inhibited epinephrine-induced HSL 
activity in L6 myotubes and was associated with reduced HSL Ser660 but not 
Ser563 phosphorylation. HSL activity was reduced in L6 myotubes expressing 
constitutively active AMPK, confirming the inhibitory effects of AMPK on HSL 
activity (161) (Figure 8).   
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Figure 8 
Contraction stimulated lipolysis. Increased calcium concentrations activate both 
PKC and CaMK.  PKC activates ERK which phosphorylates HSL at Ser660 resulting in 
increased activation. CaMK phosphorylates the inhibitory Ser565 site of HSL.  High 
ATP turnover during exercise leads to increased AMP and AMPK activity. AMPK 
phosphorylates Ser565 on HSL and inhibits its activity. (Ca2+=calcium; PKC=protein 
kinase C; ERK=extracellular signal regulated kinase; CaMK=calcium calmodulin 
kinase; ATGL=adipose triglyceride lipase; HSL=hormone sensitive lipase). 
 
Summary of HSL regulation 
 
The regulation of HSL activity in skeletal muscle involves multiple kinases 
and seems to be exercise intensity and duration dependent.  HSL activity in skeletal 
muscle is increased during exercise due to phosphorylation of the PKA sites 
(Ser563, Ser659, and Ser660 ), increased calcium leads to ERK activation which 
phosphorylates and activates HSL Ser660, while CaMK and AMPK phosphorylate 
and inhibit HSL Ser565 (124, 161). These opposing pathways appear to indicate the 
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presence of a mechanism by which HSL activity can be adjusted relative to exercise 
intensity and duration (161).  
 
Skeletal Muscle ATGL Regulation  
 
ATGL, also known as desnutrin and calcium-independent phospholipase A2ζ, 
was recently identified by three separate laboratories (77, 154, 187) and is now 
known as the predominant triacylglycerol lipase.  ATGL is critical for efficient 
triacylglycerol lipolysis in all tissues assessed to date (2, 69, 151), including skeletal 
muscle (10, 75). Unlike the wide substrate specificity of HSL, ATGL exhibits a strong 
specificity for triglycerides (77, 187, 154, 187), has very low diglyceride-hydrolase 
activity (92), and has no cholesteryl or retinyl esterases activities (187). 
Interestingly, ATGL also possess transacylase activity (77), but the importance of 
this has yet to be determined.  Although most abundantly expressed in adipose 
tissue, ATGL is also expressed in cardiac tissue and skeletal muscle (187), and like 
HSL, appears to be most abundant in type I compared to type II muscle fibres (80). 
The regulation of ATGL activity is poorly understood in skeletal muscle. In 
adipose tissue the activity of ATGL is enhanced upon interaction with its co-
activator, comparative gene identification 58 (CGI-58) (92), and reduced by 
G(0)/G(1) switch gene 2 (G0S2) (180). Both CGI-58 and G0S2 are expressed in 
skeletal muscle (9, 92, 180), although their role here has is yet to be established. The 
importance of CGI-58 in ATGL activation in skeletal muscle is demonstrated by the 
fact that individuals who have a mutation of CGI-58 have an increased IMTG content 
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(92).   Further, overexpression of ATGL in non-adipocyte cells (Hela cells and 
myotubes) enhances the degradation of triglycerides (10, 132), whereas knockout of 
ATGL in mice results in IMTG accumulation (69). Along with increased IMTG 
content, ATGL knockout mice also demonstrate an increased reliance on 
extracellular fatty acids for oxidation indicating that the ability to mobilize IMTGs is 
impaired (75). Finally, in human skeletal muscle ATGL protein content was 
significantly increased after 8 wk of endurance exercise training, consistent with 
increased IMTG stores and an enhanced capacity to utilize IMTGs (4). 
 
ATGL Phosphorylation 
 
It has been known for some time that ATGL can be phosphorylated on Ser404  
(corresponding to Ser406 in mice) (11), however the upstream kinases have 
remained elusive and thus far there is only one study in skeletal muscle. Ahmadian 
et al. (1) showed that AMPK phosphorylates ATGL at Ser406 in HEK293 (Human 
Embryonic Kidney) cells and that lipolysis is decreased in murine adipocytes 
expressing an ATGL Ser406A mutation, suggesting that AMPK phosphorylates and 
activates ATGL. The finding that AMPK phosphorylation enhances ATGL activity and 
lipolysis is interesting because it contrasts other studies demonstrating decreased 
HSL activity and lipolysis with AMPK activation (56). This indicates that the 
triacylglycerol (ATGL) and diacylglycerol (HSL) lipases, which normally act in 
unison to completely degrade triacylglycerol, are oppositely regulated by AMPK 
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phosphorylation. However, few studies have investigated the role of AMPK on ATGL 
phosphorylation in skeletal muscle.  
 A recent study investigated the phosphorylation state of Ser404 in human 
skeletal muscle during 90min of steady state cycling (106).  They found that ATGL 
Ser404 phosphorylation did not increase from rest during the 90min of exercise, 
indicating the ATGL phosphorylation may not be an important regulator of skeletal 
muscle lipolysis.  In addition, there was no evidence of a physical interaction 
between ATGL and AMPK after immunoprecipitation. To further investigate a role 
for AMPK in ATGL phosphorylation, this group used cultured myotubes and 
pharmacologically activated AMPK which resulted in no change in ATGL Ser404  
phosphorylation (106).  Due to the importance of PKA stimulation in activating 
lipolysis in skeletal muscle (79, 91, 167), this group also hypothesized that PKA 
might phosphorylate ATGL.  Using forskolin to activate PKA in cultured myotubes 
they found no effect of on ATGL Ser406 phosphorylation. Together, these studies 
suggest that neither AMPK nor PKA appear to be an important upstream kinase of 
ATGL in skeletal muscle (106). Therefore, further work is necessary to determine 
the importance of ATGL phosphorylation and to determine if phosphorylation of 
ATGL is required to modulate its interaction with its co-activator, CGI-58, or for 
ATGL’s translocation and interaction with the lipid droplet. 
 
Skeletal Muscle PLINs 
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Due to the fact that PLIN1 is not expressed in skeletal muscle (171), it is 
likely that other PLIN proteins may be required to regulate lipolysis in this tissue.  It 
has been suggested that PLIN2, PLIN3, and PLIN5 play a large role in regulating 
lipolysis in skeletal muscle (120, 128, 130, 131). As a result these are the PLIN 
members studied in this thesis. Given that the location of a protein is generally 
related to its physiological function, the myocellular locations of both PLIN2 and 
PLIN5 are crucial in understanding their roles. PLIN5 has the ability to translocate 
on and off of the lipid droplet and has also been found located on mitochondria, 
therefore an understanding of its subcellular location with contraction is important. 
Further, interactions between these PLIN proteins and both ATGL and HSL have not 
been investigated in skeletal muscle.  In addition, the reversible phosphorylation of 
PLIN1 is necessary for lipolytic activation in adipose tissue (104, 113, 139, 143), 
however the phosphorylation state of the remaining PLINs has yet to be 
investigated in skeletal muscle. A phosphorylation site has been identified on PLIN2 
(Ser 291) (11), and PLIN3 (Ser 245) (72), and some evidence indicates that PLIN5 is 
a substrate for PKA phosphorylation (156). It is possible that the phosphorylation of 
PLIN2, PLIN3, or PLIN5 may be required to optimally position ATGL, CGI-58, and/or 
HSL for activation of lipolysis in skeletal muscle.  While the importance of PLIN1 in 
adipose tissue lipolysis has been established, the role of the remaining PLIN family 
proteins in skeletal muscle remains unknown. 
 45 
Chapter 3 
 
 
 
Statement of the problem 
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The importance of proper storage and use of IMTGs has become increasingly 
more evident in the past decade. Identifying the underlying mechanisms of how 
IMTG are mobilized from lipid droplets may provide key information in regards to 
the development of metabolic diseases caused by lipotoxicity. At the time that this 
thesis was undertaken (2009), growing evidence pointed toward the PLIN proteins 
in regulating lipid storage and use.  However, there were only a handful of studies 
investigating PLIN proteins in skeletal muscle and our initial studies were based on 
what little information was known at that time. Therefore the primary objective of 
this thesis was to expand our knowledge of the role of PLIN proteins in relation to 
skeletal muscle lipolysis. 
The first study investigates the subcellular distribution of PLIN2, PLIN5, and 
lipid droplets at rest and following 30min of stimulated contraction.  The second 
study describes the skeletal muscle PLIN interactions with to ATGL and CGI-58 at 
rest and following contraction.  Finally, due to the importance of PLIN1 
phosphorylation in initiating lipolysis in adipose tissue it was important to 
determine if this occurred with any of the skeletal muscle PLIN proteins.  Thus, the 
third study investigated skeletal muscle PLIN phosphorylation at rest, following 
epinephrine incubation, and following stimulated contraction.  The isolated muscle 
technique utilized in all three studies provided a well-suited model to investigate 
lipolysis in a highly oxidative muscle (soleus). 
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Purposes and Hypotheses 
 
Study 1 – Chapter 4 
The purpose of this study was two-fold, first to investigate the myocellular location 
and co-localization of lipid droplets, PLIN2, and PLIN5 and second to determine if 
PLIN5 is recruited to lipid droplets with contraction.  It was hypothesized that 
contraction would recruit a cytosolic pool of PLIN5 to the lipid droplet surface 
allowing fatty acids to be oxidized and used for energy.   
 
Study 2 – Chapter 5 
The purpose of this study was to first determine if there were any interactions 
between PLIN2, 3, and 5 with ATGL and/or CGI-58 at rest, and second, to evaluate 
the effects of lipolytic muscle contraction on these interactions in an isolated muscle 
preparation. We hypothesized that PLIN proteins would contribute to the regulation 
of skeletal muscle lipolysis by preventing the interaction of ATGL and CGI-58 at rest.  
 
Study 3 – Chapter 6 
The purpose of this study was to examine the isolated and additive effects of 
epinephrine and contraction on skeletal muscle PLIN protein to ATGL and HSL 
interactions as well as phosphorylation status.  A major objective of this study was 
to determine if PLIN2, PLIN3, and/or PLIN5 are phosphorylated and whether this 
changes during lipolysis.   If so, this study aimed to separate adrenergic and/or 
contractile stimulation. A second objective of this study was to investigate the role 
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of PLIN2, PLIN3 and PLIN5 in governing the accessibility of ATGL and HSL via direct 
protein-protein interactions during these perturbations.  We hypothesized that 
skeletal muscle PLIN to lipase interactions are governed by PLIN phosphorylation 
status. 
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Running head: Skeletal muscle PLIN protein subcellular localization 
 
ABSTRACT 
 
Skeletal muscle lipid droplet associated proteins (PLINs) are thought to regulate 
lipolysis through protein-protein interactions on the lipid droplet surface. In 
adipocytes, PLIN2 (ADRP) is found only on lipid droplets, while PLIN5 (OXPAT, 
expressed only in oxidative tissues) is found both on and off the lipid droplet, and 
may be recruited to lipid droplet membranes when needed. Our purpose was to 
determine if PLIN5 is recruited to lipid droplets with contraction, and to investigate 
the myocellular location and co-localization of lipid droplets, PLIN2, and PLIN5. Rat 
solei were isolated and following a 30min equilibration period were assigned to one 
of two groups: 1) 30min resting incubation; 2) 30min stimulation (n=10 each). 
Immunofluorescence microscopy was used to determine subcellular content, 
distribution, and co-localization of lipid droplets, PLIN2, and PLIN5.  There was a 
main effect for lower lipid and PLIN2 content in stimulated compared to rested 
muscles (p<0.05). Lipid droplet distribution declined exponentially from the 
sarcolemma to the fibre centre in the rested muscles (p=0.001, r2=0.99) and linearly 
in stimulated muscles (slope=-0.0023±0.0006, p<0.001, r2=0.93). PLIN2 distribution 
declined exponentially from the sarcolemma to the fibre centre in both rested and 
stimulated muscles (p<0.0001, r2=0.99 rest; p=0.0004, r2=0.98 stimulated) while 
PLIN5 distribution declined linearly (slope=-0.0085±0.0009, p<0.0001, r2=0.94 rest; 
slope=-0.0078±0.0010, p=0.0003, r2=0.91 stimulated).  PLIN5-lipid droplets co-
localized at rest with no difference post stimulation (p=0.47; rest r2=0.55±0.02, 
stimulated r2=0.58±0.03). PLIN2-lipid droplets co-localized at rest with no 
difference post stimulation (p=0.48; rest r2=0.66±0.02, stimulated r2=0.65±0.02).  
Contrary to our hypothesis these results show that PLIN5 is not recruited to lipid 
droplets with contraction in isolated skeletal muscle.   
 
   
 
Keywords: intramuscular triglycerides, contraction, adipophilin, MLDP, OXPAT 
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Introduction 
 
Growing evidence indicates that skeletal muscle lipolysis is regulated by 
protein-protein interactions occurring on the surface of triacylglyerol (TAG) storing 
lipid droplets (22, 31).  The most abundant proteins found on the lipid droplet 
surface are the PLIN family of proteins, of which there are five members.  Each 
member of the family is named after the founding protein of the PAT family 
(perilipin, PLIN), with the different proteins numbered sequentially (PLIN1-5)(19). 
The PLIN family consists of five members: perilipin (PLIN1), adipocyte 
differentiation-related protein (ADRP, adipophilin, PLIN2), Tail-interacting protein 
of 47 kDa (TIP47, PLIN3), S3-12 (PLIN4) and OXPAT (MLDP, LSD5, PLIN5) (28).  In 
general, lipid droplets are coated with one or more members of this protein family 
each serving important roles in regulating lipolysis.  It is thought that each PLIN 
protein plays a unique role in regulating lipid metabolism due to distinct tissue 
distributions; however the mechanisms regulating lipid droplet dynamics in skeletal 
muscle are largely unknown.   
 To date PLIN1 is the only PAT protein for which a distinct role has been 
established in regulating both TAG storage and lipolysis in adipocytes.  At rest in 
adipocytes PLIN1 coats the lipid droplet regulating the activities of the lipases 
(adipose triglyceride lipase (ATGL) and hormone Sensitive Lipase (HSL)) to the 
triglycerides (TAGs) (5, 29).  ATGL activity requires activation by comparative gene 
identification-58 (CGI-58) (34).  At rest, CGI-58 is prevented from interacting with 
ATGL because it is co-localized with PLIN1 on the surface of lipid droplets.  HSL is 
found in the cytoplasm and has several serine residues that when phosphorylated 
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result in activation and translocation to the lipid droplet (4, 6).   In adipocytes, 
activation of the lipases occurs via a hormonal route. During lipolytic stimulation 
catecholamines bind to β-adrenergic receptors on the cell surface.  Adenylate 
cyclase is then activated through the action of a stimulatory G-protein, the 
intracellular level of cAMP is elevated, and cAMP-dependent protein kinase (PKA) is 
activated.  PKA phosphorylates both perilipin and HSL (5, 15, 29).  The 
phosphorylated perilipin releases CGI-58, which is now free to interact and activate 
ATGL, promoting degradation of TAGs to DAGs (11).  Perilipin phosphorylation also 
permits the phosphorylated HSL to access the lipid droplet (29, 30, 38).  This may be 
due to phosphorylated perilipin leaving the lipid droplet or causing the large 
droplets to fragment into smaller ones, thereby increasing the accessible droplet 
surface area which may enhance the activity of ATGL and HSL at the lipid droplets 
(25). 
 However, information on lipid droplet dynamics in skeletal muscle is scarce 
and researchers have extrapolated current knowledge from other tissues to make 
conclusions/hypotheses about skeletal muscle (26).   Given that PLIN1 is not 
present in skeletal muscle and the tissue distributions of both PLIN2 and PLIN5, 
these two PAT proteins are the most likely candidates to be involved in regulating 
muscular lipid storage and use (27).  PLIN2 is ubiquitously expressed and is one of 
the predominant PAT proteins found in skeletal muscle (3, 32). The exact role of 
PLIN2 is currently unknown, however due to its position on the lipid droplet 
membrane it may regulate lipolysis through interactions with lipolytic enzymes at 
the lipid droplet surface (21, 32).  Studies in cell culture (Chinese hamster ovary 
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cells and human embryonic kidney 293 cells) have shown that PLIN2 coats the lipid 
droplet membrane and is stable in the presence of neutral lipids but is otherwise 
targeted for degradation by proteasomes (21, 45, 46).  Information in skeletal 
muscle regarding PLIN2 distribution and its association with lipid droplets is 
limited and contradictory.   One study determined that PLIN2 is highly co-localized 
(80%) to the lipid droplet surface, making it an ideal marker of lipid droplets (32), 
while a recent study has found that this is not the case with only 64% of PLIN2 
associated with lipid droplets  (36).   
 PLIN5 is unique in that its distribution is restricted to tissues that undergo 
high rates of lipolysis, such as skeletal muscle (specifically type 1 fibers), cardiac 
muscle, liver, and brown adipose tissue (8, 44, 47).  Due to this unique distribution it 
has been hypothesized that PLIN5 facilitates the oxidation of intracellular lipids in 
these tissues.  Further, PLIN5 expression is induced by physiological, 
pharmacological, and genetic perturbations that increase utilization of fatty acids 
for oxidative phosphorylation (8, 44, 47).  For example, PLIN5 mRNA and protein 
content is increased in both the liver and the heart in response to fasting (8, 44, 47).  
Recent work indicates that PLIN5 may regulate intramuscular TAG storage and 
mobilization by controlling the availability of CGI-58, an activator of adipose 
triglyceride lipase (ATGL), on the lipid droplet surface (12).  PLIN5 is found 
associated with the lipid droplets as well as in a cytosolic form (8, 44, 47).  Lipolysis 
occurs on the surface of intracellular lipid droplets, therefore it is possible that 
PLIN5 is translocated to the lipid droplet surface in circumstances that promote 
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lipolysis, such as muscle contraction.  If this is true, PLIN5 may function by directly 
regulating lipase action at the lipid droplet surface.  
 Given that the location of a protein is generally related to its physiological 
function, the myocellular locations of both PLIN2 and PLIN5 are crucial in 
understanding their roles.  Therefore, to fully understand how PLIN5 may regulate 
skeletal muscle lipolysis, it is important to first determine the location of this 
protein at rest and following contraction.  The purpose of this study is two-fold, we 
plan first to investigate the myocellular location and co-localization of lipid droplets, 
PLIN2, and PLIN5 and second to determine if PLIN5 is recruited to lipid droplets 
with contraction.  It was hypothesized that contraction would recruit a cytosolic 
pool of PLIN5 to the lipid droplet surface allowing fatty acids to be oxidized and 
used for energy.   
 
Materials and Methods 
 
Animals.  
 
 A total of 10 male Long Evans rats (~ 4-6 weeks old, body mass 163±13 g) 
were used in this study.  Animals were housed in groups within the Brock University 
Animal Facility, where they were maintained on a 12:12 light-dark cycle at ~22°C.  
The rats were fed a standard rodent diet and had ad libitum access to food and 
water.  All experimental procedures and protocols were approved by the Brock 
University research subcommittee on animal care and conform to all Canadian 
Council on Animal Care guidelines.   
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Muscle Preparation.  
 
 Animals were anaesthetized via intraperitoneal injection of sodium 
pentobarbital (6 mg/100g body wt), and then the left and right soleus muscles were 
removed and placed in an organ bath where they were assigned to one of two 
experimental groups: 1) rest or 2) stimulated.  To briefly summarize the 
preparation, each soleus muscle was dissected from tendon-to-tendon, sutures were 
tied in-situ, the muscle was removed and immediately placed in an organ bath 
(Radnoti Glass Technology, Monrovia, CA), which contained 15 ml of fully 
oxygenated liquid Sigma medium 199 and suspended at a resting tension of 1 g 
force.  The incubation medium was continuously gassed with 95% O2 5% CO2, and 
temperature was maintained at 25°C by circulating distilled water from a bath 
through an outer water jacket of the incubation reservoir (1). Muscles were 
incubated at rest for 30 min to equilibrate.  After the initial incubation, the muscles 
were assigned to either the rest or stimulated group.  
 
Stimulation Protocol. 
 
 Following the equilibration period the muscles remained at rest or were 
stimulated to contract for 30 min.  Initially, optimal stimulus voltage was 
determined by assessing force responses (Grass Telefactor force transducer, West 
Warwick, RI) to single electrical pulses (Grass Model FT03 with P11T amplifier). 
Stimulus intensity was increased from 10 volts in 10 volt increments, until a plateau 
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in twitch force was reached, after which stimulus voltage was increased to ~ 1.25 of 
this level. During the 30 minute stimulus protocol, muscles received repeated 
volleys of brief (150 ms) but high frequency (60 Hz) trains at a train rate of 20 
tetani/min (muscles were suspended at 1 g of resting tension throughout). This 
protocol has previously proven to elicit maximal rates of triglyceride pool turnover 
and rates of  TAG oxidation without the development of fatigue (9).  Throughout this 
period, muscle force production was recorded using Grass Polyview Data 
Acquisition and Analysis System (West-Warwick, RI) and analyzed using the 
Polyview Reviewer (Grass Polyview Data Acquisition and Analysis System; Astro-
Med Inc., West-Warwick, RI).  
 
Metabolite analysis.  
 
 Following the 60-min incubations, soleus muscles were removed from the 
bath and cut into two pieces, with one piece being snap frozen in liquid nitrogen for 
metabolite analysis and the other piece mounted for histochemical analysis (see 
below).  The extraction process was completed after the frozen soleus sections were 
freeze dried (Labconco Corporation; Kansas City; MO, USA).  Muscles were 
powdered and any visible blood and connective tissue were removed and then acid 
extracted for measurement of muscle metabolites (ATP, PCr, and lactate).  Muscle 
metabolite content was determined by fluorometric techniques according to the 
procedures described by Harris et al. (16) and modified by Green et al. (14). Each 
sample was analyzed in triplicate during the same analytical session for each of the 
measured metabolites. 
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Immunohistochemical Analysis.  
 
 The muscle section used for histochemical analysis was oriented for 
transverse sections and mounted, in embedding medium (Cryomatrix, Pittsburgh, 
PA), on a piece of cork which was plunged into 2-methylbutane cooled in liquid 
nitrogen.  Following rapid freezing the samples were stored at -80°C until 
sectioning.  Sectioning was completed with a cryotome (ThermoShandon, Runcorn, 
Chesire, UK) optimally set at -20°C.  Sections were (10 µm thick) thaw mounted onto 
slides and stored at -80°C until immunohistochemical staining.   
 To permit the examination of lipid droplets stained by oil red O (ORO; 
O0625; Sigma-Aldrich, USA) together with immunolabelled PLIN5 or PLIN2, the 
same protocol developed by Koopman et al. (20) was utilized (20, 37, 41, 42).  
Phosphate buffered saline (PBS) was used for dilution of antibodies, reagents, and 
for use in the washing steps of the protocol.  Briefly, cryosections were fixed in 3.7% 
formaldehyde for 1 h. Slides were then be rinsed three times in deionised water for 
30 s then treated with 0.5% Triton X-100 in PBS for 5 min and washed three times 
with PBS for 5 min.  Sections where then incubated for 1 hour at room temperature 
with a primary antibody against PLIN5 (#GP31; Guinea pig polyclonal; Progen, 
Heidelberg, Germany) or PLIN2 (#GP40; Guinea pig polyclonal; Progen, Heidelberg, 
Germany) in the appropriate dilution (1:50 and 1:100 respectively). Incubation was 
followed by three 5 min washes in PBS.  Then the appropriate fluorescent secondary 
antibody Alexa488 (1:200 in PBS; A-11073; Goat anti-guinea pig; Molecular probes, 
Invitrogen, Breda, Netherlands) was applied for 60 min at room temperature.  This 
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was followed by a 15 min wash with three exchanges of PBS.  The slides were then 
immersed in the working solution of oil red O for 30 min.  Slides were rinsed three 
times in deionised water.  Cover slips were mounted with a prolonging agent 
(#P36930; Prolong Gold antifade reagent; Invitrogen; Breda, Netherlands).   
 Double staining of PLIN5 and PLIN2 together was performed by 
simultaneous incubation with primary antibodies against PLIN5 (#GP31; Guinea pig 
polyclonal; Progen, Heidelberg, Germany) and PLIN2 (ab37516; Chicken polyclonal; 
abcam, Cambridge, MA, USA).  Visualization of primary antibody binding was 
achieved with the following secondary antibodies: Alexa488 (1:200 in PBS; A-
11073; Goat anti-guinea pig; Molecular probes, Invitrogen, Breda, The Netherlands), 
and Alexa Fluor 555 (1:200 in PBS; A-21437; Goat anti-chicken Molecular probes, 
Invitrogen, Breda, The Netherlands).  Control steps were performed to eliminate the 
chance of cross-reaction between the oil red O and one of the antibodies, or between 
the pair of antibodies, where either oil red O or one of the antibodies were omitted, 
resulting in no signal for all cases (data not shown).   
 
Image capturing and analyses.   
 
 All sections were examined using a Nikon Eclipse 80i fluorescence 
microscope (Nikon Eclipse 80i, Chiyoda-ku, Tokyo).   Digital images of the slides 
were captured with a digital camera (Retiga 1300, QImaging, Burnaby, B.C., Canada) 
attached to the microscope.  In order to visualize the oil red O stain and the 488 and 
550 fluophores the FITC UV (450-490 nm) and TRITC (510-560 nm) excitation 
filters were used.  Digitally captured images (40x magnification), four fields of 
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view/muscle cross section (17.9 ± 1.1 fibers/field of view), were processed and 
analysed using imaging software (NIS-Elements AR 3.00, Nikon Instruments Inc., 
Melville, N.Y., USA). An intensity threshold representing minimal values 
corresponding to lipid droplets, PLIN2, and PLIN5 was set manually and applied 
uniformly in all images.  
 The lipid droplets, PLIN5, and PLIN2 fluorescent signals were quantified for 
each muscle fiber, resulting in a total of 4315 muscle fibers analyzed for each muscle 
cross section.  Fiber area as well as the number and area of objects emitting a 
fluorescent signal were recorded.  Muscle fiber lipid droplet, PLIN2, and PLIN5 
content was expressed as the fraction of the measured area that was stained (41).  
 Within each separate muscle cross section, 67 ± 5 muscle fibers were 
selected to further investigate the lipid droplet, PLIN2, and PLIN5 distribution 
patterns.  To determine distribution, the area of the objects within eight successive 
bands of 2 µm in width from the sarcolemma toward the central region (16 µm from 
sarcolemma) of each muscle fiber was recorded.  Lipid and protein content of these 
bands were recorded as area fraction (area stained divided by total area measured 
in each band/central region)(41).   
 Colocalization of the fluorescent signals was determined in four fields of view 
per muscle cross section.  Pearson’s linear regression analyses were performed for 
each field of view, and coefficients of determination (r2) were averaged for each cell.   
 All measures were manually outlined and traced by investigators for each 
individual myocyte.  The immunofluorescence method described here covers 
numerous fibers per muscle cross section and therefore gives a good representation 
 75 
of the entire muscle.  To test the reliability of the method in our hands, both intra- 
and inter-observer reliability were evaluated by two investigators.  The intra-
observer reliability involved the two investigators performing analysis of 1 image 
three times, at least 1 week apart.  The inter-observer reliability involved two 
independent investigators performing analysis for 3 separate images.   These tests 
proved to be reliable with a coefficient of variation <5% for both intra- and inter-
observer reliability. 
 
Statistics 
 
 Differences in total content and co-localization coefficients were evaluated by 
t-tests.  Comparisons of lipid droplet and protein content in successive 2 um bands 
from the sarcolemma was performed using a 2 way ANOVA (rest or stimulated, level 
of band) and a best fit multiple regression analysis. Tukey post hoc tests were 
performed when significance was detected. Statistical significance was set at p<0.05. 
All data are expressed as mean ± standard error of the mean (SEM). 
 
Results  
Muscle Viability and Force 
 
The viability of incubating muscles at 25°C was verified by the maintenance of 
muscle ATP, phosphocreatine and lactate concentrations (Table 1).  Further, 
adequate oxygenation and muscle viability were assessed by the ability to maintain 
force production over the duration of contractions (30 min) as previously 
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demonstrated (9, 33).  The initial isometric force normalized to soleus mass was 
106.8 ± 11.4 g/g wet wt (n=10).  During stimulation force output was recorded at 5 
min intervals and this was noted not to vary by more than 5% of initial at any point 
during the protocol.  Accordingly, little or no fatigue or muscle degradation was 
evident in our results indicating that muscle remained stable and viable during the 
entire protocol.    
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Table 1. Muscle Metabolite Concentrations 
 
Experimental Group ATP PCr Lactate 
Rest 21.27 ± 1.4 
 
56.49 ± 4.2 
 
12.57 ± 1.8 
 
Stimulated 20.09 ± 0.9 
 
45.18 ± 3.1† 
 
25.05 ± 3.0* 
 
Values are means ± SE (mmol/kg dry wt). PCr, phosphocreatine; *Significant 
difference between experimental groups (p < 0.05). † trend (p = 0.053). 
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Lipid droplet, PLIN2, and PLIN5 content  
 
The average muscle fiber area was 2631 ± 87 µm2.  Figure 1 shows representative 
images of rat skeletal muscle cross sections viewed with an fluorescence microscope 
following incubation with lipid droplet protein antibodies (PLIN2 and PLIN5) 
combined with oil red O staining.  The antibodies directed against PLIN2 (Fig. 1a: 
green, 1c: red) and PLIN5 (Fig. 1b: green) successfully stained the proteins with 
visually distinct dots in the central area of the muscles fibers.  In addition, areas of 
intense fluorescence signal can be seen in the subsarcolemma region most likely 
reflecting accumulations of densely packed lipid droplets.  Fiber lipid droplet 
content was greater in the resting muscle group compared to the stimulated group 
(0.030 ± 0.009% rest vs. 0.012 ± 0.006% area lipid stained contraction, p = 0.029; 
Fig. 2a). Fiber PLIN2 content did not differ between resting and stimulated muscles 
(0.22 ± 0.05% rest and 0.14 ± 0.04% area PLIN2 stained contraction, p = 0.23; Fig. 
2b).  Fiber PLIN5 content did not differ between resting and stimulated muscle 
groups (0.035 ± 0.004% rest and 0.038 ± 0.009% are PLIN5 stained stimulated, p = 
0.081; Fig. 2c).  
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Figure 9 
Figure 1: Digitally captured images of one single field of view (40x magnification) 
taken from a soleus muscle cross section.  Oil red O (ORO), PLIN5, and PLIN2 
immunofluorescent staining. A) PLIN2 (green), Oil Red O (red), and combined 
staining (3rd panel) showing higher levels of PLIN2 and lipid droplets closer to the 
sarcolemmal region. B) PLIN5 (green), Oil Red O (red), and combined staining (3rd 
panel) showing higher levels of PLIN5 and lipid droplets closer to the sarcolemmal 
region. C) PLIN5 (green), PLIN2 (red), and combined staining (3rd panel). 
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Figure 10 
Figure 2: 
Lipid droplet (A), PLIN2 (B), and PLIN5 (C) content (expressed as area fraction 
stained) in rested and stimulated rat soleus muscle (n=10).  Values are means ± 
SEM. *Significantly lower compared to values observed in rest muscle (p < 0.05). 
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Lipid droplet, PLIN2, and PLIN5 distribution 
 
 Lipid droplet distribution is presented as lipid content in 2 µm wide bands 
from the sarcolemma toward the central region (16 µm) of the fiber and is 
expressed as the area fraction lipid stained (Fig. 3a).  There was a greater lipid 
content in resting muscles when compared to stimulated muscles at all band levels 
(p = 0.001).  The concentration of the lipid droplets appeared to be greater closer to 
the sarcolemma, however no significant difference was found for lipid droplet 
content between the different band levels (p = 0.23).  Regression analysis 
demonstrates that there was an exponential decline in lipid content from the 
sarcolemma to the centre of the fibre in the resting muscles (p=0.001, r2=0.99).  
Regression analysis of the stimulated muscles revealed that there was a linear 
decline in lipid droplet content starting from the sarcolemma (slope= -0.0023± 
0.0006, p<0.001, r2=0.93). 
 Both PLIN5 and PLIN2 distribution mirror the lipid droplet distribution 
showing distinct intracellular dots and a higher concentration closer to the 
sarcolemma (Fig. 1a and 1b).  There was a main effect for PLIN2 content between 
rest and stimulated muscles regardless of band level (p = 0.004, Fig. 3b).  PLIN2 
content was significantly greater in the 2 µm region compared to the 6, 8, 10, 12, 14, 
and centre regions (p < 0.05). Regression analysis demonstrated that in both resting 
and stimulated muscles there was an exponential decline in PLIN2 content from the 
sarcolemma to the central region of the fibre (p<0.0001, r2=0.99 rest; p=0.0004, 
r2=0.98 stimulated).  PLIN5 content did not differ between resting and stimulated 
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muscles when analysed for content in 2 µm wide bands from the sarcolemma 
toward the onset of the central region of the fiber (p = 0.34, Fig. 3c).  PLIN5 content 
was significantly greater in the 2 and 4 µm regions when compared to the 8, 10, 12, 
14, and central regions (p < 0.05).  PLIN5 content in the 6 µm region was 
significantly greater when compared to the 14 and centre region (p < 0.05).  
Regression analysis demonstrated that in both resting and stimulated muscles there 
was a linear decline in PLIN5 content from the sarcolemma to the central region of 
the fibre (slope=-0.0085±0.0009, p<0.0001, r2=0.94 rest; slope=-0.0078±0.0010, 
p=0.0003, r2=0.91 stimulated). 
 83 
 
 
 
 
 
Figure 11 
 
Figure 3: Lipid droplet (A), PLIN2 (B), and PLIN5 (C) distribution presented in 2 µm wide bands from the sarcolemma toward 
the central region of the fiber (n=10).  *Main effect for lower lipid and PLIN2 content in stimulated muscles compared to 
rested muscles (p < 0.05).  Insets show best fit regression analysis for lipid content, PLIN2, and PLIN5.  Analysis demonstrates 
an exponential decline in lipid content from the sarcolemma to the centre of the fibre in the resting muscles (p=0.001, 
r2=0.99).  Analysis of stimulated muscles reveals a linear decline in lipid droplet content starting from the sarcolemma (slope= 
-0.0023± 0.0006, p<0.001, r2=0.93).  PLIN2 content demonstrates an exponential decline in resting and stimulated muscles 
from the sarcolemma to the central region of the fibre (p<0.0001, r2=0.99 rest; p=0.0004, r2=0.98 stimulated).  PLIN5 content 
demonstrates a linear decline in both resting and stimulated muscles from the sarcolemma to the central region of the fibre 
(slope=-0.0085±0.0009, p<0.0001, r2=0.94 rest; slope=-0.0078±0.0010, p=0.0003, r2=0.91 stimulated).  Values are means ± 
SEM.  
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Co-localization of lipid droplets and PLIN2, and lipid droplets and PLIN5 
 
 Combined oil red O staining of lipid droplets with PLIN2 or PLIN5 allowed 
the position of the lipid droplets to be observed in relation to each of these PAT 
proteins. All images were quantified by Pearson’s correlation coefficient (r2).  
Immunostaining of PLIN2 was combined with oil red O staining on muscle sections 
and viewed with wide field fluorescence microscopy (Fig. 4a).  The Pearson’s 
correlation coefficient demonstrated that 66.4 ± 0.02 % (rest) and 65.5 ± 0.02% 
(stimulated) of PLIN2 co-localized with lipid droplets with no significant difference 
between experimental groups (p = 0.48).  Co-localization of PLIN5 and lipid droplets 
demonstrated that 55.0 ± 0.02% (rest) and 57.7 ± 0.03% (stimulated) of PLIN5 co-
localized with lipid droplets with no significant difference between experimental 
groups (p = 0.47, Fig. 4b).   Combined staining of PLIN5 and PLIN2 reveals that 67.2 
± 0.02 % (rest) and 66.5 ± 0.02% (stimulated) of PLIN5 and PLIN2 are co-localized 
with no significant difference between rest and stimulated muscles (p=0.792, Fig. 
4c). 
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Figure 12 
Figure 4: Co-localization of lipid droplets, PLIN2 and PLIN5 (n=10). A) PLIN5-lipid 
droplet co-localization expressed as average coefficients of determination 
(Pearson’s r2) indicating the magnitude of co-localization.  B) PLIN2-lipid droplet co-
localization expressed as average coefficients of determination (Pearson’s r2) 
indicating the magnitude of co-localization.  C) PLIN5-PLIN2 co-localization 
expressed as average coefficients of determination (Pearson’s r2) indicating the 
magnitude of co-localization.  Values are means ± SEM. 
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Discussion 
 
 This is the first study to investigate the content, distribution, and co-
localization of lipid droplets, PLIN2, and PLIN5 in contracted skeletal muscle.  The 
main findings from this study are that PLIN5 is not recruited to lipid droplets with 
muscle contraction and that both PLIN2 and PLIN5 are partially co-localized to lipid 
droplets at any given time, indicating that skeletal muscle lipid droplets are 
differentially coated with PAT proteins.  
 This stimulation protocol was chosen to maximize intramuscular TG lipolysis 
and was effective as evidenced by the significant reduction in lipid droplet content 
in the stimulated group as compared to the rested group (Fig 2a)(9).   This decline in 
lipid content in the stimulated group was significant regardless of sub-cellular 
location as demonstrated when fibers were analysed using successive 2 µm bands 
from the sarcolemma to the fiber centre.  Further, regression analysis reveals that 
with stimulation there is a greater decline in lipid content in the subsarcolemmal 
region as the relationship changes from an exponential decline to a linear decline 
with stimulation (Fig 3a).  Overall, total PLIN2 content was not significantly 
different between experimental groups, however there was a significantly lower 
PLIN2 content as a main effect when analysed by regional band content (Fig 2b and 
3b).  The absence of a significant difference in overall PLIN2 content may have been 
due to the large variance in muscle fiber content from the subsarcolemmal region to 
the centre of the muscle fibers.   Nonetheless, the significant drop in PLIN2 content 
with contraction in the present study is in agreement with previous data in cultured 
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human embryonic kidney 293 and hamster ovary fibroblastic cells demonstrating 
that PLIN2 is targeted for degradation if it is not bound to the lipid droplet 
membrane (21, 46).  Consequently as the lipid droplet volume decreased during the 
contraction protocol, the PLIN2 bound to those lipid droplets may have been 
degraded in the cytosol.  However, in the present study only ~66% of PLIN2 content 
was found co-localized to lipid droplets suggesting that 34% of the PLIN2 protein is 
located in the cytosol.  There are only two previous studies in skeletal muscle with 
varying results describing the co-localization of PLIN2 and lipid droplets.  One study 
in rat soleus demonstrated a strong ~80% association between PLIN2 and lipid 
droplets, with no difference in this association in response to epinephrine or 
contraction (32).  While the other study in rested human vastus lateralis muscle 
demonstrated a partial, ~64%, association between PLIN2 and lipid droplets (36).  
Together these results suggest that there is a consistent proportion of PLIN2 
associated with lipid droplets, with some found free in the cytosol. Further research 
is needed to determine the physiological role that PLIN2 plays both at the lipid 
droplet surface and in the cytosol in skeletal muscle.  Total PLIN5 content did not 
change with stimulation and analyses of PLIN5 distribution further reveals no 
difference post-stimulation (Fig 2c and 3c).   
 A novel finding of this study is that both PLIN2 and PLIN5 mirror the 
myocellular distribution of the lipid droplets.  Lipid content as well as PLIN2 and 
PLIN5 content is found in high density at the subsarcolemmal region with a 
progressive decline towards the central regions of the muscle fiber (Fig. 3a, b, and 
c).  This lipid droplet distribution is similar to previous studies, where the amount of 
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lipid was higher in the periphery of the myofibers in comparison to the fibers 
central region (7, 35, 41).    Interestingly, the lipid droplet and PAT protein 
distribution pattern observed in the present study is similar to the distribution 
pattern that has also been reported for mitochondria (7, 10, 35, 39).  Shaw et al. (35) 
were the first to show that intramuscular TAG content and mitochondria have a 
similar pattern of distribution in human muscle with the highest density in 
subsarcolemmal regions with a progressive decline in the deeper regions of the 
muscle cell.    This is in accord with previous reports in human skeletal muscle 
showing 2-3 fold greater mitochondrial density in the subsarcolemmal region 
compared to the inter-myofibrillar area (7, 10, 24, 35, 40).  It is possible that the 
similar distribution and close proximity of lipid droplets, PLIN2, PLIN5, and 
mitochondria may indicate a functional relationship allowing the lipids to be 
hydrolysed and oxidised efficiently during exercise (17, 35, 36, 39).  
 Lipid droplets appear to be differentially coated with PLIN2 and PLIN5. Both 
PLIN2 and PLIN5 were found to be partially co-localized with lipid droplets (~66% 
and 55% respectively) and no significant changes in co-localization to lipid droplets 
in response to contraction was observed.  It is not possible to determine the 
physiological significance of the partial co-localization of PLIN2 or PLIN5 with lipid 
droplets; however it is hypothesized that subpopulations of lipid droplets 
presenting different PAT proteins have specific functions within skeletal muscle (36, 
43, 44).  Cell culture studies (murine fibroblasts, human embryonic kidney cells, 
McA-RH7777 cells, and primary rat hepatocytes) have demonstrated that 
overexpression of PLIN2 encourages lipid accumulation (18, 21, 23), whereas down 
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regulation of PLIN2 results in elevated rates of basal lipolysis (2).  Thus PLIN2 is 
thought to form a protective coat restricting lipolysis and it may be possible that 
~66% of the lipid droplets are protected from lipolysis.  We believe that PLIN5 may 
play a role in regulating the interaction of this lipase and the lipase co-activator.  
Very recently, it was demonstrated that PLIN5 facilitates lipolysis by promoting the 
co-localization and functional interaction of CGI-58 and ATGL in the basal state (12, 
13).  Interestingly, while PLIN5 binds both CGI-58 and ATGL, the same PLIN5 
molecule does not bind both at the same time (13).  Moreover, ATGL interacts with 
PLIN5 in the cytoplasm and on intracellular structures lacking neutral lipid, 
indicating that the interaction does not require lipid droplets (13).  Perhaps the 
portion of PLIN5 that is not co-localized to lipid droplets regulates how ATGL 
interacts with CGI-58 on the lipid droplet surface.  Further study is needed to 
determine how PLIN5 regulates the interaction of ATGL and CGI-58 on the lipid 
droplet surface promoting lipolysis.   
 
Perspectives 
 
 In summary, this study directly analysed the spatial organization of lipid 
droplets, PLIN5 and PLIN2 in skeletal muscle in terms of content, distribution and 
co-localisation in response to contraction.  The primary finding of this study is that 
PLIN5 is not recruited to lipid droplets with muscle contraction.  Lipid droplets 
were found to be heterogeneous in nature in terms of their PAT protein content, and 
both PLIN2 and PLIN5 mirror the distribution of lipid droplets.  Further 
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investigation is needed to establish the exact roles that these proteins play in 
skeletal muscle lipid metabolism and should focus on the interactions that these 
proteins may have with lipases and lipase co-activators.   Understanding the 
intricate mechanisms by which PAT proteins contribute to lipid storage and use will 
help to clarify both the physiology of healthy cells and tissues as well as the basis of 
some important metabolic diseases.  
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Running Head: Interactions between skeletal muscle PLINs, ATGL, and CGI-58 
 
Abstract 
 
Evidence indicates that skeletal muscle lipid droplet proteins (PLINs) regulate 
lipolysis through protein-protein interactions on the lipid droplet surface. In 
adipocytes, PLIN1 is thought to regulate lipolysis by directly interacting with CGI-
58, an activator of adipose triglyceride lipase (ATGL).  Upon lipolytic stimulation 
PLIN1 is phosphorylated releasing CGI-58 to fully activate ATGL and initiate 
triglyceride breakdown.  The absence of PLIN1 in skeletal muscle leads us to believe 
that other PLIN family members undertake this role.  Our purpose was to examine 
interactions between PLIN2, PLIN3, and PLIN5, with ATGL and its co-activator CGI-
58 at rest and following contraction. Isolated rat solei were incubated for 30 min at 
rest or during 30 min of intermittent tetanic stimulation (150 ms volleys at 60 Hz 
with a train rate of 20 tetani per min (25oC) to maximally stimulate intramuscular 
lipid breakdown.  Results show that the interaction between ATGL and CGI-58 
increased 128% following contraction (p=0.041).  Further, ATGL interacts with 
PLIN2, PLIN3, and PLIN5 at rest and following contraction. The PLIN2-ATGL 
interaction decreased significantly by 21% following stimulation (p=0.013).  Both 
PLIN3 and PLIN5 co-precipitated with CGI-58 at rest and following contraction, 
while there was no detectable interaction between PLIN2 and CGI-58 in either 
condition. Therefore, our findings indicate that in skeletal muscle during 
contraction-induced muscle lipolysis ATGL and CGI-58 strongly associate and that 
the PLIN proteins work together to regulate lipolysis in part by preventing ATGL 
and CGI-58 interactions at rest. 
 
Keywords: ADRP, adipophilin, OXPAT, MLDP, TIP47, Abhd5 
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Introduction 
 
Fatty acids (FA) released from intramuscular triglycerides (IMTG) during 
lipolysis provide an important source of energy during muscle contraction. In 
skeletal muscle IMTGs are packaged into lipid droplets that possess a unique coat of 
proteins associated with the surrounding phospholipid monolayer.  This protein 
coat provides an interface for specific processes, such as transport, lipogenesis and 
lipolysis (10, 34). Perilipins or PLIN proteins are the most recognized family of lipid 
droplet proteins and are the most likely to be involved in the regulation of 
lipogenesis and lipolysis in skeletal muscle (31).  
Our understanding of PLIN proteins in skeletal muscle is limited, however 
studies in other tissues and in cell culture indicate that PLIN proteins are key 
regulators of lipid metabolism as they appear to be directly involved with how cells 
and tissues store, mobilize, and utilize fatty acids (8, 12, 15, 34, 35, 62). The PLIN 
family consists of five members, PLIN1 (perilipin), PLIN2 (adipocyte differentiation-
related protein; ADRP), PLIN3 (Tail-interacting protein of 47 kDa; TIP47), PLIN4 
(S3-12) and PLIN5 (OXPAT, MLDP, LSDP5) (41).  Each PLIN has a unique tissue 
distribution and possibly a unique physiological function. To date PLIN1 is the only 
protein of this family for which a distinct role has been established; regulating 
triglyceride storage and lipolysis (for review see (4, 69, 74)).  PLIN1 is primarily 
expressed in adipose tissue and controls adipocyte lipolysis by directly regulating 
the activity of the lipases surrounding the droplet (11, 42, 55, 60). Lipolysis is 
regulated by three lipases, adipose triglyceride lipase (ATGL), the rate limiting 
lipase that initiates lipolysis by hydrolysing the first ester bond releasing the first 
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fatty acid, hormone sensitive lipase (HSL), which has a high affinity for 
diacylglycerol as a substrate, and finally monoacylglycerol lipase (MAG).  In order to 
fully activate ATGL in adipose tissue it must be associated with the protein 
comparative gene identification-58 (CGI-58) (51).  However, in adipocytes, under 
basal conditions CGI-58 is bound to PLIN1 thus preventing full ATGL activity (56, 
72). Adipocyte lipolysis is initiated when catecholamines bind to β-adrenergic 
receptors on the cell surface.  Through the action of a stimulatory G-protein, 
adenylate cyclase is activated leading to increased intracellular cAMP and activation 
of cAMP-dependent protein kinase (PKA).  PKA phosphorylates both PLIN1 and HSL 
(11, 18, 26, 42, 59, 60).  It is the PKA dependent phosphorylation of PLIN1 that 
causes the release of CGI-58, leading to the initiation of lipolysis by activating ATGL 
(4, 18-21).  Phosphorylation of PLIN1 and HSL promotes the translocation and 
docking of HSL to PLIN1 on the lipid droplet surface (42, 43, 53, 58, 66). 
Evidence suggests that skeletal muscle lipolysis is regulated by PLIN protein 
interactions occurring on the lipid droplet surface in a manner similar to that 
observed in adipose tissue (6, 8, 15).  However, there are a few distinct differences 
between adipose tissue and skeletal muscle lipolysis. While adipose tissue lipolysis 
aims to deliver FAs to other tissues for use, the goal of skeletal muscle lipolysis it to 
directly provide FAs to the mitochondria for oxidation and energy production. 
Further, while hormonal regulation of skeletal muscle lipolysis is similar to adipose 
tissue lipolysis, the full activation of ATGL and HSL in skeletal muscle is likely more 
complex involving contraction-mediated routes (39). PLIN1 is not expressed in 
skeletal muscle, but PLIN2, PLIN3, and PLIN5 are all expressed and may be involved 
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in regulating contraction-induced lipolysis (26, 71).  Previous studies in skeletal 
muscle have focused on the role of HSL in regulating lipolysis and there have been 
few studies investigating PLIN proteins in skeletal muscle.   Interestingly, there have 
been no studies to date investigating the interactions between PLIN proteins, ATGL 
and/or CGI-58 in response to contraction in skeletal muscle.   
PLIN2 is one of the predominant PLIN proteins found in skeletal muscle (9, 
27, 48). PLIN2 is believed to form a protective coat restricting lipolysis through 
interactions with lipolytic enzymes (3, 33, 48, 52).  Other studies have supported a 
role for PLIN2 in limiting the interaction of the lipases with the triglycerides within 
the lipid droplet (as reviewed by (5)), but this has yet to be investigated in whole 
skeletal muscle.  In support of this theory, recent work in human skeletal muscle 
found that PLIN2-associated lipid droplets are preferentially depleted over those 
lipid droplets not associated with PLIN2 (54).  Further, work in isolated rat soleus 
indicates that HSL is recruited to lipid droplets and PLIN2 with β-adrenergic 
stimulation or electrically stimulated contraction (48). Together, these results 
suggest that PLIN2 expression in skeletal muscle may be related to an enhanced 
IMTG utilization during contraction.  
PLIN3 is one of the least studied of this family of proteins, but the homology 
of PLIN3 is similar to PLIN2 (44) and PLIN3 compensates for the loss of PLIN2 in 
Plin2-/- mice (57).  It is speculated that PLIN3 prevents cell death by maintaining 
mitochondrial membrane potential although the mechanisms are not fully 
understood (29). It is possible that through interactions with skeletal muscle 
lipases, PLIN3 regulates the delivery of FAs to the mitochondria, thus preventing an 
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overload.    It is not presently known whether CGI-58 or ATGL bind to PLIN3 in 
skeletal muscle.  
PLIN5 is unique in that its distribution is restricted to tissues that undergo 
high rates of lipid oxidation, such as skeletal muscle (specifically type I fibers), 
cardiac muscle, liver, and brown adipose tissue (8, 44, 47).  Due to this unique 
distribution, it has been hypothesized that PLIN5 facilitates lipolysis and the 
oxidation of intracellular lipids in these tissues.  In support of this hypothesis 
skeletal muscle PLIN5 protein expression is increased under conditions that 
increase FA oxidation, such as fasting and insulin deficiency (13, 71).  Further, 
PLIN5 content increases in response to endurance training (47).  Recent work in 
Plin5-/- mice found that the hearts lacked detectable lipid droplets and contain less 
TG and FA as compared to wild type controls and perfusion of these hearts with an 
inhibitor of ATGL recovers the lipid droplets content, suggesting an interaction 
between PLIN5 and ATGL in this tissue (32). These findings indicate that PLIN5 
limits lipase actions, however if PLIN5 interacts with either ATGL and/or CGI-58 in 
whole skeletal muscle has yet to be determined.  
The precise mechanisms regulating contraction-induced lipolysis in skeletal 
muscle are poorly understood.  Therefore the purpose of this study was to first 
determine if there are any interactions between PLIN2, 3, and 5 with ATGL and/or 
CGI-58 at rest, and second, to evaluate the effects of lipolytic muscle contraction on 
these interactions in an isolated muscle preparation. We hypothesized that PLIN 
proteins would contribute to the regulation of skeletal muscle lipolysis by 
preventing the interaction of ATGL and CGI-58 at rest.  
 102 
Methods 
Animals.  
 
A total of 20 male Long-Evans rats (4–6 wk old, body mass 101±7g) were used in 
this study. Animals were housed in groups within the Brock University Animal 
Facility, where they were maintained on a 12:12-h light-dark cycle at 22°C. The rats 
were fed a standard rodent diet and had ad libitum access to food and water. All 
experimental procedures and protocols were approved by the Brock University 
Animal Care and Utilization Committee and conformed to all Canadian Council on 
Animal Care guidelines. 
 
Muscle preparation.  
 
Animals were anesthetized via intraperitoneal injection of pentobarbital sodium (6 
mg/100g body wt), and then the left and right soleus muscles were removed and 
placed in organ baths, where they were assigned to one of two experimental groups: 
1) rest or 2) electrically stimulated contraction (36). To briefly summarize the 
preparation, each soleus muscle was dissected from tendon-to-tendon, sutures were 
tied in-situ, the muscle was then removed and immediately placed in an organ bath 
(Radnoti Glass Technology, Monrovia, CA), which contained 15 ml of fully 
oxygenated liquid Sigma medium 199 (M 4530, Sigma-Aldrich, Canada) and 
suspended at a resting tension of 1 g. The incubation medium was continuously 
gassed with 95% O2 5% CO2, and temperature was maintained at 25°C (2). All 
muscles were allowed to equilibrate at rest for 30 min. After the initial incubation, 
the muscles were assigned to either the rest or stimulated group. The soleus was 
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chosen for this set of experiments because it is primarily oxidative in nature (~80% 
type I fibres) and has previously shown the greatest reliance on lipid metabolism 
(14, 17, 46). Further, while PLIN5 is expressed in all skeletal muscles, it’s expression 
is highest in more oxidative muscles containing more type I fibres, such as the 
soleus (71).  These characteristics make the soleus an ideal muscle for investigating 
the role of PLIN proteins in skeletal muscle lipolysis.  Further, the stimulation 
protocol that utilized in this study and a previously published study (36) was 
designed and developed to elicit maximal rates of triglyceride use in the soleus 
muscle (16). 
 
Stimulation protocol.  
 
Following the equilibration period the muscles remained at rest or were stimulated 
to contract for 30 min as previously reported by our lab (36). Initially, optimal 
stimulus voltage was determined by assessing force responses (Grass Telefactor 
force transducer, West Warwick, RI) to single electrical pulses (Grass Model FT03 
with P11T amplifier). Stimulus intensity was increased from 10 V in 10-V 
increments, until a plateau in twitch force was reached, after which stimulus voltage 
was increased to ~1.25 of this level. During the 30-min stimulus protocol, muscles 
received repeated volleys of brief (150 ms) but high-frequency (60 Hz) trains at a 
train rate of 20 tetani/min (muscles were suspended at 1 g of resting tension 
throughout). This protocol was previously proven to elicit maximal rates of 
triglyceride pool turnover and rates of TAG oxidation without the development of 
fatigue (16). Throughout this period, muscle force was recorded using Grass 
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Polyview Data Acquisition and Analysis System (West-Warwick, RI) and analyzed 
using the Polyview Reviewer (Grass Polyview Data Acquisition and Analysis System; 
Astro-Med, West-Warwick, RI). 
  
Co-Immunoprecipitation 
 
Soleus muscles were homogenized in Griffin lysis buffer (150 mM NaCl, 50 mM Tris 
HCl, 1 mM EGTA) using a 1:25 dilution of muscle to buffer with added protease 
(11836170001, Roche, QC) and phosphatase inhibitor tablets (04906845001, 
Roach, QC).  Protein concentration of the total homogenates was determined using a 
Bradford Assay. Sample homogenates were immunoprecipitated with 5 ul of the 
appropriate antibody and then immunoblotted for the corresponding protein. 
Specifically, 500-1000 ug of protein from each sample was incubated for 2 h with 
5ul of the desired primary antibody at 4 °C.  Following this 20 ul of Protein G or A–
Agarose beads (sc-2001, sc-2002; Santa Cruz Biotechnology Inc) was added to each 
sample for overnight incubation at 4 °C. The pellet of each sample was then 
collected by centrifugation at 130 rpm for 5-10 seconds. Pellets were washed three 
times in phosphate buffered saline (PBS) and re-suspended in 40 μl of 2x sample 
buffer. To test for antibody interference in the samples a blank sample containing 
only the precipitating antibody and lysis buffer was prepared in exactly the same 
manner as the experimental samples. For interactions where antibody interference 
occurred a secondary that only detects native antibodies was used (Clean Blot IP 
Detection Reagent; Thermo Scientific). All samples were then boiled and separated 
using 8 or 10% SDS–polyacrylimide gel electrophoresis. As validation that all of our 
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protein of interest precipitated from the sample, pilot work was done where the 
supernatant leftover from the IP procedure was Western blotted for the protein of 
interest. 
 
Western blotting   
 
SDS-polyacrylamide gel electrophoresis (8 or 10% separating; 4% stacking) was 
used to separate proteins (CGI-58, PLIN2, PLIN3, and PLIN5) at 120 V for 1.5 h, and 
proteins were electroblotted onto polyvinylidene difluoride membranes (Amersham 
Biosciences, Piscataway, New Jersey) for 1 h at 100 V followed by blocking in 2, 3, or 
5% fat-free milk in TBST. Primary antibodies for co-precipitated proteins were 
diluted 1:1000 in 2 or 3% fat-free milk in TBST and incubated overnight at 4 °C. 
Secondary antibodies were diluted 1:10000-20000 in 2 or 3% milk and incubated 
for 1 hour. Blots of specific proteins were visualized with enhanced 
chemiluminesence (Amersham Biosciences, Piscataway, New Jersey).  The densities 
of the individual bands were integrated using Image J software 
(http://rsbweb.nih.gov/ij/).  Each blot had loaded whole soleus homogenate as a 
positive control for the co-precipitated protein. Blots were normalized to total 
protein loaded determined by Ponceau S staining (M530; Sigma-Aldrich) and results 
are reported as the ratio of the density of the target protein to the density of the 
loaded protein in arbitrary units (50).   
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Antibodies  
 
The following antibodies were used and have been used previously: PLIN2 (52 kDa) 
mouse monoclonal antibody (Progen Biotechnik, Heidelberg, Cat. No. 610102) (47), 
PLIN3 (47 kDa) (ProSci Inc., Poway, California, Cat. No. 3883)(47), PLIN5 (52 kDa) 
guinea pig polyclonal antibody (Progen Biotechnik, Heidelberg, Cat. Nos. GP34 and 
GP31) (7, 40, 47), ATGL (54 kDa) rabbit monoclonal antibody (Cell signalling 
technology, #2439, Danvers, MA) (1), and CGI-58 (42 kDa) rabbit polyclonal 
antibody (Novus Biologicals, NB110-41576, Oakville, ON) (1, 63). 
 
Statistics 
 
Differences in protein interactions between rest and stimulated muscles were 
evaluated using two-tailed unpaired t-tests.  Statistical significance was set at 
p<0.05. All data are expressed as mean ± standard error of the mean (SEM). 
 
Results 
Muscle force  
Adequate oxygenation and muscle viability were assessed by the ability to maintain 
force production over the duration of the stimulation protocol (30 min), as 
previously demonstrated (16, 36, 49).  In our hands this type of non-fatiguing 
contraction did not deplete muscle ATP concentrations (36).  The initial isometric 
force normalized to soleus mass was 86.8 ± 4.1 g/g wet wt (n=19). During 
stimulation, force output was recorded at 5-min intervals, and this was noted not to 
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vary by more than 5% of initial isometric force at any point during the protocol. 
Accordingly, little or no fatigue or muscle degradation was evident in our results, 
indicating that the muscles remained stable and viable during the entire protocol. 
 
Association between ATGL and CGI-58 
 
ATGL co-immunoprecipitated with CGI-58 at rest and following stimulated 
contraction.  However, following stimulated contraction the amount of CGI-58 
protein that co-immunoprecipitated with ATGL significantly increased by 128% 
(p=0.041) (Figure 1).  
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Figure 13 
Figure 1.  ATGL-CGI-58 interaction at rest and following stimulated 
contraction. CGI-58 protein content (arbitrary units relative to total protein 
measured by ponceau staining) in ATGL immunoprecipitated samples at rest and 
following contraction (n=12). Representative Western blot for ATGL-CGI-58 protein 
interaction, shown as IP ATGL and Western blot for CGI-58. Lane 1 standard, 2-4 
rest samples, 5 blank (absent antibody interference), 6-8 stimulated samples, 9 
empty, 10 soleus whole homogenate used as a positive control.  * Significant 
increase in ATGL-CGI-58 interaction following stimulated contraction (p=0.041).  
IP: anti-ATGL 
IB: anti-CGI-58 
~42 kDa  
 * 
1    2      3      4      5     6      7     8    9     10 
Rest Stim Blank 
WH 
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Association between PLIN2, 3, and 5 with ATGL  
 
PLIN2, 3 and 5 all co-immunoprecipitated with ATGL at rest and following 
stimulated contraction.  PLIN2 protein content in ATGL immunoprecipitated 
samples significantly decreased by 21% following stimulated contraction (p=0.028) 
(Figure 2a).  
Similarly, PLIN3 protein content in ATGL immunoprecipitated samples decreased by 
27% following stimulated contraction however this decrease was not significant 
(p=0.266) (Figure 2b).  Finally, PLIN5 protein content in ATGL immunoprecipitated 
samples also decreased by 19% following stimulated contraction however this 
decrease was not significant (p=0.59) (Figure 2c). 
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c.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 
Figure 2. ATGL-PLIN interactions at rest and following stimulated contraction 
a. PLIN2 protein content (arbitrary units relative to total protein measured by 
ponceau staining) in ATGL immunoprecipitated samples at rest and following 
contraction (n=9).  Representative Western blot for ATGL-PLIN2 protein 
interaction, shown as IP ATGL and Western blot for PLIN2. Lane 1 standard, 2-4 rest 
samples, 5 blank, 6-8 stimulated samples, 9 empty, 10 soleus whole homogenate 
used as a positive control. * Significant decrease in ATGL-PLIN2 association 
following stimulated contraction (p=0.028).  
b. PLIN3 protein content (arbitrary units relative to total protein measured by 
ponceau staining) in ATGL immunoprecipitated samples at rest and following 
contraction (n=9).  Representative Western blot for ATGL-PLIN3 protein 
interaction, shown as IP ATGL and Western blot for PLIN3. Lane 1 standard, 2-4 rest 
samples, 5 blank (Note IgG band at ~50kDa), 6-8 stimulated samples, 9 empty, 10 
whole soleus homogenate No significant difference in ATGL-PLIN3 association 
following stimulated contraction (p=0.266). 
c. PLIN5 protein content (arbitrary units relative to total protein measured by 
ponceau staining) in ATGL immunoprecipitated samples at rest and following 
contraction (n=9).  Representative Western blot for ATGL-PLIN5 protein 
interaction, shown as IP ATGL and Western blot for PLIN5. Lane 1 standard, 2-4 rest 
samples, 5 blank (absent antibody interference), 6-8 stimulated samples, 9 soleus 
whole homogenate used as positive control. No significant difference in ATGL-PLIN5 
association following stimulated contraction (p=0.591). 
 
 
 
1      2      3      4      5         6      7      8        9     
Rest Stim Blank 
WB: anti-PLIN5 
~52kDa  
WH 
IP: anti-ATGL 
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Association between PLIN2, 3, and 5 with CGI-58 
 
There was no detectable interaction found between PLIN2 and CGI-58 in PLIN2 
immunoprecipitated samples blotted for CGI-58 (Figure 3a).  
CGI-58 immunoprecipitated with both PLIN3 and PLIN5 at rest and following 
stimulated contraction.  However, there was no change following contraction for 
either PLIN proteins (p=0.08 and p=0.42 respectively) (Figure 3b and 3c). 
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Figure 15 
Figure 3. PLIN-CGI-58 at rest and following stimulated contraction 
a. Representative western blot of CGI-58 in immunoprecipitated PLIN2 samples.  
Lane 1 standard, 2-4 rest samples, 5 blank (absent antibody interference), 6-8 
stimulated samples, 9 soleus whole homogenate used as positive control. No 
detectable interaction between PLIN2 and CGI-58. 
b. CGI-58 protein content (arbitrary units relative to total protein measured by 
ponceau staining) in PLIN3 immunoprecipitated samples at rest and following 
contraction (n=9). Representative western blot of CGI-58 in IP PLIN3 samples. Lanes 
1 standard, 2-5 rest samples, 6 blank (absent antibody interference), 7-10 
stimulated samples, 12 soleus whole homogenate used as positive control.  No 
significant difference in PLIN3-CGI-58 association following stimulated contraction 
(p=0.58). 
c. CGI-58 protein content (arbitrary units relative to total protein measured by 
ponceau staining) in PLIN5 immunoprecipitated samples at rest and following 
contraction (n=9).  Representative western blot of CGI-58 in IP PLIN5 samples. 
Lanes 1 standard, 2-5 rest samples, 6 blank (absent antibody interference), 7-10 
stimulated samples, 11 soleus whole homogenate used as positive control.   No 
significant difference in PLIN5-CGI-58 association following stimulated contraction 
(p=0.50). 
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Discussion 
 
 This is the first study to examine the interactions between PLIN proteins, 
ATGL and CGI-58 in whole skeletal muscle at rest and following stimulated 
contraction in the absence of adrenergic stimulation.  Using an isolated muscle 
technique we examined interactions of ATGL and its co-activator, CGI-58, with each 
other as well as PLIN2, PLIN3, and PLIN5.  We found that in skeletal muscle the 
interaction between ATGL and CGI-58 increases ~2-fold (128%) after 30min of 
stimulating contraction.  Further novel results from this study show that PLIN2, 3, 
and 5 all interact with ATGL at rest and following contraction, and that only PLIN3 
and 5 interact with CGI-58.  Further, the interaction between PLIN2 and ATGL is 
significantly decreased following stimulated contraction, although similar decreases 
in the interaction of PLIN3 and PLIN5 with ATGL were not significant.  These 
findings support the hypothesis that PLIN proteins may regulate skeletal muscle 
lipolysis by sequestering ATGL and CGI-58, and it is possible that in skeletal muscle 
these PLIN proteins work together in concert to regulate lipolysis.  
 The stimulation protocol used in this study was chosen because it elicits 
maximal rates of lipolysis in isolated soleus muscle and we have previously shown 
this method leads to a significant decline in IMTGs (16, 36).  This is the first study to 
show that during lipolytic stimulating contraction in skeletal muscle ATGL and CGI-
58 interact.  This interaction increased 128% post contraction consistent with an 
increased rate of lipolysis during this period (16).  We found that PLIN2, 3, and 5 all 
interact with ATGL at rest and following stimulated contraction, but the PLIN2-
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ATGL interaction was the only one to show a significant decrease post-stimulation.  
However, this decrease in the association between PLIN2 and ATGL (21%) does not 
fully account for the large increase in the association between ATGL and CGI-58 
(128%) following contraction.  With more than one PLIN protein interacting with 
ATGL and/or CGI-58, perhaps in skeletal muscle the PLIN proteins work together as 
a complex. The results of this study indicate that the role(s) of PLIN proteins in 
regulating skeletal muscle lipolysis are much more complex than what is currently 
understood in adipose tissue.   
Cell culture studies provide evidence that both PLIN2 and PLIN5 compete 
with lipases at the lipid droplet surface to lower basal lipolytic rates (3, 33, 65, 67).  
Specifically, increasing the expression of PLIN2 and/or PLIN5 in human embryonic 
kidney cells or AML12 liver cells reduces the rate of basal and PKA-stimulated 
lipolysis, potentially by interacting with ATGL (3, 33, 65).  Our finding that PLIN2 is 
associated with ATGL at rest is consistent with previous work indicating that PLIN2 
encourages lipid accumulation by inhibiting lipolysis.  In general, PLIN2 is found on 
the lipid droplet surface from the beginning of synthesis and is up regulated in 
parallel with stored lipid during lipid droplet formation (9, 30, 68).  Cell culture 
studies (murine fibroblasts, human embryonic kidney cells, McA-RH7777 cells, and 
primary rat hepatocytes) have also demonstrated that overexpression of PLIN2 
encourages lipid accumulation (30, 33, 37), whereas down regulation of PLIN2 
results in elevated rates of basal lipolysis (3).  Further, in PLIN1-null mice PLIN2 
replaces PLIN1 on the lipid droplets (61), but PLIN2 appears to be a less robust 
barrier to lipases than PLIN1(38, 61).  Although PLIN2 is similar to PLIN1 in 
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sequence homology is has been demonstrated that, unlike PLIN1, PLIN2 is not 
phosphorylated by protein kinase A (59, 61). Since PLIN2 was the only PLIN protein 
in the present study to show a significant decline in ATGL association following 
contraction it is possible that this interaction is regulated by a contraction mediated 
route rather than a hormonal one.  The exact mechanisms regulating the interaction 
between PLIN2 and ATGL in skeletal muscle needs further study.  Our finding that 
PLIN2 does not interact with CGI-58 is in agreement with a previous study using 
CHO cells that found that lipid droplets coated with PLIN2 did not recruit CGI-58 to 
the lipid droplets as effectively as either PLIN1 or PLIN5 (64).  However, there are 
other studies with conflicting results.  Yamaguchi et al. (2006) investigated the 
functions of PLIN2 and performed yeast two-hybrid screening to find any functional 
partners, finding that CGI-58 can interact with PLIN2 (73). Therefore, it is possible 
that the lack of interaction may be cell/tissue-specific.   
Due to PLIN5 being highly expressed in oxidative tissues it seems likely that 
this PLIN protein is involved in the regulation of skeletal muscle lipid droplet 
dynamics.  In PLIN5 null mice lipid droplets are undetectable in hearts, however 
lipid droplets are observed in other tissues including skeletal muscle suggesting that 
the role(s) of PLIN5 may differ depending on the individual cell/tissue type. There 
was no significant difference in TG content in soleus muscle from PLIN5 null mice 
compared to wild type controls (small decrease), however this could be due to the 
other skeletal muscle PLIN proteins compensating for the loss, or the possibility that 
more than one PLIN protein is required to fully regulate skeletal muscle lipolysis.  
Previous work investigating possible interaction partners for PLIN5 has been done 
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with a cell culture model.  Using CHO cells, Wang et al. 2011, determined that PLIN5 
directly binds to ATGL and that PLIN5 is a substrate for PKA, suggesting that 
phosphorylation of PLIN5 enables lipolysis (65).  The lack of a significant decline in 
the PLIN5-ATGL interaction seen in the present study may be due to our stimulation 
protocol, which did not include any adrenergic stimulation to activate PKA.  
Recently, it was demonstrated that PLIN5 facilitates lipolysis by promoting the co-
localization and functional interaction of CGI-58 and ATGL (23, 25).  The same 
PLIN5 molecule does not bind both at the same time (24) and appears to be 
responsible for directing CGI-58 to the droplet surface to increase ATGL activity 
(22).  In the present study we found that PLIN5 interacts with both ATGL and CGI-
58, however it is not known what proportion of PLIN5 is bound to either ATGL or 
CGI-58, or if PLIN5 interacts with both ATGL and CGI-58 at the same time. 
Previous to the current work, it was unknown if PLIN3 interacted with either 
ATGL or CGI-58.  Our results suggest that PLIN3 is also involved in reducing lipolysis 
through interactions with both ATGL and CGI-58.   It has been suggested that PLIN3 
plays a role in lipid droplet formation/growth synthesis by inhibiting lipolysis.  This 
is supported by work using immunofluorescence microscopy in 3T3-L1 cells treated 
with oleate, glucose and insulin (designed in increase TG synthesis) finding that 
PLIN3 moved from the cytosol to the lipid droplet (70).  Moreover, in PLIN2 null 
mice, PLIN2 on the LD is replaced with PLIN3 (57).  To further support a role for 
PLIN3 in preventing lipolysis and promoting TG synthesis, siRNA knockdown of 
PLIN3 in PLIN2 knockout mice resulted in reduced number of lipid droplets, 
reduced incorporation of oleate into TG, and increased incorporation of oleate to 
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phospholipids, where knockout of PLIN2 alone resulted in no change (Ducharme & 
Bickel, 2008).  Interestingly, the sequence of amino acids 191-437 of PLIN3 is 
similar to the amino acid sequence 200-463 of PLIN5 which has been found to be 
the binding site for both ATGL and CGI-58 on PLIN5 (28).  Our finding that both 
PLIN3 and PLIN5 interact with ATGL and CGI-58 in skeletal muscle is consistent 
with these findings.  However, as PLIN3 and 5 are found in the cytosol as well as on 
the lipid droplet it is unknown which population of these proteins is bound to either 
ATGL and/or CGI-58.  Further study in this area is needed to determine these 
interactions. 
 
Perspectives and Significance 
 
This study examined the interactions of the rate limiting lipase, ATGL, its co-
activator, CGI-58, and three skeletal muscle PLIN proteins at rest and following 
contraction.  This is the first study to demonstrate that in isolated skeletal muscle 
the interaction between ATGL and CGI-58 is significantly increased following a 
contraction protocol that lacks adrenergic stimulation.  Further, this study provides 
evidence that in skeletal muscle both ATGL and CGI-58 are potentially regulated by 
more than one protein of the PLIN family.  Taken together, these data suggest that, 
the skeletal muscle PLIN proteins, ATGL, and CGI-58 may not ever exist in a single 
complex at rest or during contraction but may instead represent a network of 
proteins interacting with one another at different times for different purposes.  
Evidence indicates that all three of these PLIN proteins are associated with 
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mitochondria (7, 29, 45, 67).  It is possible that in skeletal muscle these PLIN 
proteins work together to control the rate of lipolysis and thus of FA entry into the 
mitochondria during lipolysis.  Understanding the mechanisms by which PLIN 
proteins contribute to these processes will help to clarify both the physiology of 
healthy cells and tissues, as well as the pathophysiological basis of some important 
metabolic diseases.  Further research is needed to elucidate the specific roles of 
skeletal muscle PLIN proteins in regulating lipolysis and FA entry into the 
mitochondria.  
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Abstract 
In adipose tissue, access of adipose triglyceride and hormone sensitive lipases 
(ATGL and HSL) to the lipid droplet depends on PLIN1 phosphorylation, however 
PLIN1 is not expressed in skeletal muscle and the phosphorylation of the expressed 
PLINs has yet to be investigated. Further, direct interactions between skeletal 
muscle PLINs and HSL are unknown. We investigated the isolated and combined 
effects of epinephrine and contraction on PLIN-to-lipase interactions as well as 
phosphorylation. Isolated rat solei were assigned to one of four 30min in-vitro 
conditions (25oC): 1) rest; 2) intermittent tetanic stimulation (60Hz for 150ms; train 
rate 20/min); 3) 5nM epinephrine; 4) intermittent tetanic stimulation and 5nM 
epinephrine. Immunoprecipitation of serine-phosphorylated proteins followed by 
Western blotting for PLIN2, PLIN3, PLIN5, revealed that only PLIN2 is not 
phosphorylated under any of the experimental conditions.  This is the first study to 
show that in whole rat skeletal muscle PLIN3 and PLIN5 are serine phosphorylated.  
The degree of serine phosphorylation remained unchanged following adrenergic 
and/or contractile stimulation. Oil red O staining of muscle sections for lipid content 
shows a significant decrease following each condition, confirming lipolysis occurred 
(P<0.05). PLIN2, 3, and 5 all interact with HSL and ATGL, but these interactions 
were unchanged following treatments.  Our results show that in skeletal muscle, 
PLIN2 is not serine phosphorylated at rest or with lipolytic stimulation and that 
while PLIN3, PLIN5 are serine phosphorylated at rest, the degree of 
phosphorylation does not change with lipolytic stimulation.  
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Introduction 
 
Intramuscular triglycerides (IMTGs) represent an important energy source 
that can be mobilized during exercise through a combination of external hormonal 
(increased epinephrine) and internal metabolic signals (intracellular Ca2+, and 
metabolite concentrations).  However, the exact mechanisms regulating IMTG 
breakdown during exercise are poorly understood.  IMTGs are stored in 
metabolically active organelles known as lipid droplets that are encased by a 
phospholipid monolayer coated with a variety of proteins (4, 33). Evidence indicates 
that the regulation of skeletal muscle lipolysis is mediated by protein-protein 
interactions occurring on the lipid droplet surface (37, 48).  Specifically, a family of 
lipid droplet proteins, known as PLIN proteins, have emerged as likely candidates in 
mediating the hydrolysis of IMTGs (10, 37). To date, work investigating the role(s) 
of PLINs has focused on adipose tissue, however recent investigations in skeletal 
muscle support a role for PLIN proteins in the regulation of IMTG degradation (36, 
37, 51-53). 
The PLIN family is composed of five members (PLIN1 through PLIN5) (29, 
41), each with a unique tissue distribution and potentially a unique role in cellular 
lipid metabolism (26, 68). PLIN1 is the only member of this family for which a 
specific role in regulating lipolysis has been determined, however it is only 
expressed in adipose tissue.  More specifically, in a basal state PLIN1 limits the 
activity of the rate limiting lipase, ATGL, by directly binding to its co-activator, CGI-
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58 (11, 42, 54, 60).  Under lipolytic stimulation, initiated by catecholamines, it is 
believed that the PKA-dependent serine phosphorylation of PLIN1 initiates lipolysis 
by releasing CGI-58 and allowing it to bind to and activate ATGL (6, 16, 18-20).  
Further, phosphorylation of PLIN1 is required for HSL recruitment to the lipid 
droplet through binding to PLIN1 (65). Skeletal muscle does not express PLIN1 and, 
thus far, similar roles for skeletal muscle PLIN proteins have yet to be determined.  
It has been suggested that PLIN2, PLIN3, and PLIN5 play a large role in 
regulating lipolysis in skeletal muscle (36, 37, 46, 51-53). PLIN2 is the predominant 
lipid droplet associated protein in skeletal muscle (47) and PLIN5 is unique in that it 
is highly expressed in oxidative tissues (68). Although knowledge of PLIN3 in 
skeletal muscle is scarce, recent work from our laboratory showed that ATGL 
interacts with PLIN2, PLIN3, and PLIN5 in isolated rat soleus muscle (37). These 
protein interactions suggest that PLIN2, PLIN3, and PLIN5 may have a role in the 
regulation of ATGL activity and therefore the initiation of skeletal muscle lipolysis.  
In adipose tissue, the reversible phosphorylation of PLIN1 is necessary for lipolytic 
activation (38, 43, 57, 59), however the phosphorylation state of the remaining 
PLINs has yet to be investigated in skeletal muscle. A phosphorylation site has been 
identified on PLIN2 (serine 291) (4), PLIN3 (serine 245) (24), and some evidence 
indicates that PLIN5 is a substrate for PKA phosphorylation (64). It is possible that 
the phosphorylation of PLIN2, PLIN3, or PLIN5 may be required to optimally 
position ATGL, CGI-58, and/or HSL for activation of lipolysis in skeletal muscle.  
Exercise leads to the activation of several skeletal muscle kinases, all of 
which may play into regulating the rate of lipolysis.  Increased circulating 
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epinephrine concentrations leads to the activation of PKA, while at the same time 
contraction increases intramuscular calcium levels and CaMK and ERK activation. 
The use of ATP during contraction also leads to increased levels of AMP, which 
activates AMPK.  It is known that epinephrine and contraction activate skeletal 
muscle hormone sensitive lipase (HSL) with additive effects, thus indicating that 
epinephrine and contraction activate HSL through different signaling mechanisms 
(13-15, 25, 31, 55, 66). Therefore the purpose of this study was to examine the 
isolated and additive effects of epinephrine and contraction on skeletal muscle PLIN 
protein to ATGL and HSL interactions as well as phosphorylation status.  A major 
objective of this study was to determine if PLIN2, PLIN3, and/or PLIN5 are 
phosphorylated and whether this changes during lipolysis.   If so, this study aimed to 
separate adrenergic and/or contractile stimulation. A second objective of this study 
was to investigate the role of PLIN2, PLIN3 and PLIN5 in governing the accessibility 
of ATGL and HSL via direct protein-protein interactions during these perturbations.  
We hypothesized that skeletal muscle PLIN to lipase interactions are governed by 
PLIN phosphorylation status. 
 
Methods 
Animals  
 
A total of 48 male Long-Evans rats (4–6 wk old) were used in this study. 
Animals were housed in groups within the Brock University Animal Facility, where 
they were maintained on a 12:12-h light-dark cycle at 22°C. The rats were fed a 
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standard rodent diet with ad libitum access to food and water. All experimental 
procedures and protocols were approved by the Brock University Animal Care and 
Utilization Committee and conformed to all Canadian Council on Animal Care 
guidelines. 
 
Muscle preparation  
 
Animals were anesthetized via intraperitoneal injection of pentobarbital 
sodium (6 mg/100g body wt).  The left and right solei were removed and placed in 
organ baths, where they were assigned to one of four experimental conditions: 1) 
rest; 2) electrically stimulated contraction (15, 36); 3) 5nM epinephrine (45); and 4) 
epinephrine and electrical stimulation. To briefly summarize the preparation, each 
soleus muscle was dissected tendon-to-tendon, sutures tied in-situ, the muscle was 
then removed and immediately placed in an organ bath (Radnoti Glass Technology, 
Monrovia, CA), which contained 7-8 ml of fully oxygenated liquid Sigma medium 
199 (M 4530, Aigma-Aldrich, Canada) and suspended at a resting tension of 1 g. The 
incubation medium was continuously gassed with 95% O2 5% CO2, and temperature 
was maintained at 25°C (3). All muscles were allowed to equilibrate at rest for 30 
min. This isolated muscle preparation allows for the examination of the isolated 
effects of epinephrine, contraction, as well as epinephrine and contraction together 
on muscle lipid metabolism in isolation, absent other systemic perturbations. 
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Perturbation 
 
1. Epinephrine Incubation: Soleus muscles were incubated with 5nm epinephrine 
for 30 min.  This concentration of epinephrine has previously proven to maximally 
promote triglyceride breakdown in isolated soleus muscles (45).  
2. Stimulated Contraction: Soleus muscles were stimulated to contract for 30 min 
as previously reported by our lab and others (15, 36, 37). Initially, optimal stimulus 
voltage was determined by assessing force responses (Grass Telefactor force 
transducer, West Warwick, RI) to single electrical pulses (Grass Model FT03 with 
P11T amplifier). Stimulus intensity was increased from 10 V in 10-V increments, 
until a plateau in twitch force was reached, after which stimulus voltage was 
increased to ~1.25 of this level. During the 30-min stimulus protocol, muscles 
received repeated volleys of brief (150 ms) but high-frequency (60 Hz) trains at a 
train rate of 20 tetani/min whilst muscles were suspended at 1 g of resting tension.   
This protocol was previously proven to elicit maximal rates of triglyceride pool 
turnover and rates of IMTG oxidation without the development of fatigue (15, 36). 
Throughout this period, muscle force was recorded using Grass Polyview Data 
Acquisition and Analysis System (West-Warwick, RI) and analyzed using the 
Polyview Reviewer (Grass Polyview Data Acquisition and Analysis System; Astro-
Med, West-Warwick, RI). 
3. Epinephrine and Electrically Stimulated Contraction. Soleus muscles were 
incubated with 5.0 nM epinephrine as well as electrically stimulated to contract, 
describe above, for 30 min. 
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Sample Preparation 
 
Following the incubations, solei were removed from the baths and cut into 
two pieces. One piece was snap frozen in liquid nitrogen for Western blotting 
analysis and the other piece was mounted for histochemical analysis (see below). 
Soleus muscles were homogenized in Griffin lysis buffer (150 mM NaCl, 50 mM Tris 
HCl, 1 mM EGTA) using a 1:25 dilution of muscle to buffer with added protease 
(11836170001, Roach, QC), and phosphatase inhibitor tablets (04906845001, 
Roach, QC). For measures of protein phosphorylation a kinase inhibitor (7,8-
Dihydroxycoumarin, 1001251297, Sigma Aldrich) was added to the homogenization 
buffer.  Protein concentration of the total homogenates was determined using a 
Bradford Assay (Bio-Rad Protein Assay Dye Reagent Concentrate; #500-0006, Bio-
Rad, USA). 
 
Protein Interactions (co-immunoprecipitation) 
 
Sample homogenates were immunoprecipitated with 5 μl of the appropriate 
primary antibody (ATGL or HSL) and then immunoblotted for the corresponding 
protein (PLIN2; PLIN3; PLIN5; CGI-58). Specifically, 500-1000 μg of protein from 
each sample were incubated for 2 h with the antibody at 4 °C.  Pilot work was done 
in order to determine the appropriate amount of whole homogenate to incubate 
with the antibody in order to fully isolate the protein of interest. Following this 20 μl 
of Protein G Agarose beads (sc-2001, Santa Cruz Biotechnology Inc) were added to 
each sample for overnight incubation at 4 °C. The pellet of each sample was 
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collected by centrifugation at 130 rpm for 5-10 seconds. Pellets were washed three 
times in phosphate buffered saline (PBS) and re-suspended in 40 μl of 2x sample 
buffer. To test for antibody interference in the samples a blank sample containing 
only the precipitating antibody and lysis buffer were prepared in exactly the same 
manner as the experimental samples. For interactions where antibody interference 
occurred, a secondary antibody that only detects native (i.e., not denatured) 
antibodies was used (Clean Blot IP Detection Reagent; Thermo Scientific). All 
samples were boiled and separated using 8 or 10% SDS–polyacrylimide gel 
electrophoresis. 
 
Protein Phosphorylation (immunoprecipitation of PSer proteins) 
 
To ensure immunoprecipitation of all serine phosphorylated proteins sample 
homogenates were immunoprecipitated with 40 μl of anti-phosphoserine antibody 
(Millipore AB1603) and then immunoblotted for the corresponding protein (ATGL; 
PLIN2; PLIN3; PLIN5). Specifically, 500 μg of protein from each sample were used in 
order to isolate PSer proteins.  In order to avoid antibody interference as well as 
save sample these samples were prepared using a Pierce® immunoprecipitation kit 
(#26149, Thermo Scientific, Rockford, IL, USA).  A phosphoserine antibody was used 
based on previous work indicating that PLIN2, PLIN3, and ATGL contain serine 
phosphorylation sites (4, 24, 39), and that PLIN5 may be substrate for PKA (64). 
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Western blotting  
 
SDS-polyacrylamide gel electrophoresis (8 or 10% separating; 4% stacking) 
was used to separate proteins (ATGL, CGI-58, PLIN2, PLIN3, and PLIN5) at 120 V for 
1.5 h, and proteins were electroblotted onto polyvinylidene difluoride membranes 
(Amersham Biosciences, Piscataway, New Jersey) for 1 h at 100 V followed by 
blocking in 2 or 5% fat-free milk in TBST, or 5% BSA in TBST. Primary antibodies 
for co-precipitated proteins were diluted 1:1000 in 2 or 3% fat-free milk, or 1 or 5% 
BSA in TBST and incubated overnight at 4 °C. Secondary antibodies were diluted 
1:10000-20000 in 2 or 3% milk, or 1 or 5% BSA and incubated for 1 hour. Blots of 
specific proteins were visualized with enhanced chemiluminesence (Amersham 
Biosciences, Piscataway, New Jersey).  The densities of the individual bands were 
integrated using Image J software (http://rsbweb.nih.gov/ij/).  Each blot had loaded 
whole soleus homogenate as a positive control for the co-precipitated protein. Blots 
were normalized to total protein loaded determined by Ponceau S staining (M530; 
Sigma-Aldrich) and results are reported as the ratio of the density of the target 
protein to the density of the loaded protein in arbitrary units (37, 49). 
 
Antibodies  
 
The following antibodies were used and have been used previously: anti-
phosphoserine antibody (Millipore AB1603), PLIN2 (52 kDa) mouse monoclonal 
antibody (Progen Biotechnik, Heidelberg, Cat. No. 610102) (37, 46), PLIN3 (47 kDa) 
(ProSci Inc., Poway, California, Cat. No. 3883)(37, 46), PLIN5 (52 kDa) guinea pig 
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polyclonal antibody (Progen Biotechnik, Heidelberg, Cat. Nos. GP34 and GP31) (8, 
37, 40, 46), ATGL (54 kDa) rabbit monoclonal antibody (Cell Signalling Technology, 
#2439, Danvers, MA) (2, 37), CGI-58 (42 kDa) rabbit polyclonal antibody (Novus 
Biologicals, NB110-41576, Oakville, ON) (2, 37, 61), and HSL (Cell Signalling 
Technology, 4107S, Danvers, MA). 
 
Histochemical Analysis 
 
The muscle section used for histochemical analysis was oriented for cross 
sections and mounted, in embedding medium (Cryomatrix, Pittsburgh, PA), on a 
piece of cork, which was plunged into 2-methylbutane cooled in liquid nitrogen. 
Following rapid freezing, the samples were stored at -80°C until sectioning. 
Sectioning was completed with a cryotome (ThermoShandon, Runcorn, Cheshire, 
UK) optimally set at -20°C. Sections were (10 μm thick) thaw mounted onto slides 
and stored at -80°C until histochemical staining. To permit the examination of lipid 
droplets, oil red O (ORO; O0625; Sigma-Aldrich, St. Louis, MO) (30) was utilized (30, 
56, 62, 63). Briefly, cryosections were fixed in 3.7% formaldehyde for 1h. Slides 
were then rinsed 3 times in deionized water for 30 s, and then immersed in the 
working solution of ORO for 30 min. Slides were rinsed three times in deionized 
water and cover slips were mounted with a prolonging agent (no. P36930; Prolong 
Gold anti-fade reagent; Invitrogen). 
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Image capturing and analyses  
 
All sections were examined using a Nikon Eclipse 80i fluorescence 
microscope (Nikon Eclipse 80i; Chiyoda-ku, Tokyo, Japan). Digital images of the 
slides were captured with a digital camera (Retiga 1300, QImaging, Burnaby, BC, 
Canada) attached to the microscope. To visualize the ORO stain a TRITC (510–560 
nm) excitation filter was used. Digitally captured images (x40 magnification), four 
fields of view/muscle cross section (23.1 ± 0.6 fibers/field of view), were processed 
and analyzed using imaging software (NIS-Elements AR 3.00; Nikon Instruments, 
Melville, NY). An intensity threshold representing minimal values corresponding to 
lipid droplets was set manually and applied uniformly in all images. The lipid 
droplet fluorescent signals were quantified for each muscle fiber, resulting in a total 
of 92.3 ± 2.6 fibers analyzed for each muscle cross section. Fiber area, as well as 
number and area of objects emitting a fluorescent signal, were recorded. Muscle 
fiber lipid droplet content was expressed as the fraction of the measured area that 
was stained per fibre (36, 62). All measures were manually outlined and traced by 
investigators for each individual myocyte. The immunofluorescence method 
described here covers numerous fibers per muscle cross section and, therefore, 
gives a good representation of the entire muscle. To test the reliability of the method 
in our hands, both intra-observer and inter-observer reliability were evaluated by 
two investigators. The intra-observer reliability involved the two investigators 
performing analysis of one image three times, at least 1 wk apart. The inter-
observer reliability involved two independent investigators performing analysis for 
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three separate images. These tests proved to be reliable with a coefficient of 
variation <5% for both intra-observer and inter-observer reliability. 
 
Statistics 
 
Comparisons of mean lipid content, protein interactions and phosphorylation 
between groups were performed using a one-way ANOVA (incubation condition). 
Tukey post hoc tests were performed when significance was detected. Statistical 
significance was set at P < 0.05. All data are expressed as means ±SEM. 
 
Results 
Lipid droplet content 
 
The average muscle fiber area was 2604 ± 532 μm2. Figure 1 shows 
representative images of rat skeletal muscle cross sections viewed with an 
immunofluorescence microscope following incubation with ORO.  Fiber lipid droplet 
content (area lipid stained) decreased to ~30% of resting values in all groups 
(p=0.001; Figure 1).  
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Figure 1 
 
  REST          EPI   CONT      EPI+CONT  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Digitally captured images of one single field of view (x40 magnification) 
taken from a soleus muscle cross section. A. Oil red O (ORO) staining. EPI, 
epinephrine stimulate 5 nM/L; CONT, electrically stimulated contractions for 30 
min; EPI+CONT, combination of 5 nM/L epinephrine and electrically stimulated 
contractions for 30 min. 
B. Lipid content (expressed as area fraction stained) in rested and stimulated rat 
soleus muscle. Values are expressed as means ±SE. *Significantly different from 
experimental conditions (P < 0.05) (n=9 for EPI and CONT; n=10 for REST and 
EPI+CONT). 
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Protein interactions 
 
ATGL co-immunoprecipitated with CGI-58 at rest and following each 
perturbation. Contraction, epinephrine, and the combination appeared to increase 
this interaction ~50%, 25%, and 80% respectively, although this was not 
statistically significant (p=0.25; Figure 2a).  
PLIN2, 3 and 5 all co-immunoprecipitated with ATGL at rest and following 
each perturbation. There were no significant differences in PLIN protein content in 
ATGL immunoprecipitated samples following any of the perturbations (p>0.05) 
(Figure 3 and 4).  
PLIN2, 3 and 5 all co-immunoprecipitated with HSL at rest and following 
each perturbation. There were no significant differences in PLIN protein content in 
HSL immunoprecipitated samples following any of the perturbations (p>0.05) 
(Figure 3 and 4).  
 
Protein Serine Phosphorylation 
 
Western blotting for PLIN2 protein content in immunoprocipitated serine 
phosphorylated proteins resulted in no detectable PLIN2 protein at rest or with any 
of the perturbations (Figure 3). Phosphorylation of PLIN3, PLIN5, and ATGL was 
detectable at rest with no significant difference under any of the perturbations 
(p>0.05) (Figure 4).   
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Figure 2 
Figure 17 
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Figure 2. A. ATGL-CGI-58 interaction: CGI-58 protein content (arbitrary units) in 
ATGL immunoprecipitated samples at rest and following stimulation with 
representative Western blot (EPI, epinephrine stimulate 5 nM/L; CONT, electrically 
stimulated contractions for 30 min; EPI+CONT, combination of 5 nM/L epinephrine 
and electrically stimulated contractions for 30 min; B negative control containing 
just the IP antibody; WH whole homogenate) (n=12 for REST and CONT+EPI; n=11 
for CONT and EPI). CGI-58 content is relative to total protein content as measured 
by ponceau staining B. ATGL serine phosphorylation: ATGL protein content 
(arbitrary units) in phosphoserine immunoprecipitated samples at rest and 
following stimulation with representative Western blots (n=8). ATGL serine 
phosphorylation is relative to total protein content as measured by ponceau staining
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Figure 18 
 
Figure 3. ATGL/HSL-PLIN2 protein interactions and PLIN2 serine phosphorylation at rest and following stimulation shown as 
PLIN protein content (arbitrary units) in immunoprecipitated samples with representative Western blots (EPI, epinephrine 
stimulate 5 nM/L; CONT, electrically stimulated contractions for 30 min; EPI+CONT, combination of 5 nM/L epinephrine and 
electrically stimulated contractions for 30 min; B negative control containing just the IP antibody; WH whole homogenate) 
(n=10). PLIN2, Western blotting for PLIN2 in phosphoserine immunoprecipitated samples resulted in no detectable signal 
under any condition. PLIN2 content is relative to total protein content as measured by ponceau staining. 
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Figure 4.  
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Figure 19 
Figure 4. ATGL/HSL-PLIN protein interactions and PLIN serine phosphorylation at 
rest and following stimulation shown as PLIN protein content (arbitrary units 
relative to total protein measured by ponceau staining) in immunoprecipitated 
samples with representative Western blots (EPI, epinephrine stimulate 5 nM/L; 
CONT, electrically stimulated contractions for 30 min; EPI+CONT, combination of 5 
nM/L epinephrine and electrically stimulated contractions for 30 min; B negative 
control containing just the IP antibody; WH whole homogenate) (n=10). A. PLIN3; 
PLIN3 B. PLIN5.  
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Discussion 
 
Skeletal muscle PLIN proteins are believed to play a critical role in regulating 
IMTG turnover, however the exact mechanisms regulating lipolysis within skeletal 
muscle during exercise remain unknown. This study investigated the effects of 
contraction and epinephrine alone and in combination on the phosphorylation state 
of PLIN2, PLIN3, PLIN5, and ATGL, as well as the PLIN interactions with ATGL and 
HSL. This is the first study to show in intact rat skeletal muscle that PLIN2, PLIN3, 
and PLIN5 interact with HSL and that these interactions are unchanged following 
either contractile or adrenergic stimulation.   Further findings from this work 
demonstrate that both PLIN3 and PLIN5 are serine phosphorylated while PLIN2 is 
not serine phosphorylated.  Contrary to our hypothesis there was no significant 
change in PLIN3 or PLIN5 phosphorylation with contraction or epinephrine alone or 
in combination.  These novel findings indicate that, unlike adipose tissue where 
PLIN1 phosphorylation is required for lipolysis, skeletal muscle PLIN proteins are 
phosphorylated in a basal state and that overall this total phosphorylation does not 
change with lipolysis under either adrenergic or contractile stimulation. Further 
work is necessary to investigate the site specific phosphorylation of these two 
proteins to determine if there are other sites that may have been affected. 
Our experimental conditions were chosen for their ability to elicit large levels 
of intramuscular triglyceride turnover.  The stimulated contraction protocol used in 
this study has been shown to elicit maximal rates of lipolysis in isolated soleus 
muscle and we have previously shown that this method leads to a significant decline 
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in IMTGs (15, 36).  Moreover, the epinephrine concentration used (5nM) was 
previously shown to increase IMTG hydrolysis in isolated rat soleus (45). In the 
present study we found a significant reduction in intramuscular lipids stained by oil 
red O following each experimental condition (Figure 1; electrically stimulated 
contraction 68% decrease, epinephrine stimulation 65% decrease, and combination 
of both 73% decrease), thus confirming that our model elicited high rates of 
lipolysis in all experimental conditions.   
We show that the interactions of PLIN2, PLIN3, and PLIN5 with ATGL and 
HSL are unchanged following contraction or epinephrine stimulation alone or in 
combination.  PLIN2 was the only skeletal muscle PLIN protein not to be serine 
phosphorylated under any of the experimental conditions (rest, contraction, 
epinephrine, or both).  This finding is interesting, as PLIN2 has been suggested to 
function similarly to PLIN1 by increasing triglyceride storage and decreasing 
triglyceride turnover (5, 12, 17, 27, 28).  In skeletal muscle, some evidence indicates 
that PLIN2 is involved in regulating lipolysis, however other research points 
towards an essential role of PLIN2 in IMTG synthesis. Recently, Shepherd et al. (52) 
found that in human skeletal muscle PLIN2-associated lipid droplets are 
preferentially used with an acute bout of exercise, supporting a role for PLIN2 in 
regulating muscle lipolysis.  Interestingly, PLIN2 protein content is higher in cases 
where there is increased IMTG content, such as in females, type II diabetics, and 
with endurance training (40, 46, 51). Therefore, a higher PLIN2 content could 
simply be a consequence of increased PLIN2 protein stability through increased 
lipid droplet size and number.  Previous work with skeletal muscle contraction has 
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shown a translocation of HSL towards PLIN2-coated lipid droplets (48), however 
this study did not determine if there was a direct physical interaction between these 
two proteins. Our work demonstrates an interaction between PLIN2 and ATGL (37) 
as well as HSL, however this interaction remains unchanged following contraction 
and/or epinephrine stimulation in vitro.  Previously, our group found that the 
interaction between PLIN2 and ATGL is significantly decreased (21%) following 
electrically stimulated contraction (37).  The present study shows a trend for a 
decline in this interaction following each of the experimental conditions however 
this did not meet statistical significance likely due to the small sample size and the 
addition of two groups to the statistical analysis. Future work should investigate the 
importance of this interaction in skeletal muscle. It is possible that PLIN2 may not 
be directly involved in stimulated skeletal muscle lipolysis but is more involved with 
IMTG synthesis and lipid droplet growth. PLIN2 content increases with fatty acid 
loading of myotubes and with in vivo interventions that lead to an increased muscle 
lipid content (high fat diet and fasting) (7). Additionally, overexpression of PLIN2 in-
vitro and in-vivo results in increased intramyocellular lipid content, while 
knockdown of PLIN2 in cultured myotubes prevents fatty acid induced IMTG 
accumulation and lipid droplet storage (7).  Due to the association of PLIN2 with 
both ATGL and HSL it is possible that PLIN2 is important for regulating basal 
lipolysis however future work may want to investigate a role for PLIN2 in lipid 
droplet development and its relationship to proteins involved in IMTG synthesis. 
In this study both PLIN3 and PLIN5 were found to be serine phosphorylated 
and this did not change following either adrenergic or contractile stimulation.  Also, 
 151 
both PLIN3 and PLIN5 interacted with ATGL and HSL but this was unchanged 
following lipolytic stimulation.  Therefore, like PLIN2, the roles of PLIN3 and PLIN5 
in skeletal muscle lipid dynamics remain unclear.  Among the PLIN family, PLIN3 
has a high degree of sequence similarity with PLIN2 and also shows a ubiquitous 
tissue expression (34, 69), therefore PLIN3 may play a similar role as PLIN2 in lipid 
droplet dynamics.  Association of PLIN3 with lipid droplets increases in cells grown 
in media supplemented with exogenous fatty acids or glucose and insulin (designed 
to increase TG synthesis) (67, 69). Moreover, in PLIN2 null mice, PLIN2 on the LD is 
replaced with PLIN3 (58). This research suggests that PLIN3, like PLIN2, plays a role 
in lipid droplet formation and triglyceride synthesis and less of a role in stimulated 
lipolysis.  PLIN5 has previously been shown to be essential for ATGL-mediated 
lipolysis (21, 22) and was found to be a substrate for PKA in AML12 mouse liver 
cells, suggesting that PLIN5 phosphorylation may be important for lipolysis (64).  
However our results show that in skeletal muscle, PKA stimulation through 
epinephrine does not change the serine phosphorylation state of PLIN5 or the 
association with either ATGL or HSL.  PKA is both a serine and threonine kinase and 
therefore it is possible that PLIN5 is also phosphorylated on a threonine site.  This 
highlights the importance of determine the specific sites on which PLIN5 may be 
phosphorylated. Further, we show that contraction-induced kinases did not result in 
changes in the overall serine phosphorylation state of PLIN5 or change the 
interactions with lipases.  Due to the oxidative tissue expression of PLIN5 (68), as 
well as its association with mitochondria (8), it is likely that PLIN5 plays a role in 
facilitating fatty acid oxidation and not IMTG hydrolysis per se.  In support of this 
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theory, Peters et al. (46) found PLIN5 protein content increased with endurance 
training and this increase was associated with improved muscle oxidative capacity. 
Other work has demonstrated that overexpression of PLIN5 in-vitro increased fatty 
acid oxidation (68), providing evidence for a larger role of PLIN5 in enhancing the 
oxidation of the fatty acids released from the lipid droplets over IMTG synthesis or 
lipolysis.  Overexpression of PLIN5 in skeletal muscle also promotes expression of 
several genes, regulated by PPARα and PGC1α, involved in fatty acid catabolism and 
oxidation (9). The recent discovery that PLIN5 is located in direct contact with 
mitochondria and that PLIN5 overexpression results in more intimate interactions 
between these two organelles provides more evidence in support of a strong role in 
oxidation (8). Our findings that PLIN5 is associated with both ATGL and HSL with no 
change under any condition indicate that PLIN5 may be involved in regulating basal 
lipolysis but not stimulated lipolysis.  Future work should investigate a role for 
PLIN5 in fatty acid oxidation and mitochondrial association. The mechanistic 
function of interactions between PLIN2, PLIN3, and PLIN5 with both ATGL and HSL 
remains to be investigated. These interactions might be essential for maintaining a 
stable rate of basal lipolysis or ensuring that the lipases are targeted to the right 
subcellular location. 
ATGL is now known as the rate-limiting lipase in lipolysis and its activity is 
enhanced in the presence of CGI-58 (32, 70). We have previously shown that 30 min 
of isolated soleus contraction leads to a significant increase in the interaction 
between ATGL and CGI-58, consistent with the increased rates of lipolysis observed 
in our study, as well as being consistent with the activation of lipolysis in adipose 
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tissue (37).  However, in the present study we found that the increased ATGL and 
CGI-58 interaction did not reach significance with any of our experimental 
conditions.  It has been suggested that a direct physical interaction between ATGL 
and CGI-58 is not actually necessary to increase the lipolytic activity of ATGL (35).  
Gruber at al. (23) demonstrated that CGI-58 is able to bind directly to the 
phospholipid monolayer of lipid droplets and that without this there is a complete 
loss of the ability of CGI-58 to activate ATGL, regardless of their interaction.  These 
results may explain why in the present study there was no significant increase in 
protein-protein interaction between ATGL and CGI-58.  It may be more important 
for CGI-58 to bind to the lipid droplet membrane and somehow allow ATGL to 
access the triglyceride core (35).   
Previous studies have identified serine phosphorylation sites on ATGL (Ser 
406/404 and 428/430) (4, 70), however functional roles of phosphorylation and the 
kinases involved remain unknown.  While work in other cell types (HEK293 cells 
and adipocytes) indicates that AMPK (1) and PKA (44) can phosphorylate ATGL, our 
results show that ATGL serine phosphorylation remains unchanged in the face of 
contractile and/or adrenergic stimulation.  This finding is in agreement with Mason 
et al. (39) who demonstrated that ATGL Ser404 phosphorylation is not increased in 
human skeletal muscle during moderate-intensity cycling exercise. In addition, that 
study demonstrated that there was no evidence of a physical interaction between 
ATGL and AMPK after immunoprecipitation, and pharmacological activation of 
AMPK did not affect ATGL Ser404 phosphorylation in cultured myotubes (39). 
Further, direct studies in C2C12 myotubes showed no effect of forskolin (PKA 
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activation) on ATGL Ser406 phosphorylation (39).  From this, Mason et al. 
concluded that neither AMPK nor PKA phosphorylate skeletal muscle ATGL Ser404 
in intact cell systems or whole organisms.  Taken together with the results from the 
present study it seems as though there is a tissue-specific regulation of ATGL, 
potentially explaining the differences seen in skeletal muscle compared to HEK cells 
and adipocytes. 
 
Perspectives and Significance 
 
This study examined the serine phosphorylation states of skeletal muscle 
PLIN proteins (PLIN2, PLIN3, and PLIN5) as well as their interactions with ATGL 
and HSL at rest and following contraction and epinephrine stimulation in isolation 
as well as in combination. This is the first study to show that both PLIN3 and PLIN5 
are serine phosphorylated under all conditions and that PLIN2 is not. Further this is 
the first study to determine that PLIN2, PLIN3, and PLIN5 all interact with HSL and 
that this relationship remains unchanged following stimulation.  Together, the 
above-mentioned data suggest that, unlike in adipose tissue where PLIN1 is 
unphosphorylated at rest, in skeletal muscle PLIN3 and 5 are serine phosphorylated 
at rest and this is unchanged with lipolysis.  The physiological importance of skeletal 
muscle PLIN3, PLIN5, and ATGL phosphorylation as well as the PLIN-to-lipase 
interactions remains unknown.  A role for skeletal muscle PLIN phosphorylaton in 
lipid droplet dynamics should be further examined with the development of 
phospho-specific antibodies. In comparison to adipose tissue skeletal muscle has a 
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much higher triglyceride turnover (50).  Therefore, it is possible that the PLIN 
proteins are important for basal muscle lipolysis rather than epinephrine or 
contraction mediated IMTG breakdown. Future work should examine the roles that 
skeletal muscle PLINs play on lipogenesis as well as fatty acid oxidation. 
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Chapter 7 
 
 
General Discussion 
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 Research in the last 20 years has made significant progress in identifying 
lipid droplet associated proteins and developing an understanding of the role(s) 
that they may play in regulating intracellular lipid homeostasis. Specifically, the 
discovery of PLIN proteins has lead to great advancements in the understanding of 
adipose tissue lipolysis and a specific role for PLIN1 has now been established in 
this tissue.  PLIN1 is only expressed in adipose tissue and while research in the area 
continues to expand; the role(s) of the remaining PLIN proteins remains unknown. 
Among the PLIN family, PLIN2, PLIN3, and PLIN5 are all expressed in skeletal 
muscle and are therefore likely targets in regulating skeletal muscle lipid dynamics. 
A proper balance between fatty acid uptake, storage, and fat oxidation in 
skeletal muscle is important when considering metabolic diseases that are believed 
to be related to intracellular lipotoxicity (52).  Therefore, a full understanding of the 
metabolic processes regulating how IMTGs are stored and mobilized is crucial. This 
thesis describes three studies that contribute significantly to the current knowledge 
of skeletal muscle PLIN proteins and their potential roles in regulating exercise-
induced lipolysis.  Since this thesis began in 2009, the number of publications in this 
area has highlighted the importance that the skeletal muscle PLIN proteins may 
have in intracellular lipid dynamics. Thus far, most studies in skeletal muscle have 
examined changes in PLIN protein content following interventions such as exercise 
training. However, an understanding of the skeletal muscle PLIN protein 
intramyocellular location, interaction with lipases, and post-translational 
modification (e.g., phosphorylation) had not been investigated. Therefore, a specific 
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aim of this thesis was to provide information about the roles of skeletal muscle PLIN 
proteins in relation to the above listed items at rest as well as following lipolytic 
stimulation.   
 
Summary of findings 
 
 Results from Chapter 4 demonstrated that PLIN5 is not recruited to lipid 
droplets with muscle contraction and that both PLIN2 and PLIN5 are partially co-
localized to lipid droplets at any given time, indicating that skeletal muscle lipid 
droplets differentially express PLIN proteins. This was the first study to investigate 
the content, distribution, and co-localization of lipid droplets, PLIN2, and PLIN5 in 
contracted skeletal muscle.  
 From Chapter 5 and 6 it was demonstrated that PLIN2, 3, and 5 all interact 
with ATGL and HSL at rest and following contraction.  PLIN2 was the only skeletal 
muscle PLIN protein that did not interact with CGI-58.  The fact that all three 
skeletal muscle PLIN proteins interact with the rate limiting lipase, ATGL, as well as 
HSL, indicates a role for all of these PLINs in regulating lipolysis, potentially by 
working together as a complex. Further, PLIN2 was the only PLIN that was not 
serine phosphorylated at rest or with either adrenergic or contractile stimulation.  
The results from Chapter 6 show that PLIN3 and PLIN5 appear to be serine 
phosphorylated at all times with no changes under lipolytic stimulation. While the 
specific serine phosphorylation site(s) remain unknown, this study demonstrates 
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that both PLIN3 and PLIN5 are serine phosphorylated and that this level of 
phosphorylation is unchanged with lipolytic stimulation. 
 
A developing model for the role of skeletal muscle PLIN proteins 
  
Results from the studies presented in this thesis provide novel information in 
regards to the roles that the skeletal muscle PLIN proteins may have at rest as well 
as under contractile and adrenergic stimulation.  By coupling these results with the 
information that has emerged from recent publications in this area, we may be able 
to develop a working model of skeletal muscle lipid droplet metabolism at rest and 
during lipolysis. 
  
Skeletal muscle PLINs and the basal state 
  
Information presented in this thesis provides evidence that the skeletal 
muscle PLIN proteins may be involved in the regulation of basal lipolysis.  It is 
important to understand the subcellular location of each of the skeletal muscle PLIN 
proteins as well as the protein interactions between these proteins in this state.  The 
following sections aim to develop an outline of where the skeletal muscle PLIN 
proteins (PLIN2, PLIN3, and PLIN5) are found at rest as well as their protein 
interactions and post-translational state in the basal state.  
In skeletal muscle, PLIN2, PLIN3, and PLIN5 all appear to play a role in 
limiting basal rates of lipolysis by interacting with both HSL and ATGL.  Only PLIN3 
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and PLIN5 interact with CGI-58 at rest. These interactions might be essential for 
maintaining a stable rate of basal lipolysis by ensuring that the lipases are targeted 
to the right subcellular location or by controlling ATGL activity by sequestering CGI-
58.   
In the basal state, it is now known that approximately 60% of PLIN2 and 
PLIN5 are found co-localized to the lipid droplets (Chapter 1), while the rest of the 
proteins are found off of the lipid droplet.  These findings are consistent with other 
recent work in human skeletal muscle showing that lipid droplets are differentially 
coated with PLIN2 and PLIN5 (43, 45, 46).   It is known that PLIN5 is found 
associated with the lipid droplets as well as in a cytosolic form (10, 62, 66) therefore 
the finding that PLIN5 is partially co-localized to lipid droplets was not surprising.  
However, the finding that PLIN2 is found off of the lipid droplet seems odd as 
previous studies in cell culture (Chinese hamster ovary cells and human embryonic 
kidney 293 cells) have shown that PLIN2 coats the lipid droplet membrane and is 
stable in the presence of neutral lipids but is otherwise targeted for degradation by 
proteasomes and ubiquitination (29, 64, 65). It was due to this cytosolic instability 
that PLIN2 was originally considered to be a lipid droplet marker (29, 64, 65).  
However, it is possible that this partial co-localization of PLIN2 to lipid droplets is 
due to methodological limitations; the oil red O stain may not be sensitive enough to 
detect the smallest of lipid droplets.  Therefore, future work should take caution in 
utilizing PLIN2 as a marker of lipid droplets until a more conclusive method 
demonstrates this. 
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If we consider that the majority of PLIN2 is located on the lipid droplet 
surface and is interacting with both HSL and ATGL but not CGI-58, then PLIN2 may 
promote lipid accumulation at the lipid droplet by sequestering the lipases and 
inhibiting lipolysis.  In support of this, it is generally accepted that PLIN2 is found on 
the lipid droplet surface from the beginning of synthesis and is up regulated in 
parallel with stored lipid during lipid droplet formation (8, 26, 56).  Cell culture 
studies (murine fibroblasts, human embryonic kidney cells, McA-RH7777 cells, and 
primary rat hepatocytes) have also demonstrated that overexpression of PLIN2 
encourages lipid accumulation (26, 29, 31).  Further, in PLIN1-null mice PLIN2 
replaces PLIN1 on lipid droplets (50), although PLIN2 appears to be a less robust 
barrier to lipases than PLIN1(33, 50).  Since PLIN2 is mostly found co-localized with 
lipid droplets surface, it is possible that the interactions with ATGL and HSL are 
necessary for regulating basal lipolysis.   This theory is supported by work done in 
cultured AML12 (liver) cells lacking PLIN2, where an increase in ATGL at the lipid 
droplet surface was observed in conjunction with elevated rates of basal lipolysis 
(4).  Taken together, is seems as though PLIN2 may be involved in both lipolysis and 
lipogenesis, perhaps through interactions with lipases and maybe even through 
interactions with enzymes/proteins involved with IMTG synthesis. 
 The partial co-localization of PLIN5 to the lipid droplets described in this 
thesis is consistent with the ability of PLIN5 to translocate to and from the lipid 
droplet surface and also indicates that PLIN5 may be found in other subcellular 
locations. It has very recently been demonstrated that PLIN5 is not only found in the 
cytosol and the lipid droplet surface but that it is also in contact with mitochondria 
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(6, 55).  Using immunogold electron microscopy and Western blots in isolated 
mitochondria, Bosma et al. (6) found that PLIN5 in muscle is found at the lipid 
droplet surface as well as inside the mitochondria. This finding was consistent 
across various muscle types as PLIN5 was found in mitochondria in oxidative 
(soleus), glycolytic (EDL), and mixed (tibialis anterior) muscles as well as in cardiac 
muscle (6).  An exact role for PLIN5 at the mitochondria has not been determined, 
however it is hypothesized that PLIN5 may play a role in directing fatty acids from 
the lipid droplet to the mitochondria for oxidation. 
The proportion of PLIN3 co-localized to lipid droplets in skeletal muscle was 
not examined in this thesis, but it is expected that PLIN3 would show a similar 
partial co-localization as is seen with PLIN5.  PLIN3 may be found in various cellular 
locations and, like PLIN5, has the ability to translocate between the cytosol and the 
lipid droplet surface (61, 63). Prats et al. (41) found that approximately 76% of the 
lipid droplet surfaces co-localized with PLIN3 at rest and remained unchanged 
following electrical or epinephrine stimulation.  Interestingly, PLIN3 was shown to 
associate with mitochondria under conditions that would induce oxidative stress, 
and it is speculated that PLIN3 prevents cell death by maintaining mitochondrial 
membrane potential (24).  However, an investigation of basal mitochondrial PLIN3 
content has not yet been done in skeletal muscle.   
It is not possible to determine the physiological significance of the partial co-
localization of these three PLIN proteins with lipid droplets; however it was 
hypothesized that subpopulations of lipid droplets presenting different PLIN 
proteins have specific functions within skeletal muscle (43, 61, 62). For example, 
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PLIN5 is associated with distinct, high-density lipid droplets with a low size limit 
(~15 nm in diameter) (2).  Recent work has demonstrated that different PLINs 
sequester to different types of lipid droplets that are composed of either 
triglycerides or cholesterol esters.  Using cells cultured (Y1 adrenal cells and 
McARH7777 rat liver cells) in the absence or presence of fatty acid and/or 
cholesterol it was demonstrated that PLIN proteins differentially sequester to either 
triglycerides or cholesterol ester containing lipid droplets. PLIN2 and PLIN3 interact 
with both triglycerides and cholesterol esters lipid droplets, and PLIN5 primarily 
targets triglyceride-storing lipid droplets (25). Very recently, Shepherd et al. (45, 
46) have found that in human vastus lateralis there are lipid droplets that are not 
associated with PLIN2 (PLIN2-null lipid droplets) or PLIN5 (PLIN5-null lipid 
droplets). This study only assessed the co-localization of either PLIN2 or PLIN5 with 
the lipid droplets, and therefore cannot discriminate lipid droplets containing both 
PLIN2 and PLIN5 from those lipid droplets containing only PLIN2 or PLIN5.  
Together these findings emphasize the diversity of function of these PLIN proteins 
and indicate that the lipid droplet protein coat is dictated by the size of the lipid 
droplet as well as its contents. 
With the ability to translocate to and from the lipid droplet surface, both 
PLIN3 and PLIN5 may function by directing ATGL, HSL, and CGI-58 to the right 
subcellular location, or by regulating the activity of ATGL by also interacting with 
CGI-58. However, as PLIN3 and PLIN5 are found in the cytosol as well as on the lipid 
droplet it is unknown which population of these proteins is bound to either ATGL 
and/or CGI-58. Cell culture studies have determined that PLIN5 can directly bind to 
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both ATGL and CGI-58 but not to both at the same time (20, 53). In this thesis, it was 
found that PLIN5 interacts with both ATGL and CGI-58, however it is not known 
what proportion of PLIN5 is bound to either ATGL or CGI-58, or if PLIN5 interacts 
with both ATGL and CGI-58 at the same time.  Interestingly, a sequence of amino 
acids in PLIN3 is similar to the sequence of amino acids that is the binding site for 
both ATGL and CGI-58 on PLIN5 (23). Therefore, it is also possible that PLIN3, like 
PLIN5, can also bind to both ATGL and CGI-58 but not at the same time. Working 
together, PLIN3 and PLIN5 may be able to regulate lipase activity by sequestering 
both ATGL and CGI-58.  Further, Chapter 6 of this thesis demonstrated that both 
PLIN3 and PLIN5 are serine phosphorylated in the basal state, however the 
importance of this phosphorylation remains unknown.  It is possible that these PLIN 
proteins are phosphorylated in order to maintain certain protein interactions or 
subcellular locations and future work should investigate the exact residues at which 
they are phosphorylated and determine if this changes with physiological 
perturbations. 
 
Skeletal muscle PLINs and the lipolytically stimulated state 
 
During exercise, skeletal muscle lipolysis can be initiated by either 
circulating epinephrine or contraction therefore it was possible that these separate 
pathways may lead to different changes in PLIN location, protein interactions, and 
phosphorylation. Results from the studies presented in this thesis demonstrate that 
our experimental conditions (stimulated contraction and epinephrine incubation) 
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result in a significant amount of lipolysis.  Both Chapter 4 and 6 demonstrate 
lipolysis has occurred through a significant decrease in neutral lipid content 
measured by Oil Red O staining, and Chapter 5 shows a significant increase in ATGL 
to CGI-58 association, a known stimulus for enhanced ATGL activity in adipose 
tissue, cultured adipocytes, and fibroblasts (28, 68).  The question remains as to 
how the PLIN proteins are involved and what is turning on lipolysis under these 
conditions.  The following section describes our findings and discusses the potential 
roles that the PLIN proteins may have in regulating both ATGL and HSL under these 
lipolytic conditions. 
 
PLIN location with lipolysis 
 
  Due to the ability of PLIN5 to translocate from the cytosol to the lipid droplet 
(10, 62, 66) we had hypothesized that PLIN5 may be recruited to the lipid droplet 
surface with contraction in order to mediate lipolysis in skeletal muscle. However, 
we found that the fraction of PLIN5 co-localized to the lipid droplets remained 
unchanged following contraction.  This indicates that PLIN5 is not recruited to lipid 
droplets to assist with lipolysis and that there is a constant proportion of PLIN5 in 
association with lipid droplets as well as elsewhere in the cell.  This thesis did not 
investigate the association of PLIN3 with lipid droplets however previous work has 
shown that the cellular localization of PLIN3 is not altered with contraction or 
epinephrine administration (41), indicating similar findings as found with PLIN5.  
The recent findings that PLIN5 is also located at the mitochondria (6, 55) and that 
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PLIN3 may prevent oxidative stress at the mitochondria (24), make it conceivable 
that these two PLIN proteins may be recruited to the mitochondrial membrane in 
skeletal muscle during exercise to assist with the transfer of fatty acids from the 
lipid droplets, however this has yet to be investigated and is a possibility for future 
studies.   
 The portion of PLIN proteins co-localized with lipid droplets does not seem 
to change with lipolysis, however recent work indicates that both PLIN2 and PLIN5 
play an important role at the lipid droplet surface.  In the past year, Shepherd et al. 
(45, 46) have demonstrated that in human skeletal muscle, lipid droplets associated 
with either PLIN2 or PLIN5 are preferentially utilized during exercise.  The findings 
from this thesis show that the skeletal muscle PLIN proteins interact with both HSL 
and ATGL. Pairing these results with the recent discovery that lipid droplets coated 
with either PLIN2 or PLIN5 are preferentially utilized indicates that the skeletal 
muscle PLIN proteins may be important for regulating lipase access to the lipid 
droplets. 
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Figure 20 
Figure 1. Representative figures of skeletal muscle PLIN protein locations in a basal 
and stimulated state. A. Basal state; showing PLIN2, PLIN3, and PLIN5 on the lipid 
droplet surface.  PLIN5 is also located in the cytosol and in association with 
mitochondria.  PLIN3 is also located in the cytosol and potentially in association 
with mitochondria.  PLIN2 may also be found in the cytosol.  B. Stimulated state; 
dashed lines represent possible movement of PLIN5 and PLIN3 to the mitochondria. 
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PLIN regulation of ATGL 
 
As ATGL is now considered to be the rate limiting lipase in lipolysis it is 
important to examine changes in its phosphorylation state as well as any changes in 
protein interactions that might occur with lipolytic stimulation in skeletal muscle.  
Chapter 6 demonstrated that ATGL is serine phosphorylated at rest and that this 
level of phosphorylation remains unchanged following either contractile or 
adrenergic stimulation.  Previous studies have identified two serine 
phosphorylation sites on ATGL (serine 404/406 and 428/430; variation in location 
is humans vs. rodent) (3, 68) and the results from our study can not discount the 
possibility that while we observed no overall change in phosphorylation there could 
have been changes at the individual sites.  
However, recent work in human skeletal muscle found similar results in 
ATGL Ser404 phosphorylation.  Mason et al. (34) demonstrated that ATGL Ser404 
phosphorylation is not increased in human skeletal muscle during moderate-
intensity cycling exercise. In addition, that study demonstrated that there was no 
evidence of a physical interaction between ATGL and AMPK after 
immunoprecipitation, and pharmacological activation of AMPK did not affect ATGL 
Ser404 phosphorylation in cultured myotubes (34). Further, direct studies in C2C12 
myotubes showed no effect of forskolin (i.e., PKA activation) on ATGL Ser406 
phosphorylation (34).  From this, Mason et al. concluded that neither AMPK nor PKA 
phosphorylate skeletal muscle ATGL Ser404 in intact cell systems or whole 
organisms. Mason et al. did not investigate changes at the other serine 
phosphorylation site, however with our results showing no change in overall serine 
 175 
phosphorylation it is unlikely that there are any changes in Ser430 phosphorylation 
of ATGL.  Overall, the evidence from this thesis and from Mason et al. would indicate 
that ATGL activity in skeletal muscle does not seem to be regulated by 
phosphorylation.   A role for the observed basal ATGL phosphorylation remains to 
be determined, however it is possible that it may regulate basal lipolysis. 
 As mentioned previously the association between ATGL and CGI-58 is a 
known stimulus for enhanced ATGL activity (28, 68).  Chapter 4 of this thesis 
provided the first evidence of this interaction in skeletal muscle.  We found that in 
skeletal muscle the interaction between ATGL and CGI-58 increases more than 2-
fold (~128%) after 30min of electrically stimulated contraction, consistent with an 
increased rate of lipolysis during this period (12). In Chapter 6, we found that the 
increased ATGL and CGI-58 interaction did not reach statistical significance with 
any of our experimental conditions (contraction or epinephrine or the 
combination), however there was a tendency for an increased interaction in all 
cases (contraction 56%; epinephrine 25%; contraction + epinephrine 79%).  The 
lack of statistical significance may be due to a lack in power when comparing four 
group means rather than two, or to the large variability in the values.  While we 
cannot definitely say that the ATGL-CGI-58 interaction is increased with skeletal 
muscle lipolysis, we should not discount these findings as they may be 
physiologically relevant even though they are statistically insignificant.  Another 
possible explanation for the variability seen with the ATGL-CGI-58 interaction is 
that a direct physical interaction between ATGL and CGI-58 may not actually be 
necessary to increase the lipolytic activity of ATGL (30).  Gruber at al. (22) 
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demonstrated that CGI-58 is able to bind directly to the phospholipid monolayer of 
lipid droplets and that without this there is a complete loss of the ability of CGI-58 to 
activate ATGL, regardless of their interaction. It may be more important for CGI-58 
to bind to the lipid droplet membrane and somehow allow ATGL to access the 
triglyceride core (30).   
 ATGL may also be regulated by the protein interactions that were 
demonstrated in Chapters 5 and 6.  In skeletal muscle we showed that PLIN2, PLIN3, 
and PLIN5 all interact with ATGL, and that PLIN3 and PLIN5 interact with CGI-58.  
Therefore it may be possible that these PLINs work together as scaffolding proteins 
sequestering ATGL and CGI-58 until there is a lipolytic stimulus.  In Chapter 5 the 
interaction between PLIN2 and ATGL was significantly decreased following 
stimulated contraction, however, in Chapter 6 a significant decline in the PLIN2-
ATGL interaction did not occur with either contractile or adrenergic stimulation, but 
there was a tendency towards a decrease (contraction 12%; epinephrine 18%).   
Further, similar decreases in the interaction between PLIN5 and ATGL were found 
in both Chapter 5 and 6 with contractile and adrenergic stimulation although this 
did not reach significant. Alone, the decline in the association between either PLIN2 
or PLIN5 and ATGL likely do not fully account for the increased association between 
ATGL and CGI-58, but together they may explain it. Interestingly, the interaction 
between PLIN3 and ATGL does not seem to change with either contraction or 
epinephrine-induced lipolysis. 
 From Chapter 5 we have shown that in skeletal muscle both PLIN3 and 
PLIN5 interact with CGI-58 and that these interactions do not change following 
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stimulated contraction.  It is thought that PLIN5 facilitates lipolysis by promoting 
the co-localization and functional interaction of CGI-58 and ATGL (18, 19, 21), 
however the mechanisms are unknown.  Given that PLIN5 can bind to both ATGL 
and CGI-58 but not both at the same time (20) and that this amino acid sequence is 
similar to one in PLIN3, it is possible that PLIN3 and PLIN5 play similar roles in 
regulating the location and activation of ATGL and CGI-58. Future studies should 
investigate proportions of PLIN3 and PLIN5 that are bound to CGI-58 or ATGL as 
well as their subcellular locations. 
In adipose tissue, it is the PKA-dependent phosphorylation of PLIN1 that 
causes the release of CGI-58, leading to the initiation of lipolysis by activating ATGL 
(5, 14-17) (32, 36, 47, 48).  This thesis presents novel findings that PLIN3 and PLIN5 
are serine phosphorylated, however the level of phosphorylation does not change 
with either contractile or adrenergic stimulation.  This indicates that serine 
phosphorylation of these two proteins may not be important in regulating lipolysis.  
However, we cannot conclude that phosphorylation does not play a role, as we do 
not know if there are multiple serine phosphorylation sites that could potentially be 
altered or if there are sequences other than serine phosphorylation sites.  Therefore, 
the exact role of skeletal muscle PLIN3 and PLIN5 phosphorylation remains 
unknown and warrants further investigation.  Further, we found that PLIN2 is the 
only PLIN protein that is not serine phosphorylated at rest or following lipolytic 
stimulation. 
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Figure 21 
Figure 2. Representative figures for ATGL regulation by skeletal muscle PLIN 
proteins. A. Basal state; PLIN2, PLIN3, and PLIN5 interact with ATGL while only 
PLIN3 and PLIN5 interact with CGI-58.  It is currently unknown if PLIN3 and PLIN5 
can interact with both CGI-58 and ATGL at the same time or if these interactions are 
occurring at the lipid droplet or in the cytosol. B. Stimulated state; the interaction 
between ATGL and CGI-58 is increased at the lipid droplet.  The association between 
PLIN2 and ATGL has decreased.  It is currently unknown if the associations between 
PLIN3 and PLIN5 with ATGL are also decreased, allowing for the large increase in 
ATGL to CGI-58 interactions. 
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PLIN regulation of HSL 
 
 As discussed in Chapter 1, the function of HSL in skeletal muscle has been 
extensively studied and reviewed (58, 59, 67).  It is now known that HSL activity in 
skeletal muscle is increased during exercise due to phosphorylation by PKA at 
Ser563, Ser659 , and Ser660, and by ERK at Ser660 (11),  and that HSL activity is 
reduced later on in prolonged exercise and recovery likely due to phosphorylation 
of HSL Ser565 by AMPK and/or CaMK (42, 57, 60). Prior to this thesis, a role for the 
skeletal muscle PLIN proteins in regulating HSL activity was unknown and we can 
now add to the HSL story.  
In adipose tissue, phosphorylation of PLIN1 and HSL promotes the 
translocation and docking of HSL to PLIN1 on the lipid droplet surface (35, 37, 44, 
49, 54).  Chapter 6 of this thesis aimed to determine if a similar series of events 
occurs in skeletal muscle during lipolysis.   Previous work with skeletal muscle 
contraction has shown a translocation of HSL towards PLIN2-coated lipid droplets 
(41), however this study did not determine if there was a direct physical interaction 
between these two proteins. The results from Chapter 6 provide the first evidence of 
a physical interaction between PLIN2 and HSL, however this interaction remains 
unchanged following contraction or epinephrine stimulation alone or in 
combination. This indicates that PLIN2 may not be involved in recruiting HSL to the 
lipid droplet surface, or that once HSL has translocated to the lipid droplet it does 
not interact with PLIN2.  
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Chapter 6 also demonstrated that both PLIN3 and PLIN5 interact with HSL. 
Statistical analysis revealed that the interaction between PLIN3 and PLIN5 with HSL 
is unchanged following contraction and epinephrine alone as well as in combination. 
From Chapter 4 we know that PLIN5 is not recruited towards lipid droplets with 
contraction, and results from Prats et al. (41) show the same for PLIN3, therefore it 
seems unlikely that they are acting as a chaperone for HSL with lipolytic stimulation.   
A closer look at the results from Chapter 6 indicates that the association between 
PLIN3 and HSL may be decreased with lipolysis (even though this was not 
statistically significant), and this association should be investigated further.  If this is 
true, it may indicate that PLIN3 acts to sequester HSL in the basal state and releases 
it with lipolytic stimulation, allowing HSL to translocate to the lipid droplet.  
Regardless, the finding that all three skeletal muscle PLIN proteins interact with HSL 
indicates a potential role for these proteins in regulating either the location of HSL 
or its activity at the lipid droplet surface. 
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Figure 22 
Figure 3. Representative figure of HSL regulation by skeletal muscle PLIN proteins. 
A. Basal state; PLIN2, PLIN3, and PLIN5 interact with HSL. B. Stimulated state; HSL 
is phosphorylated on multiple serine sites (shown as P) and has translocated to the 
lipid droplet.  It is not known if HSL is interacting with PLIN2 at the lipid droplet 
surface or if PLIN2 is released from either PLIN3 or PLIN5. 
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Summary 
 
 A full understanding of the roles that the skeletal muscle PLINs (PLIN2, 
PLIN3, and PLIN5) play in lipid droplet dynamics is still in its infancy.  The discovery 
of the PLIN proteins, their tissue distributions and the important role that PLIN1 
plays in regulating adipose tissue lipolysis has provided an excellent starting point.  
Study of the potential roles of the skeletal muscle PLINs has only evolved in the past 
few years and should continue to piece together the role(s) that these proteins may 
have in lipid storage and use. This thesis has provided novel information to the ever-
expanding model of skeletal muscle lipolysis.  It is now known that ATGL, CGI-58 
and HSL are all likely regulated by all three of these PLIN proteins.  Results from this 
thesis support a role for the PLIN proteins in sequestering the lipases during basal 
conditions and potentially working together to allow for lipase translocation and 
activity during lipolysis. The results of this thesis have laid the ground-work for 
examining the role(s) of PLIN2, PLIN3, and PLIN5 in skeletal muscle lipolysis. Future 
work using both acute and chronic perturbations in lipid metabolism will contribute 
to completing the overarching PLIN protein puzzle. 
 
Future Studies 
 
The results of the studies presented in this thesis indicate that the role(s) of 
PLIN proteins in regulating skeletal muscle lipolysis are much more complex than 
what is currently understood in adipose tissue.  Future work investigating the roles 
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of skeletal muscle PLIN proteins can go in several directions.  This thesis has 
focused on a role in regulating lipolysis and has presented some necessary first 
steps in understanding the roles of skeletal muscle PLIN proteins. Further, the 
recent finding that PLIN5 is located at the mitochondria warrants more studies to 
elucidate the role of PLIN5 at this location. 
 
Role for skeletal muscle PLINs in lipid synthesis 
 
To date most studies in skeletal muscle PLIN research have focused on 
adaptations to training or, as presented in this thesis, roles in lipolysis. Future work 
should explore the importance of free fatty acids and insulin in mediating the up-
regulation of the PLIN proteins in skeletal muscle as well as their role in lipid 
droplet growth/synthesis.  These investigations can use both acute and chronic 
approach. 
Insulin has potent anti-lipolytic effects, as well as a pro-lipogenic effects in 
resting skeletal muscle (1, 13, 38, 39). The mechanisms underlying insulin’s 
potential regulation of muscle lipid metabolism have remained relatively 
unexamined.  It is possible that insulin promotes the interactions of PLIN2, PLIN3 
and PLIN5 with HSL and ATGL. Further, interactions between the PLIN proteins and 
any of the synthetic machinery have yet to be evaluated. Initial studies should focus 
on an acute stimulation with insulin and/or free fatty acids to promote lipid uptake 
and synthesis, as well as inhibit lipolysis. Previous work using an isolated muscle 
incubation model (similar to the one utilized in this study) have shown that insulin 
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can increase fatty acid esterification in resting skeletal muscle (38, 39) while 
simultaneously lowering the rate of fatty acid oxidation in this tissue (1, 38, 39). 
Evidence indicates that the skeletal muscle PLIN proteins are involved in 
both lipolysis as well as lipid droplet synthesis but it remains unclear if the PLIN 
proteins are present on/or interact with the cellular site of synthesis (endoplasmic 
reticulum) and this should be investigated. To date only PLIN3 has been suggested 
to be present on the endoplasmic reticulum, suggesting it might have a role in lipid 
droplet synthesis (9).  It is also possible that the PLINs interact with enzymes 
involved in neutral lipid synthesis. These interactions should be investigated in the 
basal as well as the lipogenic or insulin-stimulated state. 
 Once it has been determined if the PLIN proteins also reside at the 
endoplasmic reticulum and do in fact interact with lipogenic enzymes studies using 
chronic treatments known to increase lipid storage such as high fat diets or exercise 
training can be undertaken to determine if there are changes in these interactions.  
This will provide much needed information on lipid droplet dynamics and perhaps 
explain differences in IMTG storage between trained vs untrained individuals. 
 
Role for PLIN5 at the mitochondria 
 
Due to the oxidative tissue expression of PLIN5 (62), as well as its association 
with mitochondria (6), it is likely that PLIN5 plays a role in facilitating fatty acid 
oxidation and not IMTG hydrolysis per se.  In support of this theory, Peters et al. 
(40) found PLIN5 protein content increased with endurance training and this 
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increase was associated with improved muscle oxidative capacity. Other work has 
demonstrated that overexpression of PLIN5 in-vitro increased fatty acid oxidation 
(62), providing evidence for a larger role of PLIN5 in enhancing the oxidation of the 
fatty acids released from the lipid droplets over IMTG synthesis or lipolysis.  
Overexpression of PLIN5 in skeletal muscle also promotes expression of several 
genes, regulated by PPARα and PGC1α, involved in fatty acid catabolism and 
oxidation (7). The recent discovery that PLIN5 is located in direct contact with 
mitochondria and that PLIN5 overexpression results in more intimate interactions 
between these two organelles provides more evidence in support of a strong role in 
oxidation (6). It has been hypothesized that PLIN5 may direct fatty acids from the 
lipid droplet to the mitochondria for oxidation.  If this were true in skeletal muscle 
one would expect that the content of PLIN5 interacting with the mitochondria 
would increase in times where the reliance on fatty acids for energy is higher.  These 
situations can arise from acute bouts of moderate intensity exercise as well as 
endurance training.  Initially it would be wise to investigate this theory with an 
acute study using either an isolated muscle contraction model, similar to what was 
utilized in this thesis.  However in order to isolate enough mitochondria for analysis 
larger and/or more skeletal muscle tissue may be needed. Therefore an acute bout 
of hindlimb exercise via sciatic nerve stimulation or whole body exercise via 
treadmill running would be more appropriate. 
It is known that exercise training results in an increase in the proportion of 
lipid droplets in contact with mitochondria (51), presumably allowing for a more 
efficient transfer of fatty acids to be oxidized.  Further, the content of PLIN5 is 
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increased with training (40, 46), however the location of this increased protein 
content is unknown. If PLIN5 is recruited to the mitochondria with an acute bout of 
exercise it may also be possible that training results in an increased mitochondrial 
content of PLIN5.  
Further, the use of the recently development PLIN5 knockout mice (27) may 
provide more information of the role of PLIN5 in providing fatty acids to the 
mitochondria for energy production.   These knockout mice could be subjected to 
either acute or chronic exercise training, similar to what has been described above.  
These studies would provide details as to whether PLIN5 is essential for fatty acid 
provision from lipid droplets as well as fatty acid oxidation during exercise. 
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Limitations 
This section discusses limitations of the presented studies and potential 
avenues by which future work may be improved.  Physiological studies are 
frequently underpowered due to smaller sample sizes.  The most straightforward 
consequence of underpowered studies is that effects of practical importance may 
not be detected.  Further underpowered studies result in larger variance of the 
estimates of the parameter being estimated. This might explain the differences in 
the results for ATGL to CGI-58 protein interactions from Chapters 5 and 6.  In 
Chapter 5 with an n=12 and a direct comparison between rested and contracted 
muscles there was a significant increase in the interactions, however these results 
were not repeated in Chapter 6.  This could be due to the small sample size resulting 
in low power as the power of the performed ANOVA test (0.106) was far below the 
desired power of 0.80.  This also may have occurred because there were multiple 
groups (4 groups) to compare compared to only 2 in the previous study.  Using the 
means and standard deviations from the data, a power calculation (with an alpha 
level of 0.05 and power of 0.80) reveals that a sample size of 21 would be needed in 
order to observe significant results. However, when animal testing is involved, 
designing an overpowered study may be considered unethical if it wastes resources 
such as time and research money for materials.   As well, it is necessary to limit the 
sample size to avoid unnecessary use of animals.  While we did not observe 
statistically significant results in Chapter 6 these results still provide insight into the 
interactions between ATGL and CGI-58 and it is impossible to discount the 
importance of this association in accelerating lipolysis. Further studies may want to 
 188 
include more than one method to determine protein-protein interactions to further 
strengthen these results. 
  In examining protein-protein interactions this thesis utilized a co-
immunoprocipitation method. While this method can provide great insight into 
protein interactions there are inherent limitations that should be discussed.  
Immunoprecipitation methods (and co-IP) typically require a great deal of 
optimization and troubleshooting to determine the optical conditions and methods 
to use. Prior to the study, pilot work was performed in order to ensure that we were 
pulling down all of our protein of interest and therefore we are confident that we 
have fully precipitated our proteins. Ideally we would have preferred to have been 
able to show the interactions between proteins both ways (i.e., co-IP one protein 
and look for the second followed by co-IP of the second to look for the first). 
However, with the currently available antibodies we were unable to do so.  One of 
the most commonly encountered problems with both IP and co-IP approaches is 
interference from antibody bands during Western blotting.  Detection of the 
antibody (light and heavy chain, ~25 and ~50kDa bands, in SDS-PAGE gels, 
respectively) used to pull out the protein of interest during the co-IP can interfere 
with the interpretation of the results from a Western blot. The ideal situation would 
be to analyze the co-IP without contamination of the eluted antigen with antibody; 
with this potential interference eliminated, only the co-precipitated proteins would 
be present and detected on the gel.  In developing the methods to examine each 
protein interaction for these studies we tried several different approaches in order 
to eliminate antibody interference.  Other than traditional co-IP we tried two 
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methods to avoid this problem: 1) using a detection reagent that does not recognize 
the denatured antibody fragment and 2) antibody immobilization.  We used a Pierce 
secondary (The Clean-Blot IP Detection Reagent (Thermo Scientific, Rockford, IL, 
USA) that does not recognize or bind to denatured IgG that has undergone 
electrophoresis under reducing SDS-PAGE. However, like most methods, this was 
also dependent on the primary antibody used and did not work for the CGI-58 
primary antibody, resulting in completely blank blots.  To immobilize the antibody 
used for the IP we used a Pierce Co-IP Kit (Thermo Scientific, Rockford, IL, USA) to 
covalently link the IP antibody to the beads. However, this kit was unsuccessful at 
binding certain antibodies to the resin, resulting in blank blots.  In developing our 
methods we had gone through each of these approaches with each interaction and 
determined the appropriate method to investigate each one.  In order to be 
consistent with our methods we found that immunoprecipitating ATGL and HSL and 
then Western blotting for a protein of interest was most appropriate and saved a 
considerable amount of tissue.  For the detection of serine phosphorylation, the 
traditional IP route resulted in significant antibody interference and the most 
appropriate approach ended up being antibody immobilization with use of the kit. 
Future studies may want to include another method of detecting protein 
interactions to strengthen the results. One potential method may be FRET (Forster 
Resonance Energy Transfer) analysis. This method is similar to the 
immunohistochemical methods describe in this thesis, but two proteins would be 
tagged with fluorescent antibodies that would only fluoresce if the proteins were 
interacting.   
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a. Preparation of muscle for histological analysis 
 
Snap freezing muscle tissue 
Principle:  
The use of fresh unfixed snap-frozen tissue is employed to preserve muscle and 
cellular detail without compromising or sacrificing enzyme activity.  The amount of 
time taken to freeze the muscle is proportional to the amount of freezing artifact 
observed under the microscope. (ie. if rapid freezing is not achieved, there will be a 
considerable amount of freezing artefact). Prior to staining, the muscle tissue must 
be mounted on cork chucks in an embeddingmedium (Cryomatrix). The fibres are 
aligned on the cork for either cross-sectional or longitudinal sections. The 
embedding medium is used to maintain the fibre arrangement prior to freezing and 
to present a hard surface at the time of cutting. 
 
Equipment: 
1. Liquid nitrogen 
2. 2-Methyl butane 
3. Long-handled forceps 
4. A container for liquid nitrogen 
5. A metal bowl that fits into the liquid nitrogen container 
6. label cork for each specimen 
 
Procedure: 
1. Cool 2-methyl butane in a small metal container to -155°C in a liquid nitrogen 
bath. 
2. Cool the 2-methyl butane until the outer area is frozen solid and the inner 
area is thick and slushy. 
3. place a drop of O.C.T embedding compound in the centre of a labelled piece of 
cork. 
4. Put the piece of cork with the O.C.T. into the isopentane container, cork first 
to cool the O.C.T. slightly 
5. Place the specimens in the centre of the O.C.T.  doughnut with the muscle 
fibres horizontal (or vertical) to the surface of the cork (mark the direction 
on the cork) 
6. if the muscle sample is not completely submerged in O.C.T. place more O.C.T. 
on the top to cover the sample. 
7. Plunge the O.C.T. covered specimen into the 2-methyl butane for 30 seconds. 
8. Rapid freezing prevents ice crystal formation 
9. Wrap in aluminium foil and label specimen. 
10. Store at -80°C until sectioniong. 
 
Sectioning: 
Carried out in a cryostat, optimally at -22 C 
1. samples should be left for ~ 20 min to equilibrate to cryostat temperature 
(~-22 C) 
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2. re-orientate the muscle if need be 
3. 3 transverse serial sections per slide at a thickness of 10um are sufficient 
from each specimen to carry out one required staining protocol 
4. allow 30 min or more for samples to dry before storing samples at -80 C 
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b. Oil Red O Staining 
 
Principle: Histology uses specific dyes and reagents to stain for properties of cellular 
components so that these cellular features and structures can be seen. 
Histochemistry uses substrates reacting with tissues enzymes to form colour 
precipitates at the site of the reaction. The physical properties of the muscle should 
be closely linked to the enzymes present in the tissue.  Histochemical staining using 
Oil Red O can be used to stain neutral lipids (mainly triglycerides) with an orange-
red tint (Lillie and Ashburn 1943).  The histological mechanism of the staining of 
lipids is invariably a function of the physical properties of the dye being more 
soluble in the lipid to be demonstrated than in the vehicular solvent.   
 
Muscle samples 
1. sections 10 um 
2. thaw mounted 
3. air dry samples for 15 min 
4. stored at -80°C 
 
Reagents: 
 
1. 3.7% formaldehyde solution: 
 37 % stock solution 
 Deionised water 
 
2. Oil Red O: 
 Dissolve to a stock solution 
 oil red O (500.0 mg) 
 60% triethyl-phosphate (C2H50)3PO (100.0 ml) 
 mix on heat  
 Prior to staining (during formaldehyde incubation) 
 36% triethyl-phosphate working solution 
 oil red O stock solution (12.0 ml) 
 deionised water (8.0 ml) 
 mix on heat 
 filter 2x through Whatman paper number 42 to remove crystallized oil 
red O 
 
3. Phosphate-buffer saline (PBS) (1x working solution) 
 Sodium chloride (NaCl) (137 mM) 
 Potassium chloride (KCl) (3 mM) 
 Disodium hydrogen phosphate (Na2HPO4) (8mM) 
 Potassium dihydrogen phosphate (KH2PO4) (3mM pH 7.4) 
 Can be used for dilution of Triton X-100, glycerol and antibodies 
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Note: make a 10x stock solution for long term storage 
 
 
Oil Red O Staining  
 
Procedure: 
 
1. Staining protocol starts with 1 h fixation of the air-dried, thawed sections 
using 3.7% formaldehyde solution in deionised water. 
2. Mix working solution of ORO on heat, double filter 
3. Prepare beaker of dH2O 
4. Wash excess formaldehyde with 3 rinses in deionized water for 30 sec. 
(3dips in beaker; dab dry using kimwipes) 
5.  Immerse slides in working solution of oil red O for 30 min. 
6. prepare beaker of dH20 
7. Wash sections were washed with 3 exchanges of deionised water for 3 x 30 
sec (3 dips; dab dry). 
8. If desired, sections can be counter stained using Mayer’s haematoxylin for 
60s to visualise nuclei. 
9. Sections rinsed with running tap water for 10 min and covered with a 
coverslip using 10% glycerol in PBS (Note: if using fluorescence mount using 
an antifade reagent, Prolong Gold Antifade) 
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c. Combined oil red O and immunofluorescence staining 
 
Principle:  
Combining conventional Oil Red O with other (immuno) histochemical stains, 
provides information on the exact subcellular location of intramuscular triglycerides 
and its potential vicinity with proteins involved in lipid metabolism. 
 
Reagents: 
 
4. 3.7% formaldehyde solution: 
 37 % stock solution 
 Deionised water 
 
5. Oil Red O: 
 Dissolve to a stock solution 
 oil red O (500.0 mg) 
 60% triethyl-phosphate (C2H50)3PO (100.0 ml) 
 mix on heat  
 Prior to staining (during formaldehyde incubation) 
 36% triethyl-phosphate working solution 
 oil red O stock solution (12.0 ml) 
 deionised water (8.0 ml) 
 mix on heat 
 filter 2x through Whatman paper number 42 to remove crystallized oil 
red O 
 
6. Phosphate-buffer saline (PBS) (1x working solution) 
 Sodium chloride (NaCl) (137 mM) 
 Potassium chloride (KCl) (3 mM) 
 Disodium hydrogen phosphate (Na2HPO4) (8mM) 
 Potassium dihydrogen phosphate (KH2PO4) (3mM pH 7.4) 
 Can be used for dilution of Triton X-100, glycerol and antibodies 
Note: make a 10x stock solution for long term storage 
 
7. 0.5% Triton X-100 in PBS 
 
 
Procedure: 
 
1. Staining protocol starts with 1 h fixation of the air-dried, thawed sections 
using 3.7% formaldehyde solution in deionised water. 
2. Prepare beaker of dH2O 
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3. Wash excess formaldehyde with 3 rinses in deionized water for 30 sec. 
(3dips in beaker; dab dry using kimwipes) 
4. sections were treated with 0.5% Triton X-100 in PBS 5 min 
5. washed 3 x in PBS for 5 min 
6. incubate for 30 min at room temp with primary antibody in appropriate 
dilution (dilute in PBS) 
7. 3x5 min washing with PBS 
8. incubate for 30 min at room temp with secondary antibody in appropriate 
dilution (in PBS) 
 
Protein 1° Ab in PBS 2° Ab 
PLIN2 1:100 (Progen GP40; 
guinea pig polyclonal) 
1:200 (anti guinea pig 
Alexa Fluor 488) 
PLIN5 1:50 (Progen GP31; 
guinea pig polyclonal) 
1:200 (anti guinea pig 
Alexa Fluor 488) 
Notes:  
- use ~10ul of Ab PBS solution per muscle section 
- when optimizing ensure that there is no cross talk between 
wavelengths from the 1° Ab by testing each filter. 
- also optimize with slides that have only been incubated with the 1° or 
2°Ab to  
 
9. 3x5 min washing with PBS 
10. slides immersed in the working solution of oil red O for 30 min 
11. slides rinsed 3x with deionised water 
12. 10 min wash with running tap water 
13. stained sections were embedded in 10% glycerol in 10 mM TRIS-HCl, pH 8.5 
(containing DAPI to visualise nuclei if wanted) (use Prolong Gold antifade 
reagent to coverslip) 
14. cover with coverslip 
 
 
Summarized staining protocol for oil red O (from Koopman et al. 2001): 
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References: 
René Koopman, Gert Schaart, Matthijs K.C. Hesselink. Optimization of oil red O 
staining permits combination with immunofluorescence and automated 
quantification of lipids. Histochem Cell Biol (2001) 116:63–68 
 
Lillie RD and Ashburn LL,(1943), Supersaturated solutions of fat stains in dilute 
isopropanol for demonstration of acute fatty degeneration not shown by 
Herxheimer’s technique. Archs.Path.,36,432. 
 
Minnaard R, Schrauwen P, Schaart G, Jorgensen JA, Lenaers E, Mensink M, and 
Hesselink MKC. Adipocyte differentiation-related protein and OXPAT in rat and 
human skeletal muscle: involvement in lipid accumulation and type 2 diabetes. J Clin 
Endocrinol Metab 94: 4077–4085, 2009. 
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d. Western Blotting 
 
Background: Western blotting is a technique that identifies specific proteins in a 
given sample or extract after separation by molecular weight using polyacrylamide 
gel electrophoresis.  The polyacrylamide gel is placed to a membrane, which is 
typically nitrocellulose or PVDF (polyvinylidene fluoride), and the application of an 
electrical current induces the proteins to migrate from the gel to the membrane on 
which they become immobilized.  The membrane is then a replica of the gel protein 
and can be tagged with an antibody. 
 
Reagents: 
Homogenizing Buffer 
- 250mM sucrose (21.4g) 
- 100mM KCL (1.865g) 
- 5mM EDTA (0.4695g) 
- add 225mL dH2O, fix pH 6.8, top up to 250mL dH2O 
- mix and store in fridge 
 
Laemelli Buffer (2x Sample Buffer) 
- 2.5ml 0.5M Tris-HCl pH 6.8 
- 2ml glycerol 
- 2ml 10% SDS 
- 0.2mL 1% bromophenol blue 
- 1ml -mercaptoethanol 
- 0.3mL dH2O 
 
Running Gel Buffer 
- 1.5M Tris-HCl, pH 8.8 
 
Stacking Gel Buffer 
- 0.5M Tris-HCl, pH 6.8 
 
10x Running Buffer, pH 8.3 
- 250mM Tris base 
- 1.92M glycine 
- 1% SDS 
- Store at 4oC. If precipitation occurs, warm to room temp before use. 
 
10x Transfer Buffer (semi-dry) 
- 312.5mM Tris base (3.786g) 
- 2.4M glycine (18g) 
- fill to 100mL with dH2O 
- 0.01% SDS 
- *before use, dilute 80mL in 720 mL dH2O and add 200mL of methanol 
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10x TBS 
- 200mM Tris base (24.2 g/L) 
- 1.37M NaCl (80.1 g/L) 
- 38mL of 1M HCl/L of TBS made 
- adjust to pH 7.5 
 
TBST 
- dilute 100mL of 10x TBS in 900mL dH2O 
add 4mL of 25% Tween 20 while stirring (polyoxyethylenesorbitan monolaurate) 
 
 
Sample Preparation 
 
Homogenization: 
1. Make up homogenization buffer: 
 250mM sucrose = 21.4g 
 100mM KCl = 1.865g 
 5mM EDTA = 0.4695 
 add 225mL dH2O, fix pH 6.8, top up to 250mL dH2O and mix well, 
store in fridge 
2. Add protease inhibitor tablet (from antibody drawer) (Roche, 1 tablet 
/10mL) and add phosphatase inhibitor (Roche, 1 tablet /10mL) 
3. Prepare glass homogenizers with ~ 200L of buffer, tear in scale, remove ~ 
10mg chunk of muscle from sample for analysis, add muscle and weigh 
 keep on ice when possible 
4. Correct buffer volume in homogenizer so that 25L of buffer is present for 
every 1mg of sample 
5. Homogenize well on ice (~30 plunges) 
 
Protein Determination (Bradford Assay) 
 
Standard Curve Preparation: 
1. Retrieve all samples (whole homogenate) from –80° C storage and place on 
ice. 
2. Remove one aliquoted sample of 1 mg/mL stock BSA solution from -20° C 
storage. 
3. Prepare all BSA standard solutions in eppendorf tubes on ice. 
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Table d1. Volumes of Stock BSA Solution and dH2O required for the preparation of 
Bradford protein assay standard solutions. 
 
Protein Concentration 
(mg/mL) 
Stock BSA Solution 
(μL) 
dH2O 
(μL) 
1 1000 0 
0.5 500 (from 1 mg/mL) 500 
0.25 500 (from 0.5 mg/mL) 500 
0.125 500 (from 0.25 mg/mL) 500 
0.05 100 (from 0.5 mg/mL) 900 
0 0 1000 
 
4. Prepare 10–fold dilutions for all samples by loading individual eppendorf 
tubes with 10 μL of whole homogenate and 90 μL of DDH2O. 
4. Pipette 10ul of each sample (standard and diluted samples) into 96 well 
plate, do this in triplicate. (Hint: the Bradford method is a sensitive 
spectrophotometric procedure that is fully dependent upon samples’ color 
perception and subsequent light absorption. Colour presents as a result of a 
reaction between the protein assay dye reagent and the positively charged 
amine groups of proteins within a sample. Consequently, any debris on the 
well plate could interfere with light absorption readings.)  
5. Add 200L of diluted buffer (1:4 with Bio-Rad Protein Assay Dye Reagent: 
dH2O) 
6. Let incubate for 5min and read absorbance as wavelength 595nm 
7. Insert the well plate into the spectrophotometer to generate absorbance 
readings. 
8. Open KC4™ data analysis software, and ensure that the reading parameters 
are set to absorbance. 
9. Define the reading parameters by the following details: absorbance 
wavelength of 595 nanometers, shaking intensity level of 3 and shaking 
duration of 5 seconds  
10. Proceed to read the absorbance of each standard and sample  
11. Copy the absorbance readings into a Microsoft® Excel spreadsheet, and 
generate a standard curve by plotting known protein concentrations (BSA 
standard solutions) against their average absorbance readings. Make sure 
that you substract the absorbance reading of water from each sample so that 
he curve starts at zero-zero. 
12. Outfit the standard curve with a polynomial trendline, and display the 
quadratic equation derived from this curve. 
13. Subtract the average absorbance reading of water for every sample, and 
calculate the unknown protein concentrations of all samples using the 
quadratic equation. Don’t forget to multiple sample concentrations by 10. 
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Sample preparation for Western blotting 
 
1. To prepare samples for blotting (best done on same day as SDS PAGE) first 
determine your desired total volume of sample as well as the sample 
concentration needed (this will vary depending on which protein you are 
probing for; optimization is recommended). Then using the results from the 
Bradford assay calculate your sample volume, sample buffer volume, water 
volume and DTT volume (if needed). 
 
 
Total Volume (TV) Optional 25 - 100 L 
Sample Volume (SV) 
  
SV = TV ·
[Desired Final Protein]
[Protein]  
Sample (Laemelli) Buffer (SB) 
  
SB f =
TV
[SBi]
 (i.e. 
TV
5
 for 5x SBi)
 
Water (dH20) 
  
dH2O= TV - SV - SB 
1M DTT (optional) = 10% of total volume 
 
References 
Bradford MM. (1976). A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein–dye binding. Anal 
Biochem, 72, 248–54. 
 
 
SDS PAGE Procedure 
 
Electrophoresis Preparation: 
 
1. Before using glass plates, wipe with methanol and a kimwipe 
2. Assemble the glass-holding apparatus with the short plate facing front. 
Ensure plates are flush and level before locking and inserting onto the gel 
casting stand 
3. Prepare gels (makes 2): 
 
Percent Gel dH2O (ml) 
Protogel (ml) 
(30% acrylamide) 
Gel Buffer (ml) 
 
  4 (Stacking) 6.1 1.3 2.5 Stacking 
  6 5.3 2.0 2.5 Resolving 
  8 4.62 2.67 2.5 Resolving 
  10 (Running) 3.96 3.33 2.5 Resolving 
  12 3.29 4.0 2.5 Resolving 
  15 2.29 5.0 2.5 Resolving 
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4. Before pouring the running gel, add 100L APS (60mg/600L) and 10L of 
TEMED. Swirl and pour until reaching the depth of the comb. Use methanol 
to remove any bubbles and dump once hardened 
5. Before pouring the stacking gel, add 100L APS and 20L TEMED. Swirl and 
pour until the top of the short plate is reached. Insert combs of desired size. 
Once hardened, remove combs and rinse with dH2O 
6. Place gel cassettes into electrode assembly with the short plates facing 
inwards, clamp down firmly and place into mini-tank 
7. Boil samples for 5-minutes and place subsequently on ice for 5-minutes 
while preparing running buffer (50mL 10x running buffer + 450mL dH2O) 
8. Fill the inner chamber of the apparatus with diluted running buffer add 
~200mL to the outside chamber 
9. Load the standard (5ul) and the appropriate amount of sample into each 
well. (Note: to determine the appropriate amount of sample to load, perform 
a separate optimization with varying amounts of protein). 
10. Run electrophoresis at 120-volts for 90-minutes or until the blue dye travels 
to the bottom edge of the plate. If tiny bubbles rise then electrophoresis is 
working. Prepare transfer buffer. 
 
Transfer 
1. Remove gels carefully, discard the stacking gel, and transfer to a plastic tray 
to equilibrate in transfer buffer 
2. Soak all transfer materials in freshly prepared transfer buffer to equilibrate 
before electrophoresis. 
3. Create the "transfer sandwich" in a shallow container filled with transfer 
buffer: 
 white/clear side of the holder 
 sponge/ fibre pad (presoaked in transfer buffer) 
 filter paper (presoaked in transfer buffer) 
 membrane (PVDF presoaked in methanol) 
 Gel 
 filter paper (presoaked in transfer buffer) 
 sponge/ fibre pad (presoaked in transfer buffer) 
 black side of the holder 
*Be sure to roll out any air bubbles, close firmly, and place the black side of the 
holder to the black (/back) side of the electrophoresis apparatus. 
4. Fill the tank with transfer buffer and the surrounding environment with 
plenty of ice to prevent from cooking the gel and add a stir-bar to help with 
heat loss. 
5. Run the transfer at 100-volts for 60-minutes 
 
Determining efficient transfer: 
 
6. Place the membrane in a disposable square petri dish with the proteins 
facing upward. 
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7. Add 10 ml Ponceau S solution to stain protein bands. Rock until stained 
bands are visible (~10min). 
8. Pour off Ponceau S solution. Rinse membrane in dH20 to wash off excess 
stain. Repeat as necessary. 
9. Place membrane between transparent film and scan an image for future 
reference of total protein content in each lane 
(Hint: this step is crucial towards eliminating any error that may have occurred 
during sample loading.  At times protein of interest contents must be normalized to 
total protein contents in order to control for any error during sample loading.) 
10. Rinse the membrane in TBST until stain has disappeared then continue to 
next step.  
 
Antibodies 
 
1. Discard the gel and filter papers and transfer the membranes to small dishes 
2. Block with 20mL TBST-5% skim milk or TBST-3% BSA solution for 1-hour 
3. Discard blocking solution and add 1o AB in TBST-% skim milk or TBST-% 
BSA, incubating for 1-hour or overnight with the appropriate dilution 
 
Antibody Size (kDa) Dilution Blocking 
Solution 
1o AB 
solution 
PLIN2 48 (apparent 
at 52) 
1:1000 5% milk 3% milk 
PLIN3 47 1:1000 5% BSA 1% BSA 
PLIN5 50.8 
(apparent 
52) 
1:1000 5% milk 3% milk 
ATGL 50 1:1000 5% BSA 5% BSA 
CGI-58 42 1:1000 2% milk 2% milk 
 
4. Wash 3-5x 5-minutes with TBST (10mL) 
5. Add 2o Ab (dependent on 1o Ab) in TBST-% skim milk or TBST-% BSA 
solution for 1-hour with the appropriate dilution 
 
1o Ab 2o Ab Dilution Solution 
PLIN2 Anti-mouse 1:10000 3%milk 
PLIN3 Anti-rabbit 1:10000 1% BSA 
PLIN5 Anti-guinea pig 1:10000 3% milk 
ATGL Anti-rabbit 1:10000 5% BSA 
CGI-58 Anti-rabbit 1:20000 2% milk 
 
 
Enhanced Chemiluminesence 
 
1. Wash 3x 5-minutes with TBST  
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2. Combine 1mL of each chemiluminescent HPR substrate (peroxide solution + 
luminal reagent) over membrane and continue to pipette over membrane or 
let rock for 5-minutes 
3. Place membrane protein-side down on transparency sheet cover back with 
another transparency sheet 
4. Take an initial photo with a pin beside the standard that represents the 
weight of your protein for overlapping later if need be. Take a subsequent 
photo with the appropriate exposure time and analyze later with "Imagej". 
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Representative blots: 
 
 
A. Representative blot for ATGL or soleus whole homogenate (10, 20 30, 37.5ug) 
 
 
B. Representative blot for CGI-58 of soleus whole homogenate (10, 20 30, 37.5ug) 
 
 
C. Representative blot for PLIN2 in soleus whole homogenate (5, 8, 10, 12, 15 ug) 
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D. Representative blot for PLIN3 in soleus whole homogenate (10, 15, 20 ug). 
 
 
E. Representative blot for PLIN5 in soleus whole homgenate, showing the effects of 
boiling (Lanes: no boil, 30s, 1min, 2min, 5min). 
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e. Co-immunoprecipitation of proteins 
 
Principle:  
 
1. 10x Stock Phosphate Buffered Saline (PBS) – pH 7.4 
 1.37 M NaCl 
 30 mM KCl 
 80 mM Na2HPO4 
 30 mM KH2PO4 
 ddH2O (100 mL final volume) 
 Dilute to 1x PBS as needed 
 
2. Homogenization buffer (Griffin) 
 150 mM NaCl  
 50 mM TrisCl  
 1 mM EGTA 
 
Sample Homogenization: 
 
The homogenization procedure is the same as that described for standard Western 
blotting, however the homogenization buffer differs. Homogenization buffer 
components can and will influence the efficiency of the IP reaction and detergent 
composition is a major factor for IP reactions.  The choice to use a homogenization 
buffer that did not contain detergents in this thesis was made because co-
immunoprecipitation depends so much on antibody-antigen binding and protein-
protein interactions.  Further, the ability to maintain stable physiological 
interactions throughout the mechanical and chemical stresses of the incubation and 
washing steps is a critical factor when performing a co-IP reaction. Therefore for co-
IP, the homogenization buffer should be relatively mild so as not to disrupt the 
protein-protein interactions. In our case it was important to preserve protein-
protein interactions and to minimize denaturation, therefore a buffer without ionic 
or non-ionic detergents was used. We believe that the homogenization and 
disruption of the lipid droplets using with detergent-free buffer was achieved by 
physical disruption using a Dounce homogenizer, and freezing and thawing of the 
samples.  
 
Immunoprecipitation procedure: 
 
1. Using previously collected protein concentrations from the Bradford assay, 
incubate 500-1000ug or protein from whole homogenates with 5ul of 
primary antibody. (Note: optimal protein content for incubation will need to 
be optimized) 
2. Incubate samples for 2 hours at 4° C with gentle agitation  
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3. Add 20 ul of agarose A or G beads to the samples. Incubate all samples 
overnight at 4° C with gentle agitation. (Note: when pipetting agarose beads 
cut the pipette tip). 
4. Collect pellet by centrifugation at 2,500 rpm (approximately 1,000xg) for 5-
10 seconds. A touch spin will work. With enough samples, gravity will pellet 
the beads as well.  
5. Carefully aspirate and discard supernatant. The trick here is to slowly 
aspirate using a gel loading pipette tip (or syringe and needle) touching just 
the top of the liquid and slowly draw down so that you are pulling at the 
surface tension of the supernatant. This will ensure no loss of beads. Note: 
when optimizing keep the supernatant to ensure that all protein of interest 
has been collected in the pellet.  
 
Figure a. Western blot of ATGL.  Lane 1 is IP ATGL and lane 2 is the supernatant left 
over from the IP, showing that we have fully isolated ATGL with our IP methods 
 
 
 
 
 
 
 
 
 
 
 
6. Wash pellet 3 times with ~500ul PBS (a more stringent buffer can be used if 
needed), each time repeating centrifugation step above. 
7. After final wash resuspend pellet in 40ul of 2x sample buffer. 
8. Boil samples in order to separate the protein of interest from the bead.  
Samples are now prepared for gel electrophoresis.  
 
Note: 
When doing co-immunoprecitpitation one of the most commonly encountered 
problems with both IP and co-IP approaches is interference from antibody bands 
during Western blotting.  Detection of the antibody (light and heavy chain, ~25 and 
~50kDa bands, in SDS-PAGE gels, respectively) used to pull out the protein of 
interest during the co-IP can interfere with the interpretation of the results from a 
Western blot.  The ideal situation would be to analyze the co-IP without 
contamination of the eluted antigen with antibody; with this potential interference 
eliminated, only the co-precipitated proteins would be present and detected on the 
gel.  In developing the methods to examine each protein interaction for this study 
we tried several different approaches in order to eliminate antibody interference.  
Other than traditional co-IP we tried two methods to avoid this problem: 1) using a 
detection reagent that does not recognize the denatured antibody fragment (Pierce 
secondary, The Clean-Blot IP Detection Reagent) and 2) antibody immobilization 
(Pierce Co-IP Kit). 
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Figure b. Immunoblot of rested and stimulated muscles showing significant 
antibody interference in the “blank” lane that only contains buffer and the IP 
antibody. 
 
 
 
References 
Elion, E. A. (2006). Detection of protein–protein interactions by coprecipitation. 
Current Protocols in Neuroscience, 35, 5.25.1–5.25.10. 
Rest Blank Stim 
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f. Immunoprecipitation of serine–phosphorylated proteins 
 
Reagents 
 
 Pierce Co-immunoprecipitation Kit (#26149) 
 7,8–dihydroxycoumarin 
 
Note: Due to significant antibody interference when immunoprecipitating all serine 
phosphorylated proteins and blotting for PLIN2, PLIN3, or PLIN5, the Pierce co-
immunoprecipitation kit was utilized.  This kit enables isolation of native protein 
complexes from a lysate by directly immobilizing antibodies to an agarose support. 
The antibodies are covalently coupled onto an amine-reactive resin therefore 
resolving issues with antibody inference. 
 
Procedure 
As described by the instruction provided with the Pierce Co-immunoprecipitation 
(Co-IP) kit. 
 
Anti body immobilization 
1. 40 ul of anti-phosphoserine primary antibody was used when preparing the 
antibody resin  
 
Sample Preparation 
 
1. Skeletal muscle homogenization is as described in Appendix d Western 
Blotting, with the addition of a kinase inhibitor (200 μm of 7,8–
dihydroxycoumarin) to the buffer 
2. Using previously collected protein concentrations from the Bradford assay, 
aliquot 500 μg of protein per sample was added to the antibody resin. 
 
 
 
References 
 
1. Yang, E. B., Zhao, Y. N., Zhang, K., & Mack, P. (1999). Daphnetin, one of coumarin 
derivatives, is a protein kinase inhibitor. Biochemical and Biophysical Research 
Communications, 260, 682–685. 
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g. Sigma medium 199 
 
Product Name Medium 199 
Product Number M4530 
  
TEST SPECIFICATION 
APPEARANCE CLEAR SOLUTION 
PH TEST 7.0-7.6 
OSMOLALITY TEST 280-310 mOsm•kg-1 
STERILITY BY USP STERILE 
ENDOTOXIN ASSAY NMT 1EU/ML 
GLUCOSE CONTENT 0.9-1.1 g•-1 
CELL CULTURE TEST PASS 
EXPIRATION DATE 12 MONTHS 
 
 
Components    M4530 
     [1X] 
     g•L-1 
Inorganic Salts 
CaCl2·2H2O    0.265 
Fe(NO3)3·9H2O     0.00072 
MgSO4 (anhyd)    0.9767 
KCl     0.4 
KH2PO4     -- 
Na·Acetate (anhyd)   0.05 
NaHCO3    2.2 
NaCl     6.8  
Na2HPO4 (anhyd)   -- 
NaH2PO4 (anhyd)   0.122 
 
 
Amino Acids 
DL-Alanine    0.05 
L-Arginine·HCl    0.07 
DL-Aspartic Acid   0.06 
L-Cysteine·HCl·H20   0.00011 
L-Cystine·2HCl    0.026 
DL-Glutamic Acid   0.1336 
L-Glutamine    0.1 
Glycine     0.05 
L-Histidine·HCl·H2O   0.02188 
Hydroxy-L-Proline   0.01 
DL-Isoleucine    0.04 
DL-Leucine    0.12 
L-Lysine·HCl    0.07 
DL-Methionine    0.03 
DL-Phenylalanine   0.05 
L-Proline    0.04 
DL-Serine    0.05 
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DL-Threonine    0.06 
DL-Tryptophan    0.02 
L-Tyrosine 2Na·2H20   0.05766 
DL-Valine    0.05 
 
 
Vitamins 
Ascorbic Acid·Na   0.000056 
D-Biotin    0.00001 
Calciferol    0.0001 
Choline Chloride   0.0005  
Folic Acid    0.00001 
Menadione (sodium bisulfite)  0.000016 
myo-Inositol    0.00005 
Niacinamide    0.000025 
Nicotinic Acid    0.000025 
p-Amino Benzoic Acid   0.00005 
D-Pantothenic Acid·½Ca  0.00001 
Pyridoxal·HCl    0.000025 
Pydridoxine·HCl    0.000025 
Retinol Acetate    0.00014 
Riboflavin    0.00001 
DL-α-Tocopherol Phosphate·Na  0.00001 
Thiamine·HCl    0.00001 
 
Other 
Adenine Sulfate    0.01 
Adenosine Triphosphate·2Na  0.001 
Adenosine Monophosphate·Na  0.000238 
Cholesterol    0.0002 
Deoxyribose    0.0005 
Glucose    1.0    (5.5 mmol/L – same as blood glucose) 
Glutathione (reduced)   0.00005 
Guanine·HCl    0.0003 
HEPES (synthetic buffer)    -- 
Hypoxanthine    0.0003 
Phenol Red·Na    0.0213 (pH indicator) 
Tween 80    0.02 
Ribose     0.0005 
Thymine    0.0003 
Uracil     0.0003 
Xanthine·Na    0.000344 
 
 
References 
1. Morgan, J. F., Campbell, M. E., & Morton, H. J. (1955). The nutrition of animal 
tissues cultivated in vitro. I. A survey of natural materials as supplements 
to synthetic medium 199. Journal of the National Cancer Institute, 16, 
557–567. 
2. Morgan, J. F., Morton, H. J., & Parker, R. C. (1950). Nutrition of animal cells in 
tissue culture; initial studies on a synthetic medium. Proceedings of the 
Society for Experimental Biology and Medicine, 73, 1–8. 
 
